Uric acid activates NFκB in a variety of cell culture models including proximal tubular cells. Uric acid suppresses 1-α hydroxylase mRNA and protein expression in dose dependent and time dependent manner.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | Hydroxylase ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ro 61-8048 |
+++
KMO, IC50: 37 nM KMO, Ki: 4.8 nM |
99%+ | |||||||||||||||||
DMOG | ✔ | 98% | |||||||||||||||||
Nepicastat HCl |
+++
Human dopamine-beta-hydroxylase, IC50: 9 nM Bovine dopamine-beta-hydroxylase, IC50: 8.5 nM |
98% | |||||||||||||||||
Telotristat etiprate | ✔ | 99%+ | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | Uric acid acts as a scavenger of oxygen radicals and is a crucial antioxidant that helps maintain blood pressure stability and manage oxidative stress. It effectively removes reactive oxygen species (ROS) such as singlet oxygen and peroxynitrite, thus preventing lipid peroxidation[1].[2]. |
体内研究 | Uric acid, administered orally at a dose of 250 mg/kg, mitigates indomethacin-induced enteropathy[2]. Oral administration of uric acid decreased ROS accumulation in the ileum in a mouse model of indomethacin-induced enteropathy[2]. |
体外研究 | In experimental settings, Uric acid at a concentration of 400 μM for 48 hours protects Caco-2 cells from lipid peroxidation induced by indomethacin[2]. Co-treatment of cells with Indomethacin and Uric acid (200 μM IND plus 400 μM UA for 24 hours) significantly reduces ROS levels compared to cells treated with indomethacin alone. Additionally, cell viability is enhanced in Caco-2 cells treated with both Indomethacin and Uric acid compared to those treated with only indomethacin. This indicates that Uric acid provides a protective effect against indomethacin-induced changes in intestinal cells through its antioxidant properties[2]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00664144 | Hyperuricemia | Phase 2 | Terminated(due to poor enrollm... 展开 >>ent) 收起 << | - | Belgium ... 展开 >> Sanofi-Aventis Administrative Office Diegem, Belgium France Sanofi- Aventis Administrative Office Paris, France Germany Sanofi-Aventis Administrative Office Berlin, Germany Italy Sanofi-Aventis Administrative Office Milan, Italy 收起 << |
NCT00477789 | Chronic Heart Failure | Phase 4 | Completed | - | Italy ... 展开 >> Division of Cardiology, University Hospital of Verona Verona, Italy, 37129 收起 << |
NCT00290992 | Nutritional and Metabolic Dise... 展开 >>ases 收起 << | Phase 2 | Completed | - | Japan ... 展开 >> Sanofi-Aventis Tokyo, Japan 收起 << |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
5.95mL 1.19mL 0.59mL |
29.74mL 5.95mL 2.97mL |
59.48mL 11.90mL 5.95mL |
CAS号 | 69-93-2 |
分子式 | C5H4N4O3 |
分子量 | 168.11 |
别名 | |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,Room Temperature |
溶解度 |
H2O: 6 mg/mL(35.69 mM),配合低频超声,并调节pH至10 1M NaOH: 8 mg/mL(47.59 mM),配合低频超声,水浴加热至45℃,并调节pH至12 |
动物实验配方 |
Tags: Uric acid | Drug Standard | Bile Acid | Hydroxylase | AmBeed-信号通路专用抑制剂 | Uric acid 纯度/质量文件 | Uric acid 亚型比较 | Uric acid 生物活性 | Uric acid 临床数据 | Uric acid 参考文献 | Uric acid 实验方案 | Uric acid 技术信息
请填写此表格索取QC报告。我们很快就会发送到您的邮箱。您的信息在我们这里是安全的。*是必填项.
靶点 | 数值 |
需要的总药量: mg
您需要配制的工作液浓度为:mg/mL
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00664144 | Hyperuricemia | Phase 2 | Terminated(due to poor enrollm... 展开 >>ent) 收起 << | - | Belgium ... 展开 >> Sanofi-Aventis Administrative Office Diegem, Belgium France Sanofi- Aventis Administrative Office Paris, France Germany Sanofi-Aventis Administrative Office Berlin, Germany Italy Sanofi-Aventis Administrative Office Milan, Italy 收起 << |
NCT00477789 | Chronic Heart Failure | Phase 4 | Completed | - | Italy ... 展开 >> Division of Cardiology, University Hospital of Verona Verona, Italy, 37129 收起 << |
NCT00290992 | Nutritional and Metabolic Dise... 展开 >>ases 收起 << | Phase 2 | Completed | - | Japan ... 展开 >> Sanofi-Aventis Tokyo, Japan 收起 << |
NCT00174915 | Gout | Phase 3 | Completed | - | - |
NCT00325195 | Gout | Phase 3 | Completed | - | - |
NCT02187029 | Gout | Phase 1 | Terminated(B7911002 was premat... 展开 >>urely discontinued due to a safety concern that led to decision to terminate the study on 10 Nov 2014) 收起 << | - | United States, Florida ... 展开 >> MRA Clinical Research, LLC Miami, Florida, United States, 33143 Miami Research Associates, Inc. South Miami, Florida, United States, 33143 United States, Kansas Vince and Associates Clinical Research Inc. Overland Park, Kansas, United States, 66211 Vince and Associates Clinical Research, Inc. Overland Park, Kansas, United States, 66212 收起 << |
NCT00325195 | - | Completed | - | - | |
NCT00174915 | - | Completed | - | - | |
NCT01472692 | Prehypertension ... 展开 >> Gout Pulse Wave Velocity Hypertension 24 Hour Blood Pressure 收起 << | Phase 4 | Completed | - | United States, California ... 展开 >> Univerisity Of California San Diego San Diego, California, United States, 92037 收起 << |
NCT03511248 | Heart Failure ... 展开 >> Heart Failure, Systolic 收起 << | Phase 2 | Recruiting | December 2020 | United Kingdom ... 展开 >> Queen Mary University of London Recruiting London, United Kingdom Contact: Prof Amrita Ahluwalia, BSc PhD a.ahluwalia@qmul.ac.uk Contact: Dr Christopher P Primus, MBBS BSc MRCP c.primus@qmul.ac.uk Principal Investigator: Amrita Ahulwalia, BSc PhD Sub-Investigator: Christopher P Primus, MBBS BSc MRCP Principal Investigator: Simon Woldman, MD FESC FRCP Principal Investigator: Ceri Davies, MD FRCP FESC Sub-Investigator: Charlotte Manisty, MBBS PhD MRCP Sub-Investigator: Shanti Velmurugan, MBBS PhD MRCP Sub-Investigator: Clement Lau, MBChB BMedSci MRCP Sub-Investigator: Krishnaraj Rathod, MBBS BMedSci MRCP 收起 << |
NCT03506919 | Treatment of Arthritis | Phase 1 Phase 2 | Recruiting | June 30, 2018 | Pakistan ... 展开 >> clinical trial was conducted in Bahawalpur, and Rawalpindi Recruiting Bahawalpur, Punjab, Pakistan, 062 Contact: Muhammad Asif, Ph.D 923346911256 doctor.asif101@gmail.com Principal Investigator: Muhamamd Bilal, M. PHil 收起 << |
NCT02129764 | Heart Failure, Hyperuricemia | Phase 2 Phase 3 | Completed | - | China, Hebei ... 展开 >> Shijiazhuang, Hebei, China, 050031 收起 << |
NCT02187029 | - | Terminated(B7911002 was premat... 展开 >>urely discontinued due to a safety concern that led to decision to terminate the study on 10 Nov 2014) 收起 << | - | - | |
NCT01973088 | - | Unknown | - | - | |
NCT00174967 | Gout | Phase 2 | Completed | - | - |
NCT00174967 | - | Completed | - | - | |
NCT01077284 | Hyperuricosuria ... 展开 >> Kidney Stones 收起 << | Phase 2 | Completed | - | - |
NCT02837198 | Hyperuricemia | Phase 2 | Completed | - | Japan ... 展开 >> Tokyo, Japan 收起 << |
NCT01077284 | - | Completed | - | - | |
NCT00111657 | Gout | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << |
NCT01510769 | Tophaceous Gout | Phase 3 | Completed | - | - |
NCT00111657 | - | Completed | - | - | |
NCT02038179 | Pre-hypertension ... 展开 >> JNC 7 Stage I Hypertension 收起 << | Phase 2 Phase 3 | Completed | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 收起 << |
NCT02371421 | Hyperuricemia, Gout | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01510769 | - | Completed | - | - | |
NCT01568879 | Recurrent or Tophaceous Gout | Not Applicable | Completed | - | United States, California ... 展开 >> Kaiser Permanente Northern California Medical Facilities All KPNC Facilities, California, United States 收起 << |
NCT03495999 | - | Terminated(The study interest ... 展开 >>was reached) 收起 << | - | Taiwan ... 展开 >> Tri-service General Hospital, songshan branch Taipei, Songshan Dist., Taiwan, 105 收起 << | |
NCT02614469 | Healthy | Phase 1 | Completed | - | United States, Indiana ... 展开 >> Covance Clinical Research Unit Inc. Evansville, Indiana, United States, 47710 收起 << |
NCT02500641 | Gout | Phase 4 | Completed | - | Germany ... 展开 >> Dresden, Germany Italy Avezzano, Italy Bologna, Italy Brescia, Italy Chieti, Italy Coppito, Italy Netherlands Reade Amsterdam, Netherlands Poland Gdansk, Poland Grudziadz, Poland Katowice, Poland Krakow, Poland Lodz, Poland Warsaw, Poland Zgierz, Poland Romania Bucharest, Romania Craiova, Romania Timisoara, Romania Serbia Belgrade, Serbia 收起 << |
NCT03157960 | Chronic Kidney Diseases ... 展开 >> Diabetes Mellitus, Type 2 收起 << | Not Applicable | Recruiting | November 30, 2019 | Sweden ... 展开 >> Karolinska University Hospital Recruiting Stockholm, Sweden, 17176 Contact: Neda R Ekberg, M.D./Ph.D. +46-51770000 neda.ekberg@ki.se 收起 << |
NCT00921375 | Hyperuricemia | Phase 3 | Completed | - | India ... 展开 >> Dr. Raghunathrao Hyd, Andhra Pradesh, India 收起 << |
NCT03375632 | Hyperuricemia With or Without ... 展开 >>Gout 收起 << | Phase 1 | Completed | - | Japan ... 展开 >> Mochida Investigational sites Tokyo, Japan 收起 << |
NCT03353298 | Renal Transplant Donor of Left... 展开 >> Kidney Renal Transplant Donor of Right Kidney 收起 << | Phase 2 | Recruiting | December 31, 2021 | Norway ... 展开 >> Oslo University Hospital Recruiting Oslo, Norway Contact: NE Langberg nlangb@ous-hf.no Contact: DO Dahle dagdah@ous-hf.no Principal Investigator: DO Dahle 收起 << |
NCT02614469 | - | Completed | - | - | |
NCT01407874 | Gout Hyperuri... 展开 >>cemia Arthritis Joint Disease Renal Insufficiency 收起 << | Phase 2 | Completed | - | United States, Alabama ... 展开 >> Mobile, Alabama, United States, 36608 United States, Arizona Peoria, Arizona, United States, 85381 United States, California Irvine, California, United States, 92618 United States, Florida Oldsmar, Florida, United States, 34677 United States, Hawaii Honolulu, Hawaii, United States, 96814 United States, Kansas Newton, Kansas, United States, 67114 United States, Tennessee Knoxville, Tennessee, United States, 37923 United States, Texas Dallas, Texas, United States, 75235 San Antonio, Texas, United States, 78215 United States, Virginia Alexandria, Virginia, United States, 22304 收起 << |
NCT02797028 | Cardiovascular Disease | Phase 4 | Unknown | December 2017 | China, Guangdong ... 展开 >> General Hospital of Guangzhou Military Command of People's Liberation Army Recruiting Guangzhou, Guangdong, China, 020 Contact: Hui Dai 020-36653321 daihui66@sina.com Contact: Yuan Zhang 020-61653566 1035834805@qq.com 收起 << |
NCT01320722 | Renal Function ... 展开 >> Endothelial Function Blood Pressure Overweight Obesity 收起 << | Phase 3 | Completed | - | United States, Massachusetts ... 展开 >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 收起 << |
NCT03162341 | Gout | Not Applicable | Recruiting | November 2020 | France ... 展开 >> Hospital Group of the Catholic Institute Recruiting Lomme, France, 59462 Contact: Amélie Lansaux, MD PhD Principal Investigator: Tristan Pascart, MD Bichat Hospital Recruiting Paris, France, 75018 Contact: Sébastien Ottaviani, MD sebastien.ottaviani@aphp.fr Lariboisière Hospital Recruiting Paris, France, 75475 Contact: Pascal Richette, MD PhD pascal.richette@aphp.fr 收起 << |
NCT00985127 | Gout | Phase 2 | Completed | - | - |
NCT01564277 | Adult Acute Myeloid Leukemia W... 展开 >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Blastic Phase Chronic Myelogenous Leukemia Contiguous Stage II Adult Burkitt Lymphoma de Novo Myelodysplastic Syndromes Noncontiguous Stage II Adult Burkitt Lymphoma Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Stage I Adult Burkitt Lymphoma Stage III Adult Burkitt Lymphoma Stage IV Adult Burkitt Lymphoma Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia 收起 << | Phase 2 | Terminated(low accrual) | - | United States, New York ... 展开 >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 收起 << |
NCT01320722 | - | Completed | - | - | |
NCT00738842 | Gout Coronary... 展开 >> Artery Disease 收起 << | Phase 1 | Completed | - | - |
NCT02984358 | Healthy | Not Applicable | Completed | - | - |
NCT02903446 | Gout | Phase 2 | Recruiting | December 2019 | United States, Alabama ... 展开 >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Jeff Foster, MPH 205-996-6086 pjfoster@uabmc.edu Principal Investigator: Angelo L Gaffo, MD, MPH 收起 << |
NCT01564277 | - | Terminated(low accrual) | - | - | |
NCT00987415 | Heart Failure ... 展开 >> Elevated Serum Uric Acid 收起 << | Phase 2 | Completed | - | United States, Georgia ... 展开 >> Morehouse School of Medicine Atlanta, Georgia, United States United States, Massachusetts Harvard University Boston, Massachusetts, United States United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States Mayo Clinic Rochester, Minnesota, United States United States, North Carolina Duke University Medical Center Durham, North Carolina, United States United States, Ohio University Hospitals-Case Medical Center Cleveland, Ohio, United States, 44106 United States, Texas Baylor College of Medicine Houston, Texas, United States United States, Utah Univ. of Utah Health Sciences Center Salt Lake City, Utah, United States United States, Vermont University of Vermont Burlington, Vermont, United States Canada University of Montreal Montreal PQ, Canada 收起 << |
NCT02642393 | Parkinson's Disease | Phase 3 | Active, not recruiting | October 2019 | - |
NCT03211403 | Gout Hyperuri... 展开 >>cemia 收起 << | Phase 1 | Completed | - | Australia, New South Wales ... 展开 >> Atridia Pty Limited Sydney, New South Wales, Australia, 2000 收起 << |
NCT01425125 | Cerebral Hyponatremia ... 展开 >> SIADH Cerebral Salt-wasting Syndrome Reset Hypothalamic Osmostat 收起 << | Not Applicable | Withdrawn | - | United States, New York ... 展开 >> Winthrop-University Hospital Mineola, New York, United States, 11501 收起 << |
NCT03648996 | Diabetes Mellitus, Type 2 ... 展开 >> Hyperuricemia 收起 << | Phase 2 | Not yet recruiting | September 30, 2021 | - |
NCT00230178 | - | Completed | - | - | |
NCT03336203 | Gout CKD Stag... 展开 >>e 1-4 SUA Level (>8 mg/dL; 480 µmol/L) 收起 << | Phase 4 | Recruiting | March 1, 2021 | Ukraine ... 展开 >> Medical Practice Prof D.Ivanov Recruiting Kiev, Ukraine, 01014 Contact: Dmytro Ivanov, MD, Prof 504448788 ivanovdd@i.kiev.ua Sub-Investigator: Tatyana B Bevzenko, MD, PhD Sub-Investigator: Oleg B Synyachenko, MD, PhD, Prof Sub-Investigator: Iryna Yu Golovach, MD, PhD, Prof 收起 << |
NCT03218709 | Hyperuricemia | Phase 4 | Recruiting | April 2018 | China, Guangdong ... 展开 >> Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Min Xia, Ph.D xiamin@mail.sysu.edu.cn Contact: Yi Guo, Ph.D guoyi_019@126.com 收起 << |
NCT00230178 | Tumor Lysis Syndrome ... 展开 >> Cancer Hyperuricemia 收起 << | Phase 3 | Completed | - | United States, California ... 展开 >> Alta Bates Comprehensive Cancer Center Berkeley, California, United States, 94704 UCLA Medical Center Los Angeles, California, United States, 90095 United States, Colorado Rocky Mountain Cancer Center Denver, Colorado, United States, 80218 United States, Florida University of Florida Health Science Center at Jacksonville Jacksonville, Florida, United States, 32209 United States, Louisiana Ochsner Clinic Foundation New Orleans, Louisiana, United States, 70121 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York New York Methodist Hospital Brooklyn, New York, United States, 11215 Roswell Park Cancer Institute Buffalo, New York, United States, 14263 University of Rochester Medical Center Rochester, New York, United States, 14642 New York Medical College Valhalla, New York, United States, 10595 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Oregon Oregon Health and Sciences University Portland, Oregon, United States, 97201 United States, Pennsylvania University of Pennsylvania Health Systems Philadelphia, Pennsylvania, United States, 19194 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, West Virginia Mary Babb Randolph Cancer Center Morgantown, West Virginia, United States, 26506-9162 收起 << |
NCT00756964 | Hyperuricemia | Phase 2 | Completed | - | United States, Florida ... 展开 >> University of Florida Gainesville, Florida, United States, 32610 收起 << |
NCT00756964 | - | Completed | - | - | |
NCT00987415 | - | Completed | - | - | |
NCT03361618 | Infertility Unexplained | Not Applicable | Completed | - | Iraq ... 展开 >> Mahmoud Hussein Hadwan Hilla, Babylon, Iraq, 51002 收起 << |
NCT03569020 | Gout Hyperuri... 展开 >>cemia 收起 << | Not Applicable | Recruiting | June 30, 2019 | United States, Maryland ... 展开 >> Johns Hopkins ProHealth Research Clinic Recruiting Woodlawn, Maryland, United States, 21207 Contact: Jeanne Charleston, RN 410-281-1600 digo@jhu.edu Contact: Beiwen Wu, MSPH 410-281-1600 digo@jhu.edu Principal Investigator: Edgar R Miller, MD, PhD Sub-Investigator: Stephen P Juraschek, MD, PhD United States, Massachusetts Massachusetts General Hospital Active, not recruiting Boston, Massachusetts, United States, 02114 收起 << |
NCT02063997 | Gout | Phase 2 | Completed | - | - |
NCT02671656 | - | Unknown | April 2016 | France ... 展开 >> Service de Rhumatologie, Hôpital Lariboisière Not yet recruiting Paris, France, 75010 Contact: Thomas BARDIN, MD, PhD 33 1 49 95 62 90 thomas.bardin@lrb.aphp.fr 收起 << | |
NCT03580226 | - | Completed | - | - | |
NCT03274063 | Gout | Not Applicable | Not yet recruiting | March 2021 | - |
NCT01881919 | Hyperuricemia ... 展开 >> Gout Kidney Calculi Diabetes Cardiovascular Disease 收起 << | Early Phase 1 | Completed | - | United Kingdom ... 展开 >> School of Food Science and Nutrition Leeds, West Yorkshire, United Kingdom, LS2 9JT 收起 << |
NCT02344602 | Type 1 Diabetes Mellitus | Phase 4 | Completed | - | Canada, Ontario ... 展开 >> Renal Physiology Laboratory, University Health Network Toronto, Ontario, Canada, M5G 2N2 收起 << |
NCT03168711 | Amyotrophic Lateral Sclerosis | Phase 2 | Recruiting | January 2020 | United States, Florida ... 展开 >> Holy Cross Hospital Recruiting Fort Lauderdale, Florida, United States, 33308 Contact: Lindita Burba 954-489-4314 Lindita.burba@holy-cross.com Contact: Franco Salas 954-229-7965 franco.salas@holy-cross.com Principal Investigator: Eduardo Locatelli, MD, MPH United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Jianing (Ning) Liu 617-726-1880 jliu45@mgh.harvard.edu Principal Investigator: Katharine Nicholson, MD United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Valerie Ferment 612-301-1535 ferm0016@umn.edu Principal Investigator: David Walk, MD 收起 << |
NCT00793585 | - | Completed | - | - | |
NCT02598596 | Gout | Phase 2 | Recruiting | April 2020 | United States, Alabama ... 展开 >> University of Alabama at Birminingham Recruiting Birmingham, Alabama, United States, 35294 Rheumatology Associates of North Alabama Recruiting Huntsville, Alabama, United States, 35801 United States, California Pacific Arthritis Center Medical Group Withdrawn Santa Maria, California, United States, 93454 United States, Maryland The Center for Rheumatology and Bone Research Recruiting Wheaton, Maryland, United States, 20902 United States, Massachusetts Clinical Pharmacology Study Group Recruiting Worcester, Massachusetts, United States, 01609 United States, Michigan Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 United States, Minnesota Saint Paul Rheumatology Recruiting Eagan, Minnesota, United States, 55121 United States, New York Montefiore Medical Center Recruiting Bronx, New York, United States, 10467 Buffalo Rheumatology and Medicine Recruiting Orchard Park, New York, United States, 14127 United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 United States, Pennsylvania Altoona Center for Clinical Research Recruiting Duncansville, Pennsylvania, United States, 16635 United States, South Carolina ACME Research, LLC Recruiting Orangeburg, South Carolina, United States, 29118 收起 << |
NCT00241839 | Cardiovascular Diseases ... 展开 >> Heart Diseases Hypertension 收起 << | Phase 3 | Completed | - | United States, Florida ... 展开 >> University of Florida Gainesville, Florida, United States, 32610 收起 << |
NCT01158911 | - | Completed | - | United States, Massachusetts ... 展开 >> Tufts Medical Center Boston, Massachusetts, United States, 02111 收起 << | |
NCT00833690 | Parkinson Disease | Phase 2 | Completed | - | United States, California ... 展开 >> University of Southern California Los Angeles, California, United States, 90083 United States, Connecticut Eastern Connecticut Neurology Specialists, LLC Manchester, Connecticut, United States, 06040 Institute for Neurodegenerative Disorders New Haven, Connecticut, United States, 06510 United States, Florida Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton, Florida, United States, 33486 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Louisiana Ochsner Clinic Foundation New Orleans, Louisiana, United States, 70121 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Boston University Medical Center Boston, Massachusetts, United States, 02118 United States, Michigan Michigan State University East Lansing, Michigan, United States, 48824 United States, Minnesota Struthers Parkinson's Center Golden Valley, Minnesota, United States, 55427 United States, North Carolina Duke University School of Medicine Durham, North Carolina, United States, 27705 United States, Ohio University of Cincinnati Cincinnati, Ohio, United States, 45219 Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Rhode Island Butler Hospital Movement Disorder Program Providence, Rhode Island, United States, 02906 United States, Texas Scott & White Hospital Temple, Texas, United States, 76508 收起 << |
NCT01112982 | Gout | Phase 4 | Completed | - | United States, Florida ... 展开 >> University of South Florida Medical Clinics Tampa, Florida, United States, 33612-4742 收起 << |
NCT00868673 | Overweight and Obesity ... 展开 >> Metabolic Syndrome Hyperuricemia 收起 << | Not Applicable | Completed | - | Mexico ... 展开 >> Instituto Nacional de Cardiología Igancio Chávez Mexico, Mexico city, Mexico, 14080 收起 << |
NCT03316131 | Asymptomatic Hyperuricemia | Phase 2 | Completed | - | United States, California ... 展开 >> Research Site Glendale, California, United States, 91206 United States, Maryland Research Site Baltimore, Maryland, United States, 21225 收起 << |
NCT03395977 | Oxidative Stress ... 展开 >> Endothelial Function Cardiovascular System Hypertension 收起 << | Not Applicable | Recruiting | December 31, 2020 | Belgium ... 展开 >> Erasme Hospital Recruiting Brussels, Belgique, Belgium, 1070 Contact: Benjamin De Becker +32474328542 Benjamin.De.Becker@erasme.ulb.ac.be Principal Investigator: Benjamin De Becker 收起 << |
NCT00833690 | - | Completed | - | - | |
NCT00978653 | Hyperuricemia ... 展开 >> Chronic Kidney Disease 收起 << | Not Applicable | Completed | - | Turkey ... 展开 >> Istanbul Faculty of Medicine Istanbul, Turkey, 34390 收起 << |
NCT00793585 | IgA Nephropathy | Not Applicable | Completed | - | China, Guangdong ... 展开 >> The 1st Affiliated Hospital, Sun Yet-sen University GuangZhou, Guangdong, China, 510080 收起 << |
NCT01589705 | - | Terminated(Patients recruitmen... 展开 >>t and analysis were terminated) 收起 << | - | Turkey ... 展开 >> Erciyes University Medical School Kayseri, Turkey, 38039 收起 << | |
NCT02959918 | Gout Chronic ... 展开 >>Hyperuricemia 收起 << | Phase 2 | Active, not recruiting | January 2019 | United States, California ... 展开 >> Anaheim Clinical Trials Anaheim, California, United States, 92801 Tri West Research Associates LLC El Cajon, California, United States, 92020 Irvine Center for Clinical Research Inc. Irvine, California, United States, 92614 United States, Florida Clinical Research of West Florida Clearwater, Florida, United States, 33765 Omega Research Consultants LLC DeBary, Florida, United States, 32713 Compass Research LLC Orlando, Florida, United States, 32806 United States, Hawaii East-West Medical Research Institute Honolulu, Hawaii, United States, 96814 United States, Idaho Advanced Clinical Research Boise, Idaho, United States, 83642 United States, Kentucky L-MARC Louisville, Kentucky, United States, 40213 United States, North Carolina Triad Clinical Trials LLC Greensboro, North Carolina, United States, 27410 United States, Ohio New Horizons Clinical Research Cincinnati, Ohio, United States, 45242 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 United States, Utah Advanced Clinical Research West Jordan, Utah, United States, 84088 收起 << |
NCT00241839 | - | Completed | - | - | |
NCT03473951 | - | Recruiting | December 2018 | Taiwan ... 展开 >> Tri-service General Hospital, songshan branch Recruiting Taipei, Songshan Dist., Taiwan, 105 Contact: Liu, MD +886-910682383 issac700319@gmail.com Principal Investigator: Cheng-Wei Liu, MD Sub-Investigator: Wei-Cheng Chang, MD 收起 << | |
NCT02502565 | - | Active, not recruiting | March 2019 | United States, District of Col... 展开 >>umbia Howard University Hospital Washington, District of Columbia, United States, 20060 WashingtonVAMC Washington, District of Columbia, United States, 20422 收起 << | |
NCT02502071 | Type 1 Diabetes ... 展开 >> Diabetic Nephropathy Diabetic Kidney Disease 收起 << | Phase 4 | Completed | - | United States, Colorado ... 展开 >> Barbara Davis Center for Diabetes Aurora, Colorado, United States, 80045 收起 << |
NCT02648269 | Gout | Phase 1 | Completed | - | United States, Arkansas ... 展开 >> Baptist Health Center for Clinical Research Little Rock, Arkansas, United States, 72205 United States, Florida Miami Research Associates Miami, Florida, United States, 33143 Orlando Clinical Research Center, Inc. Orlando, Florida, United States, 32809 United States, Maryland SNBL Clinical Pharmacology Center Inc. Baltimore, Maryland, United States, 21201 United States, Minnesota Davita Clinical Research Minneapolis, Minnesota, United States, 55404 United States, Pennsylvania Altoona Center for Clincal Research Duncansville, Pennsylvania, United States, 16635 收起 << |
NCT02502071 | - | Completed | - | - | |
NCT03118739 | Hyperuricemia ... 展开 >> Albuminuria Type 2 Diabetes 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Research Site Canyon Country, California, United States, 91351 Research Site Chula Vista, California, United States, 91911 Research Site Corona, California, United States, 92882 Research Site Escondido, California, United States, 92025 Research Site Lakewood, California, United States, 90805 Research Site Lincoln, California, United States, 95648 Research Site Los Angeles, California, United States, 90017 Research Site Los Angeles, California, United States, 90022 Research Site Los Angeles, California, United States, 90036 Research Site North Hollywood, California, United States, 91606 Research Site Oceanside, California, United States, 92056-4510 Research Site Orange, California, United States, 92868 Research Site Sacramento, California, United States, 95821 United States, Texas Research Site Houston, Texas, United States, 77058 Research Site Houston, Texas, United States, 77070 Research Site Pearland, Texas, United States, 77584 Research Site Sugar Land, Texas, United States, 77478 Research Site Webster, Texas, United States, 77598 收起 << |
NCT02862522 | - | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << | |
NCT03616418 | - | Enrolling by invitation | August 1, 2020 | - | |
NCT03076684 | Hyperuricemia | Early Phase 1 | Recruiting | December 2019 | United States, Missouri ... 展开 >> University of Missouri Recruiting Columbia, Missouri, United States, 65212 收起 << |
NCT02464605 | Gout | Phase 1 | Completed | - | United States, Pennsylvania ... 展开 >> Altoona Center for Clincal Research Duncansville, Pennsylvania, United States, 16635 United States, Texas Metroplex Clinical Research Center Dallas, Texas, United States, 75231 收起 << |
NCT01532622 | Hyperuricemia | Not Applicable | Completed | - | United States, Mississippi ... 展开 >> University of Mississippi Medical Center Jackson, Mississippi, United States, 39216 收起 << |
NCT01363869 | Hyperuricemia ... 展开 >> Gout 收起 << | Not Applicable | Completed | - | Thailand ... 展开 >> Department of Internal Medicine, Faculty of Medicine, Chiang Mai University Chiang Mai, Thailand, 50200 收起 << |
NCT03568864 | Healthy | Not Applicable | Completed | - | United Kingdom ... 展开 >> St Luke's Campus - University of Exeter Exeter, Devon, United Kingdom, EX1 2LU 收起 << |
NCT00474396 | Healthy | Not Applicable | Completed | - | - |
NCT01830725 | - | Completed | - | United States, Mississippi ... 展开 >> Keesler Medical Center Keesler AFB, Mississippi, United States, 39564 收起 << | |
NCT03425305 | - | Active, not recruiting | February 2019 | - | |
NCT03691688 | - | Recruiting | March 1, 2022 | China, Shanghai ... 展开 >> Shanghai Zhongshan Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Shalaimaiti Shali, MD 86+13761553110 shali@zs-hospital.sh.cn Contact: Yuxiang Dai, MD,PhD +86-13818988550 dai.yuxiang@zs-hospital.sh.cn Principal Investigator: Junbo Ge, Professor 收起 << | |
NCT01368185 | - | Completed | - | - | |
NCT00904046 | Uric Acid Kidney Stone Disease | Not Applicable | Recruiting | December 2019 | United States, Texas ... 展开 >> UT Southwestern Medical Center - Center for Mineral Metabolism Recruiting Dallas, Texas, United States, 75390-8885 收起 << |
NCT02891031 | Hyperuricemia | Not Applicable | Recruiting | November 2017 | Iran, Islamic Republic of ... 展开 >> Shahid Motahhari Clinic, Shiraz University of Medical Sciences Recruiting Shiraz, Fars, Iran, Islamic Republic of Contact: Mesbah Shams, M.D. +989171115134 shams@sums.ac.ir 收起 << |
NCT01931527 | Obesity Metab... 展开 >>olic Syndrome Hyperuricemia 收起 << | Not Applicable | Completed | - | United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 收起 << |
NCT01368185 | - | Completed | - | - | |
NCT01931527 | - | Completed | - | - | |
NCT01825070 | Inflammation | Not Applicable | Completed | - | United Kingdom ... 展开 >> Northumbria University Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST 收起 << |
NCT01228903 | Kidney Disease | Not Applicable | Completed | - | United States, Colorado ... 展开 >> University of Colorado at Denver Aurora, Colorado, United States, 80045 收起 << |
NCT00860366 | Acute Ischemic Stroke | Phase 2 Phase 3 | Completed | - | Spain ... 展开 >> Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Hospital Universitari de Bellvitge Bellvitge, Barcelona, Spain Corporació Sanitària del Parc Taulí Sabadell, Barcelona, Spain, 08208 Hospital Universitari Mútua de Terrassa Terrassa, Barcelona, Spain, 08221 Hospital de Navarra Pamplona, Navarra, Spain, 31008 Hospital General Universitario de Albacete Albacete, Spain, 02006 Hospital de la Santa Creu y Sant Pau Barcelona, Spain, 08025 Hospital Clínic de Barcelona Barcelona, Spain, 08036 Hospital Dr Josep Trueta Girona, Spain, 17007 Hospital Clínico Universitario de Valladolid Valladolid, Spain, 47005 收起 << |
NCT01228903 | - | Completed | - | - | |
NCT03512600 | Lithiasis, Urinary | Not Applicable | Completed | - | Spain ... 展开 >> Universitat de les Illes Balears, IUNICS Palma De Mallorca, Islas Baleares, Spain, 07122 收起 << |
NCT03403309 | Multiple System Atrophy | Phase 2 | Not yet recruiting | December 31, 2018 | - |
NCT01323335 | Healthy Volunteers | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institute of Aging, Clinical Research Unit Baltimore, Maryland, United States, 21224 收起 << |
NCT02561858 | Uric Acid Stones | Not Applicable | Completed | - | France ... 展开 >> CHU de Nice Nice, France, 06000 收起 << |
NCT02563405 | Hypertension | Phase 2 Phase 3 | Unknown | October 2018 | China, Heilongjiang ... 展开 >> uric acid test and 24-hour ambulatory BP monitoring Recruiting Harbin, Heilongjiang, China, 150001 Contact: Yujiao Pan, MM 86-451-85555671 panyujiao@163.com 收起 << |
NCT03306758 | Asymptomatic Hyperuricemia ... 展开 >> Gout 收起 << | Not Applicable | Not yet recruiting | September 30, 2018 | - |
NCT01523327 | - | Unknown | October 2012 | Egypt ... 展开 >> Ain shams maternity hospital Recruiting Cairo, Egypt, 11117 Principal Investigator: nermin marzouk touma, M.B.,B.Ch 收起 << | |
NCT02975986 | Uric Acid Nephrolithiasis | Not Applicable | Recruiting | December 2021 | United States, Texas ... 展开 >> UT Southwestern Medical Center - Center for Mineral Metabolism Recruiting Dallas, Texas, United States, 75390-8885 UT Southwestern Medical Center Active, not recruiting Dallas, Texas, United States, 75390 收起 << |
NCT03531203 | Blood Pressure ... 展开 >> Prehypertension Uric Acid 收起 << | Not Applicable | Completed | - | Indonesia ... 展开 >> Mlati 2 Health Center working area (Sumberadi, Tlogoadi,Tirtoadi) Sleman, Yogyakarta, Indonesia, 55284 收起 << |
NCT03483532 | - | Recruiting | September 2018 | Spain ... 展开 >> Hospital de Manacor Recruiting Manacor, Islas Baleares, Spain, 07500 Contact: Yumaira Elena Hernández Martínez 658666975 yumairah@yahoo.com 收起 << | |
NCT03616769 | - | Completed | - | - | |
NCT03622632 | - | Recruiting | September 2019 | Canada, Quebec ... 展开 >> Hôpital du Sacré-Cœur de Montréal Recruiting Montreal, Quebec, Canada, H4J1C5 Contact: Emmanuel Charbonney, MD PhD 收起 << | |
NCT03752567 | - | Recruiting | October 31, 2019 | Italy ... 展开 >> Farmacia La Regina dott. Rocco Vito Recruiting San Rufo, Salerno, Italy, 84030 Contact: Raffaele La Regina 0975395336 raffaele.laregina@gmail.com 收起 << | |
NCT03006445 | Hyperuricemia With or Without ... 展开 >>Gout 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> Tokyo, Japan 收起 << |
NCT01025076 | Morbid Obesity | Phase 2 | Completed | - | Canada, Alberta ... 展开 >> CAMIS, Royal Alexandra Hospital Edmonton, Alberta, Canada, T5H 3V9 收起 << |
NCT00302653 | Hyperuricemia | Phase 4 | Completed | - | Brazil ... 展开 >> Sanofi-aventis administrative office São Paulo, Brazil 收起 << |
NCT01953497 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of 收起 << |
NCT00610532 | Epilepsy | Phase 4 | Terminated(Investigators decid... 展开 >>ed not to continue) 收起 << | - | United States, Ohio ... 展开 >> The Ohio State University Columbus, Ohio, United States, 43210 收起 << |
NCT03314727 | Hypertension ... 展开 >>Sodium Excess Oxidative Stress Inflammation 收起 << | Not Applicable | Completed | - | Turkey ... 展开 >> Koc University Hospital Istanbul, Turkey, 34010 收起 << |
NCT00002297 | Lymphatic Disease ... 展开 >> HIV Infections 收起 << | Not Applicable | Completed | - | United States, California ... 展开 >> Newport Pharmaceuticals International Inc Laguna Hills, California, United States, 92656 收起 << |
NCT00976365 | Metastatic Breast Cancer | Phase 2 | Completed | - | Taiwan ... 展开 >> National Taiwan University Hospital Taipei city, Taiwan, 110 收起 << |
NCT02905448 | Hyperlipidemia ... 展开 >> Metabolic Syndrome X 收起 << | Not Applicable | Unknown | March 2017 | - |
NCT02094768 | Obesity Dysli... 展开 >>pidemia 收起 << | Not Applicable | Completed | - | United States, California ... 展开 >> Cholesterol Research Center Berkeley, California, United States, 94705 收起 << |
NCT01547650 | - | Active, not recruiting | February 2023 | Japan ... 展开 >> Nagaoka Red Cross Hospital Nagaoka, Niigata, Japan, 940-2085 收起 << | |
NCT02160496 | Weight Loss O... 展开 >>besity Overweight Diet, Reducing Lipids 收起 << | Not Applicable | Completed | - | - |
NCT01025076 | - | Completed | - | - | |
NCT02377076 | Type 2 Diabetes Mellitus ... 展开 >> Overweight 收起 << | Not Applicable | Completed | - | Brazil ... 展开 >> Metabolism and body composition laboratory, Federal University of Vicosa Viçosa, Minas Gerais, Brazil, 36570-000 收起 << |
NCT00567905 | Type 2 Diabetes | Phase 2 Phase 3 | Completed | - | Taiwan ... 展开 >> Branch of Chinese Medicine, Taipei City Hospital Taipei, Taiwan, 886 Branch of Chinese Medicine Taipei, Taiwan, 886 收起 << |
NCT00610532 | - | Terminated(Investigators decid... 展开 >>ed not to continue) 收起 << | - | - | |
NCT00141310 | Pre-Eclampsia | Phase 2 | Terminated(Study prematurely d... 展开 >>iscont’d 20-Apr-2006 after interim analysis suggested sample size could be reduced without losing power. No safety concerns led to decision.) 收起 << | - | United Kingdom ... 展开 >> Pfizer Investigational Site Pembury, Kent, United Kingdom, TN2 4QJ Pfizer Investigational Site Royal Tunbridge Wells, Kent, United Kingdom, TN1 1JU Pfizer Investigational Site Ashton under Lyne, Lancs, United Kingdom, 0L6 9RW Pfizer Investigational Site Bolton, United Kingdom, BL4 0JR Pfizer Investigational Site Dundee, United Kingdom, DD1 9SY Pfizer Investigational Site Fife, United Kingdom, KY2 5RA Pfizer Investigational Site London, United Kingdom, SE1 7EH Pfizer Investigational Site London, United Kingdom, SW10 9NH Pfizer Investigational Site Manchester, United Kingdom, M14 0JH Pfizer Investigational Site Manchester, United Kingdom, M6 8HD 收起 << |
NCT00509470 | Essential Hypertension | Phase 4 | Completed | - | Japan ... 展开 >> Department of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine Tokyo, Japan, 113-8655 收起 << |
NCT01500265 | - | Completed | - | France ... 展开 >> CHU d'Amiens Amiens, France, 80054 CHU d'Angers Angers, France, 49933 CHU de Besancon Besancon, France, 25000 CHU de Bordeaux - Hôpital Saint André Bordeaux, France, 33000 CHU de Brest Brest, France, 29609 CHU de CAEN Caen, France, 14033 CHU de Clermont Ferrand Clermont Ferrand, France, 63003 AP-HP - Hôpital Beaujon Clichy, France, 92110 Centre Hospitalier Laennec de Creil Creil, France, 60109 Centre Hospitalier d'Hyères Hyères, France, 83407 Centre Hospitalier de La Roche sur Yon La Roche sur Yon, France, 85925 AP-HP - Hôpital Kremlin Bicêtre Le Kremlin Bicêtre, France, 94275 CHU de Lille - Hôpital Huriet Lille, France, 59037 CHU de Limoges - Fédération Hépatologie Limoges, France, 87042 Hospices Civils de Lyon - Hôpital Croix Rousse Lyon, France, 69317 CHU de Montpellier - Hôpital Saint Eloi Montpellier, France, 34295 CHU de Nice Nice, France, 06202 AP-HP - Hôpital La Pitié Salpétrière Paris, France, 75651 AP-HP - Hôpital Bichat Paris, France, 75877 CHU de Bordeaux - Hôpital Haut Levêque Pessac, France, 33604 CHU de Point à Pitre Point à Pitre, France, 97159 CHU de Poitiers Poitiers, France, 86021 CHU de Strasbourg - Hôpital Civil Strasbourg, France, 67091 CHU de Tours - Hôpital Trousseau Tours, France, 37044 CHU de Nancy - Hôpital Brabois Vandoeuvre les Nancy, France, 54511 收起 << | |
NCT02290613 | Systemic Sclerosis ... 展开 >> Pulmonary Hypertension 收起 << | Phase 2 | Active, not recruiting | July 2018 | Germany ... 展开 >> Thoraxclinic at the University of Heidelberg Heidelberg, Germany, 69126 收起 << |
NCT03602573 | - | Recruiting | July 31, 2019 | Taiwan ... 展开 >> Chang Gung Memorial Hospital Recruiting Taoyuan, Taiwan, 333 Contact: Yi-Cheng Chen, MD 886-3-3281200 ext 8107 yichengliver@gmail.com Sub-Investigator: Rong-Nan Chien 收起 << | |
NCT01696448 | Metabolic Syndrome | Not Applicable | Completed | - | United States, Georgia ... 展开 >> Atlanta Vascular Research Foundation Atlanta, Georgia, United States, 30342 收起 << |
NCT02295852 | Hypertension ... 展开 >>Body Weight 收起 << | Not Applicable | Unknown | July 2016 | Italy ... 展开 >> Hypertention Outpatient Clinic Dept. of Clinica Medica; Federico 2nd University of Naples Recruiting Naples, Italy, 80131 Contact: Aldo L Ferrara, MD +390817462302 ferrara@unina.it Contact: Delia Pacioni, Dietician +390817463688 pacioni@unina.it Sub-Investigator: Valentina Di Fronzo, MD Sub-Investigator: Barbara Russo, MD Sub-Investigator: Viviana Carlino, MD Sub-Investigator: Francesco Gargiulo, MD Sub-Investigator: Enza Speranza, Nutritionist 收起 << |
NCT02559479 | Weight Loss O... 展开 >>besity Diabetes Diet, Reducing Carbohydrates Protein 收起 << | Not Applicable | Unknown | June 2017 | Spain ... 展开 >> Fernando Civeira Recruiting Zaragoza, Spain, 50009 Contact: Rocio Mateo-Gallego, RD, PhD +34 976765500 ext 2895 rmateo.iacs@aragon.es Contact: Victoria Marco-Benedí, RD +34 976765500 ext 2895 vito2911@hotmail.com 收起 << |
NCT00461448 | Rheumatoid Arthritis | Phase 1 | Completed | - | Iran, Islamic Republic of ... 展开 >> Division of Rheumatoloy, Sina Teaching Hospital, Tabriz Medical Sciences University Tabriz, East Azerbaidjan, Iran, Islamic Republic of Sheikh-ol-Raees Ultra Specialized Clinic Tabriz, East Azerbaidjan, Iran, Islamic Republic of 收起 << |
NCT01735188 | - | Completed | - | - | |
NCT00360438 | Leukemia Lymp... 展开 >>homa Tumor Lysis Syndrome 收起 << | Phase 1 Phase 2 | Completed | - | United States, Texas ... 展开 >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02361255 | - | Recruiting | April 2019 | United States, Pennsylvania ... 展开 >> PVAMC Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: James Morley 215-823-5800 ext 5934 james.morley@va.gov 收起 << | |
NCT02259153 | Lipid Metabolism Disorders ... 展开 >> Sterols Diet, High-Fat Cholesterol Fatty Acids Hyperlipidemias 收起 << | Not Applicable | Completed | - | - |
NCT01424917 | - | Withdrawn(Investigator Left un... 展开 >>iversity) 收起 << | - | United States, Minnesota ... 展开 >> Cardiology Division, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << | |
NCT00207974 | Hyperuricemia, Anserine, Pharm... 展开 >>acokinetic 收起 << | Phase 1 | Unknown | - | Taiwan ... 展开 >> China Medical University Hospital Taichung, Taiwan 收起 << |
NCT00963118 | Metabolic Syndrome | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Jean Mayer USDA-Human Nutrition Research Center on Aging at Tufts University Boston, Massachusetts, United States, 02111 收起 << |
NCT00572403 | - | Completed | - | Canada, Ontario ... 展开 >> Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N3M5 收起 << | |
NCT01907373 | Drug Interaction of Olmesartan... 展开 >> in Healthy Chinese Volunteers 收起 << | Phase 4 | Completed | - | China, Hunan ... 展开 >> Center of New Drug Clinical Trial, Hunan Provincial Tumor Hospital (The Affiliated Tumor Hospital of Xiangya Medical School of Central South University) Changsha, Hunan, China, 410006 收起 << |
NCT00795847 | Hypertension | Phase 4 | Completed | - | Japan ... 展开 >> Cardio-vascular Medicine, Kurume University Kurume, Fukuoka, Japan, 830-0011 收起 << |
NCT00208000 | "Hyperuricemia,Anserine" | Phase 2 | Unknown | April 2006 | Taiwan ... 展开 >> China Medical University Hospita Recruiting Taichung, Taiwan, 404 Contact: Chiu-Shong Liu, PhD 886-4-22052121 ext 5068 huang@lsc.net.tw Contact: Kuo-Chin Huang, PhD 886-4-22052121 ext 5068 huang@lsc.net.tw 收起 << |
NCT02974478 | Healthy | Not Applicable | Completed | - | Germany ... 展开 >> Institute of Nutritional Medicine, University of Hohenheim Stuttgart, Germany, 70599 收起 << |
NCT03053986 | Endothelial Dysfunction | Not Applicable | Recruiting | April 1, 2017 | Italy ... 展开 >> S. Orsola-Malpighi University Hospital Recruiting Bologna, Italy, 40038 Contact: Arrigo FG Cicero, MD, PhD ++39 512142224 arrigo.cicero@unibo.it Contact: Arrigo FG Cicero, MD, PhD ++39 3498558017 afgcicero@gmail.com 收起 << |
NCT00443092 | Osteoarthritis | Phase 4 | Completed | - | United States, Pennsylvania ... 展开 >> VA Medical Center Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT02081261 | - | Completed | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 收起 << | |
NCT03440164 | - | Completed | - | - | |
NCT01249209 | Morbid Obesity | Not Applicable | Completed | - | Norway ... 展开 >> Sykehuset Innlandet Kongsvinger Kongsvinger, Norway, 2214 收起 << |
NCT02569268 | - | Completed | - | - | |
NCT02190786 | Hyperuricemia | Phase 2 | Completed | - | Japan ... 展开 >> Tokyo and Other Japanese City, Japan 收起 << |
NCT01965990 | - | Completed | - | Italy ... 展开 >> Clinical Nutrition Unit - A.O.R.N. "San Giuseppe Moscati" Avellino, Italy, 83100 收起 << | |
NCT00356252 | Oxidative DNA Damage | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Jean Mayer USDA-Human Nutrition Research Center on Aging, Tufts University Boston, Massachusetts, United States, 02111 收起 << |
NCT03459703 | Obesity | Not Applicable | Recruiting | May 2019 | United States, Alabama ... 展开 >> UAB Weight Loss Medicine Clinic Recruiting Birmingham, Alabama, United States, 35205 Contact: David Bryan, M.A. 205-975-0269 dbryan@uab.edu 收起 << |
NCT00149305 | - | Terminated(Non significative p... 展开 >>reliminary data) 收起 << | - | Italy ... 展开 >> Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 收起 << | |
NCT01479855 | - | Unknown | December 2013 | Norway ... 展开 >> OsloUH, Ullevål Recruiting Oslo, Norway, 0424 Principal Investigator: Ingun D Ulstein, MD PhD 收起 << | |
NCT02224092 | Heart Health Markers ... 展开 >> General Nutritional Status 收起 << | Not Applicable | Completed | - | Russian Federation ... 展开 >> Russian Institute of Nutrition Moscow, Russian Federation 收起 << |
NCT02716870 | - | Active, not recruiting | January 2019 | Canada, Ontario ... 展开 >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 收起 << | |
NCT00374595 | - | Active, not recruiting | April 2019 | United States, Nebraska ... 展开 >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-1230 收起 << | |
NCT00980187 | Hypertension ... 展开 >>Type 2 Diabetes Mellitus 收起 << | Phase 4 | Completed | - | Romania ... 展开 >> Cardiology, University and Emergency Hospital Bucharest, Romania, 050098 收起 << |
NCT00560079 | Mania | Phase 4 | Completed | - | Brazil ... 展开 >> Hospital Espirita de Porto Alegre Porto Alegre, RS, Brazil, 91720-440 收起 << |
NCT01172886 | - | Unknown | - | Italy ... 展开 >> Dept. of Senology - National Cancer Institute of Naples Recruiting Naples, Italy, 80131 Contact: immacolata capasso, MD 00393381829067 icapasso@tiscali.it Principal Investigator: immacolata capasso, MD 收起 << | |
NCT02815839 | Gout; Hyperuricemia | Phase 1 | Completed | - | China, Sichuan ... 展开 >> Southwest Hospital Chongqing, Sichuan, China, 400038 收起 << |
NCT01894659 | Neonatal Procedural Pain | Not Applicable | Active, not recruiting | June 2019 | United States, California ... 展开 >> Loma Linda University Medical Center Loma Linda, California, United States, 92354 收起 << |
NCT03305562 | - | Enrolling by invitation | October 20, 2027 | United States, North Carolina ... 展开 >> Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157 收起 << | |
NCT00651001 | - | Completed | - | Spain ... 展开 >> Renal Unit of Mateo Orfila Hospital, Balearic Islands - Spain Menorca, Balearic Islands, Spain, 07703 收起 << | |
NCT02829177 | Type 1 Diabetes ... 展开 >> Diabetic Nephropathy 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> Steno Diabetes Center Gentofte, Denmark, 2820 收起 << |
NCT02974491 | Oxidative Stress | Not Applicable | Completed | - | - |
NCT02237339 | Hypertension ... 展开 >>Hypertrophy, Left Ventricular 收起 << | Phase 4 | Completed | - | United Kingdom ... 展开 >> University of Dundee, Ninewells Hospital Dundee, Tayside, United Kingdom, DD1 9SY 收起 << |
NCT02513927 | Hypertension | Phase 2 Phase 3 | Unknown | October 2018 | Hungary ... 展开 >> Twenty-four-hour ambulatory BP monitoring Recruiting Budapest, Hungary Contact: Jingyan Piao, MM 86-451-85555333 411483521@qq.com Contact: Yujiao Pan, MM 86-451-85555671 panyujiao@163.com 收起 << |
NCT02956278 | Chronic Gout ... 展开 >>Hyperuricemia 收起 << | Phase 4 | Active, not recruiting | December 30, 2019 | United States, California ... 展开 >> Open Medicine Institute Mountain View, California, United States, 94040 收起 << |
NCT00631579 | Hyperuricemia ... 展开 >> Leukemia Lymphoma 收起 << | Phase 2 | Completed | - | Japan ... 展开 >> Sanofi-Aventis Tokyo, Japan 收起 << |
NCT03169257 | Obesity, Childhood ... 展开 >> Cardiovascular Diseases 收起 << | Not Applicable | Active, not recruiting | December 2019 | - |
NCT03592511 | Food Selection ... 展开 >> Metabolic Syndrome 收起 << | Not Applicable | Completed | - | - |
NCT03341650 | Diet Therapy | Not Applicable | Completed | - | Italy ... 展开 >> Department of Food and Drug, University of Parma Parma, Italy, 43125 收起 << |
NCT00679679 | Polycystic Ovary Syndrome | Phase 4 | Completed | - | Argentina ... 展开 >> Hospital Privado de Córdoba Cordoba, Argentina, X5016KEH 收起 << |
NCT01510158 | Gout | Phase 3 | Completed | - | - |
NCT02017171 | Diabetic Nephropathies ... 展开 >> Coronary Artery Disease 收起 << | Phase 3 | Active, not recruiting | June 2019 | - |
NCT01508702 | Gout | Phase 3 | Completed | - | - |
NCT01350388 | - | Completed | - | - | |
NCT01510158 | - | Completed | - | - | |
NCT01508702 | - | Completed | - | - | |
NCT01350388 | Chronic Kidney Disease ... 展开 >> Diabetes 收起 << | Not Applicable | Completed | - | United States, Utah ... 展开 >> University of Utah Salt Lake City, Utah, United States, 84112 收起 << |
NCT00199043 | Adult Acute Lymphocytic Leukem... 展开 >>ia High-Grade Lymphoma 收起 << | Phase 3 | Completed | - | Germany ... 展开 >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 收起 << |
NCT00559624 | Leukemia, B-Cell, Chronic | Phase 1 Phase 2 | Completed | - | Belgium ... 展开 >> Hematology Department, ZNA Stuivenberg Antwerpen, Belgium Cliniques universitaires Saint-Luc Haematology Dept Brussels, Belgium Hematology Department UZ Gasthuisberg Leuven, Belgium France Hôpital Avicenne Bobigny, France Service des maladies du sang Hôpital HURIEZ, CHRU Lille, France Spain Hematologia Clinica, Institut Catala d'Oncologia Barcelona, Spain, 08907 Hospital Madrid Nortesanchinarro Madrid, Spain, 28050 Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 收起 << |
NCT02176499 | Hypertension | Phase 3 | Completed | - | - |
NCT01988402 | - | Completed | - | - | |
NCT00749801 | Hyperlipidemia | Not Applicable | Completed | - | Taiwan ... 展开 >> Chi Mei Medical Hospital Tainan, Taiwan, 710 收起 << |
NCT01808131 | Gout | Phase 3 | Completed | - | - |
NCT01988402 | Gout | Phase 4 | Completed | - | United States, Texas ... 展开 >> Wilford Hall Ambulatory Surgical Center Lackland Air Force Base, Texas, United States, 78236 收起 << |
NCT00563771 | Hyperuricemia | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Sanofi-Aventis Seoul, Korea, Republic of 收起 << |
NCT01808144 | Gout | Phase 3 | Completed | - | - |
NCT02509780 | Healthy | Not Applicable | Completed | - | Belgium ... 展开 >> CHU Brugmann Brussels, Belgium, 1020 收起 << |
NCT00760162 | - | Completed | - | United States, New York ... 展开 >> Downstate Medical Center,HSCB, State University of New York Brooklyn, New York, United States, 11203 SUNY DownState Medical Center-Renakl Division Brooklyn, New York, United States, 11203 收起 << | |
NCT01713023 | Type 1 Diabetes | Not Applicable | Completed | - | Brazil ... 展开 >> University Hospital of Rio de Janeiro, Federal University of Rio de Janeiro Rio de Janeiro, Brazil, 21941-590 收起 << |
NCT02176460 | Knee Osteoarthritis | Phase 2 Phase 3 | Completed | - | Singapore ... 展开 >> Singapore General Hospital Singapore, Singapore, 169608 收起 << |
NCT00230217 | Tumors Hyperu... 展开 >>ricemia Tumor Lysis Syndrome 收起 << | Phase 4 | Completed | - | United States, California ... 展开 >> Alta Bates Comprehensive Cancer Center Berkley, California, United States, 94704 United States, Colorado Rocky Mountain Cancer Center Denver, Colorado, United States, 80218 United States, Florida University of Florida Health Science Center at Jacksonville Jacksonville, Florida, United States, 32209 United States, New York New York Medical College Valhalla, New York, United States, 10595 United States, Oklahoma University of Oklahoma HSC Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania University of Pennsylvania Health Systems Philadelphia, Pennsylvania, United States, 19104 United States, West Virginia Mary Babb Randolph Cancer Center Morgantown, West Virginia, United States, 26506-9162 收起 << |
NCT01808144 | - | Completed | - | - | |
NCT01109121 | Moderate to Severe Gout ... 展开 >> Hyperuricemia 收起 << | Phase 2 | Completed | - | - |
NCT01007656 | - | Completed | - | - | |
NCT02338323 | Chronic Kidney Disease ... 展开 >> Hyperuricemia Abnormal Renal Function 收起 << | Not Applicable | Unknown | December 2018 | China, Shanghai ... 展开 >> Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital Recruiting Shanghai, Shanghai, China, 200072 Contact: Ai Peng, MD, PhD pengai@tongji.edu.cn Contact: Ling Wang, MD, PhD nowax@126.com Sub-Investigator: Ling Wang, MD, PhD 收起 << |
NCT02979106 | Hereditary Fructose Intoleranc... 展开 >>e Fructose Metabolism, Inborn Errors Glucose Metabolism Disorders 收起 << | Not Applicable | Completed | - | - |
NCT00288158 | Obesity Pre-H... 展开 >>ypertension Hyperuricemia 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 收起 << |
NCT01007656 | Healthy | Not Applicable | Completed | - | Taiwan ... 展开 >> PingTung Christian Hospital Pingtung, Taiwan 收起 << |
NCT02037321 | - | Unknown | December 2017 | Canada, Ontario ... 展开 >> Toronto 3-D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 收起 << | |
NCT00607152 | Hyperuricemia | Phase 3 | Terminated(the patient enrollm... 展开 >>ent is too difficult) 收起 << | - | China ... 展开 >> Sanofi-Aventis Administrative Office Shanghai, China 收起 << |
NCT01477346 | Gout | Not Applicable | Completed | - | United Kingdom ... 展开 >> Academic Rheumatology, University of Nottingham Nottingham, United Kingdom, NG5 1PB 收起 << |
NCT03545581 | Hereditary Fructose Intoleranc... 展开 >>e 收起 << | Not Applicable | Recruiting | April 1, 2019 | Belgium ... 展开 >> Guillaume Debray Recruiting Liège, Belgium Contact: Guillaume F Debray, MD +3242249057 fg.debray@chu.ulg.ac.be 收起 << |
NCT02564679 | Morbid Obesity ... 展开 >> NAFLD 收起 << | Not Applicable | Completed | - | - |
NCT01129648 | Gout | Phase 2 | Completed | - | - |
NCT01500343 | Heart Failure | Phase 2 | Completed | - | Brazil ... 展开 >> Hospital Universitário Antonio Pedro Niteroi, Rio de Janeiro, Brazil, 24033-900 收起 << |
NCT00675103 | - | Completed | - | - | |
NCT00675103 | Chronic Gout Refractory to Con... 展开 >>ventional Therapy 收起 << | Phase 3 | Completed | - | United States, Illinois ... 展开 >> University of Chicago- Dept. Biological Services Chicago, Illinois, United States, 60637 United States, Maryland The Center for Rheumatology and Bone Research Wheaton, Maryland, United States, 20902 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Oregon Portland Rheumatology Clinic, L.L.C. Lake Oswego, Oregon, United States, 97035 收起 << |
NCT01294995 | Cardiovascular Diseases | Phase 1 | Completed | - | China, Zhejiang ... 展开 >> Department of food science and nutrition Hangzhou, Zhejiang, China, 310029 收起 << |
NCT02649140 | Urolithiasis | Not Applicable | Unknown | March 2016 | China, Guangdong ... 展开 >> Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510230 Contact: Guohua Zeng, Ph.D and M.D +86 13802916676 gzgyzgh@vip.tom.com Principal Investigator: Guohua Zeng, Ph.D and M.D Sub-Investigator: Zhou Yang 收起 << |
NCT01398748 | Parkinson's Disease (PD) | Phase 1 | Completed | - | United States, Washington ... 展开 >> Bastyr Clinical Research Center Kenmore, Washington, United States, 98023 收起 << |
NCT02623894 | - | Unknown | December 2017 | Spain ... 展开 >> Primary care Research unit. La Alamedilla health centre Recruiting Salamanca, Spain, 37003 Contact: Jose I Recio 0034 923124465 Lgarciao@usal.es Principal Investigator: Manuel A Gomez Marcos, MD Sub-Investigator: Luis Garcia Ortiz, MD Sub-Investigator: José I Recio Rodríguez Sub-Investigator: Yolanda Castaño Sánchez Sub-Investigator: Emiliano Rodríguez Sanchez, MD Sub-Investigator: Angel de Cabo Laso Sub-Investigator: Benigna Sanchez Salgado Manuel A Gómez Marcos Completed Salamanca, Spain, 37006 收起 << | |
NCT01893918 | - | Unknown | July 2013 | Italy ... 展开 >> Azienda Ospedaliero-Universitaria di Modena Recruiting Modena, Italy, 41100 Contact: Bianca Beghé, MD PhD +39 059 4225814 bianca.beghe@unimore.it Contact: Alessia Verduri, MD PhD +39 059 4225769 alessia.verduri@unimore.it 收起 << | |
NCT02373579 | Acute Lymphoblastic Leukemia | Phase 2 | Completed | - | - |
NCT00600392 | - | Completed | - | United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << | |
NCT02650336 | - | Completed | - | China, Guangdong ... 展开 >> Xiaodong Zhaung Guangzhou, Guangdong, China, 510080 收起 << | |
NCT00694824 | - | Completed | - | Italy ... 展开 >> Nhephrology Dialysis Transplantation Unit St.Orsola University Hospital Bologna, Italy, 40100 收起 << | |
NCT02122146 | Neoplasms | Phase 1 | Terminated(The study was prema... 展开 >>turely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results.) 收起 << | - | United States, California ... 展开 >> Keck Hospital of USC Los Angeles, California, United States, 90033 LAC&USC Medical Center Los Angeles, California, United States, 90033 USC/Norris Comprehensive Cancer Center / Investigational Drug Services Los Angeles, California, United States, 90033 USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Colorado Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Denver CTO (CTRC) Aurora, Colorado, United States, 80045 University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Washington Swedish Medical Center Seattle, Washington, United States, 98104 Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195 收起 << |
NCT02029066 | Actinic Keratosis | Phase 1 | Completed | - | Taiwan ... 展开 >> National Cheng Kung University Hospital Tainan, Taiwan, 70403 收起 << |
NCT02702479 | - | Unknown | June 2016 | Canada, Ontario ... 展开 >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 收起 << | |
NCT01414179 | - | Unknown | December 2011 | France ... 展开 >> Centre médecine Preventive Recruiting Vandoeuvre lès Nancy, France, 54500 Contact: Celine Hertz +33 3 83 15 73 12 cel.hertz@chu-nancy.fr 收起 << | |
NCT02122146 | - | Terminated(The study was prema... 展开 >>turely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results.) 收起 << | - | - | |
NCT03126981 | PreDiabetes | Not Applicable | Active, not recruiting | April 30, 2019 | United States, Florida ... 展开 >> MB Clinical Research Boca Raton, Florida, United States, 33487 United States, Illinois Illinois Institute for Food Safety and Health (IFSH) at Illinois Instiute of Technology (IIT) Chicago, Illinois, United States, 60616 收起 << |
NCT00196755 | Peritoneal Dialysis ... 展开 >> Chronic Kidney Disease 收起 << | Phase 3 | Completed | - | Belgium ... 展开 >> UZ Gasthuisberg Leuven, Belgium, B-3000 Denmark Fredericia Sygehus Fredericia, Denmark, DN-7000 Copenhagen University Hospital Herlev, Denmark, DN-2730 Aarhus University Hospital Århus N, Denmark, DN-8200 France CHRU Clémenceau Caen, France, FR-14033 Italy Ospedale civico e benfratelli Palermo, Italy, IT-90127 Ospedale San Bortolo Vicenza, Italy, IT-36100 Netherlands AMC Amsterdam, Netherlands, NL-1105 AZ Spain Fundacion Jimenez Diaz Madrid, Spain, ES-28040 Hospital Universitario La Paz Madrid, Spain, ES-28046 United Kingdom University Hospital ,Queen Elizabeth Hospital Birmingham, United Kingdom, B15 2TH High Wycombe Hospital Buckinghamshire, United Kingdom, HP11 2TT University of Wales College of Medicine Cardiff, United Kingdom, CF 14 4XN Glasgow Western Infirmary Glasgow, United Kingdom, G11 6NT Royal Hospital The Royal London London, United Kingdom, E1 1BB Milton Keynes General Hospital Milton Keynes, United Kingdom, MK6 5LD The Churchill Hospital, Oxford Radcliffe Hospitals NHS Trust Oxford, United Kingdom, OX3 7LJ 收起 << |
NCT02477163 | - | Unknown | April 2018 | India ... 展开 >> P D Patel Ayurveda Hospital Recruiting Nadiad, Gujarat, India, 387001 Contact: Manishkumar V Patel, MD(Ayurveda) 9979589865 manishayu97@yahoo.com 收起 << | |
NCT02213770 | - | Completed | - | Norway ... 展开 >> OUS- Rikshospitalet Oslo, Norway, 0424 收起 << | |
NCT01444807 | Metastatic Renal Cell Carcinom... 展开 >>a 收起 << | Phase 2 | Recruiting | September 2019 | Italy ... 展开 >> Istituto Tumori Milano Recruiting Milan, Mi, Italy, 20156 Contact: Giuseppe Procopio, MD +390223902557 Giuseppe.Procopio@istitutotumori.mi.it Contact: Elena Verzoni, MD +390223902557 elena.verzoni@istitutotumori.mi.it Principal Investigator: Giuseppe Procopio, MD Cinzia Ortega Recruiting Alba, Italy Alessandra Bearz Recruiting Aviano, Italy Alfredo Berruti Recruiting Brescia, Italy Saverio Cinieri Recruiting Brindisi, Italy Francesco Atzori Recruiting Cagliari, Italy Rodolfo Passalaqua Recruiting Cremona, Italy Francesco Di Costanzo Recruiting Firenze, Italy Vincenzo Emanuele Chiuri Recruiting Lecce, Italy Alessandra Mosca Recruiting Novara, Italy Vittorio Gebbia Recruiting Palermo, Italy Enrico Cortesi Recruiting Roma, Italy Francesco Cognetti Recruiting Roma, Italy Contact: Michele Milella Franco Morelli Recruiting San Giovanni Rotondo, Italy 收起 << |
NCT00745303 | - | Completed | - | Taiwan ... 展开 >> Taipei Veterans General Hospital Taipei, Taiwan, 112 收起 << | |
NCT03672591 | - | Not yet recruiting | March 31, 2019 | - | |
NCT00882336 | - | Completed | - | - | |
NCT01114386 | - | Completed | - | Italy ... 展开 >> Azienda Ospedaliero-Universitaria di Modena Modena, Italy, 41124 收起 << | |
NCT02321553 | Metabolic Syndrome | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Clinical and Translation Research Center, Tufts Medical Center Boston, Massachusetts, United States, 02111 收起 << |
NCT02808013 | Lower Urinary Tract Symptoms | Phase 2 | Unknown | - | - |
NCT01814904 | Chronic Kidney Disease ... 展开 >> Dialysis Hyperphosphatemia Paediatric 收起 << | Phase 3 | Terminated(This study has been... 展开 >> terminated because of insufficient patient recruitment.) 收起 << | - | United Kingdom ... 展开 >> Investigational site London, United Kingdom 收起 << |
NCT01971476 | Leukemia Neop... 展开 >>lasms 收起 << | Phase 1 | Completed | - | Belgium ... 展开 >> UNIV UZ Gent Gent, Belgium, 9000 Czechia University Hospital Motol Prague, Czechia, 150 06 France INS Curie Paris, France, 75248 Germany Universitätsklinikum Köln (AöR) Köln, Germany, 50937 Italy Osp. Pediatrico Bambin Gesù Roma, Italy, 00165 收起 << |
NCT01838759 | - | Completed | - | Turkey ... 展开 >> Bulent Ecevit University Hospital Zonguldak, Turkey, 67300 收起 << | |
NCT00940797 | Diabetes Type 2 | Phase 2 | Completed | - | Mexico ... 展开 >> Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, México Guadalajara, Jalisco, Mexico, 44340 收起 << |
NCT01977430 | Chronic Kidney Insufficiency ... 展开 >> Hemodialysis Treatment Diuresis Preserved 收起 << | Phase 4 | Unknown | March 2015 | Spain ... 展开 >> Corporació Sanitària Parc Taulí Recruiting Sabadell, Barcelona, Spain, 08208 Contact: Mabel - Bolos-Contador, MD 0034937231010 ext 25010 mabeline17@hotmail.com 收起 << |
NCT01971476 | - | Completed | - | - | |
NCT01845870 | - | Completed | - | China, Tianjin ... 展开 >> General Hospital of Tianjin Medical University Tianjin, Tianjin, China, 300052 收起 << | |
NCT01221714 | - | Terminated(Ameriscience went b... 展开 >>ankrupt.) 收起 << | - | United States, Mississippi ... 展开 >> Mississippi Family Doctors Pearl, Mississippi, United States, 39208 United States, North Carolina Carolina Medical Associates Charlotte, North Carolina, United States, 28226 United States, West Virginia Logan General Hospital Logan, West Virginia, United States, 25601 收起 << | |
NCT01637168 | Memory Deficit | Phase 3 | Unknown | September 2014 | Brazil ... 展开 >> Cliníca Dr. Felício Savioli Not yet recruiting Cotia, São Paulo, Brazil, 06710-670 收起 << |
NCT02420418 | Bipolar Disorder | Not Applicable | Unknown | May 2017 | Brazil ... 展开 >> State University of Londrina Not yet recruiting Londrina, Paraná, Brazil, 86.057-970 Contact: Kamila Landucci Bonifácio, MS +554333386447 kamilalondrina@hotmail.com Principal Investigator: Kamila Landucci Bonifácio, MS Principal Investigator: Ana Carolina Rossaneis, PhD 收起 << |
NCT02521038 | - | Recruiting | January 2018 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Hyo-Soo Kim, MD,PhD 82-2-2072-2226 收起 << | |
NCT02471261 | - | Unknown | March 2017 | United States, Maryland ... 展开 >> The Center for Rheumatology and Bone Research Recruiting Wheaton, Maryland, United States, 20902 Contact: Theresa Bass-Goldman 301-942-6610 tbgoldman@arapc.com Principal Investigator: Paul J DeMarco, MD Sub-Investigator: Alan K Matsumoto, MD Sub-Investigator: Herbert S Baraf, MD Sub-Investigator: Robert L Rosenberg, MD Sub-Investigator: Evan L Siegel, MD Sub-Investigator: Ashley D Beall, MD Sub-Investigator: Nicole Sadddic-Thomas, MD 收起 << | |
NCT00643123 | - | Completed | - | - | |
NCT02348372 | Anaemia | Phase 1 | Completed | - | Australia, New South Wales ... 展开 >> GSK Investigational Site Randwick, Sydney, New South Wales, Australia, 2031 收起 << |
NCT00893724 | Neovascular Age-related Macula... 展开 >>r Degeneration Diabetic Macular Edema 收起 << | Not Applicable | Unknown | September 2011 | United States, West Virginia ... 展开 >> Mid-Atlantic Retina Consultations, Inc. Morgantown, West Virginia, United States, 26505 收起 << |
NCT00643123 | Bipolar Disorder ... 展开 >> Mixed Mania Treatment-Resistant Mania 收起 << | Phase 4 | Completed | - | United States, California ... 展开 >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 收起 << |
NCT01982201 | Healthy | Phase 1 | Completed | - | United States, Michigan ... 展开 >> Kalamazoo, Michigan, United States, 49007 收起 << |
NCT03128229 | - | Recruiting | June 2019 | United States, Colorado ... 展开 >> Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80238 Contact: Petter Bjornstad, M.D. Principal Investigator: Petter Bjornstad, M.D. Sub-Investigator: Kristen Nadeau, M.D. 收起 << | |
NCT00005520 | - | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States 收起 << | |
NCT01855048 | Healthy Volunteers ... 展开 >> Anti-Bacterial Agents Methicillin-Resistant Staphylococcus Aureus 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 << |
NCT02116751 | - | Completed | - | Spain ... 展开 >> Ramon y Cajal Hospital Madrid, Spain, 28034 收起 << | |
NCT01828528 | - | Completed | - | Israel ... 展开 >> Liver Disease Center, Sheba Medical Center, Tel-Hashomer Ramat-Gan, Israel, 52621 收起 << | |
NCT01038947 | Gout Hyperuri... 展开 >>cemia 收起 << | Phase 1 | Unknown | May 2010 | United States, Florida ... 展开 >> MRA Clinical Research Recruiting Miami, Florida, United States, 33143 Contact: Vivian Rosales 305-772-2857 vrosales@miamiresearch.com Principal Investigator: Patricia Pardo, MD United States, Pennsylvania Altoona Center for Clinical Research Recruiting Duncansville, Pennsylvania, United States, 16635 Contact: Ellen Kivitz 814-693-0300 ext 224 Principal Investigator: Alan J Kivitz, MD 收起 << |
NCT02195388 | - | Completed | - | Poland ... 展开 >> Departament of Cardiology Lodz, Lodzkie, Poland, 91-347 收起 << | |
NCT01276288 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | Germany ... 展开 >> 1245.42.1 Boehringer Ingelheim Investigational Site Neuss, Germany 收起 << |
NCT01276288 | - | Completed | - | - | |
NCT00095147 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT01805258 | HIV/TB Co-infection | Phase 3 | Completed | - | India ... 展开 >> All India Institute of Medical Sciences New Delhi, India, 110029 收起 << |
NCT00406575 | Congestive Heart Failure (CHF) | Phase 2 | Terminated | - | Russian Federation ... 展开 >> Russian Scientific Centre of Surgery n.a. B.V.Petrovsky of Russian Academy of Medical Sciences Moscow, Russian Federation, 119992 Educational Scientific Medical Center of the General Management Department of the President of Russian Federation. City Clinical Hospital №51 Moscow, Russian Federation, 121309 收起 << |
NCT01619735 | - | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic Scottsdale, Arizona, United States, 85259 United States, California UCSD San Diego, California, United States, 92103 United States, Maryland James Buchanan Brady Urological Institute Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York Bellevue Hospital New York, New York, United States, 10016 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 Ohio State University Columbus, Ohio, United States, 43210 United States, Tennessee Vanderbilt University School of Medicine Nashville, Tennessee, United States, 37232 Canada, British Columbia University of British Columbia Vancouver, British Columbia, Canada 收起 << | |
NCT02189850 | Colonoscopy | Phase 2 | Completed | - | United States, Arkansas ... 展开 >> Arkansas Children's Hospital Research Institute Little Rock, Arkansas, United States United States, Georgia Children's Center for Digestive Health Care Atlanta, Georgia, United States United States, Louisiana Delta Research Partners Bastrop, Louisiana, United States United States, Mississippi Gastrointestinal Associates Jackson, Mississippi, United States United States, New York University of Buffalo Pediatric Associates Buffalo, New York, United States 收起 << |
NCT01475240 | - | Completed | - | United Kingdom ... 展开 >> St Stephen's AIDS Trust London, United Kingdom, SW10 9NH 收起 << | |
NCT00095147 | - | Completed | - | - | |
NCT02422992 | - | Completed | - | United States, California ... 展开 >> University of California San Diego, California, United States, 92093 United States, Washington Bastyr University Research Institute Kenmore, Washington, United States, 98028 University of Washington Seattle, Washington, United States, 98195 收起 << | |
NCT00664001 | Acute Mountain Sickness | Phase 3 | Completed | - | United Kingdom ... 展开 >> University of Edinburgh Edinburgh, United Kingdom 收起 << |
NCT00584311 | Gout | Not Applicable | Completed | - | United States, Florida ... 展开 >> University of South Florida Tampa, Florida, United States, 33612 收起 << |
NCT02175654 | Colorectal Neoplasms ... 展开 >> Metastatic Disease 收起 << | Phase 2 | Terminated(The trial was prema... 展开 >>turely closed due to lack of accrual) 收起 << | - | Spain ... 展开 >> Spanish Cooperative Group for Digestive Tumour Therapy (TTD) Madrid, Spain, 28046 收起 << |
NCT03733262 | - | Not yet recruiting | March 1, 2020 | Canada, British Colombia ... 展开 >> Providence Health Care Not yet recruiting Vancouver, British Colombia, Canada, V6Z 1Y6 Contact: Judith Marin, PharmD 604-806-8146 judith.marin@fraserhealth.ca Contact: Monica Beaulieu, MD 604 681-7191 MBeaulieu@providencehealth.bc.ca Canada, Manitoba Manitoba Renal Program Not yet recruiting Winnipeg, Manitoba, Canada, R2V 3M3 Contact: Cali Orsulak, PharmD 204 770-9312 COrsulak@hsc.mb.ca Contact: Clara Bohm, MD 204-787-3583 CBOHM@hsc.mb.ca Canada, Nova Scotia Nova Scotia Health Authority Not yet recruiting Halifax, Nova Scotia, Canada Contact: Jo-Anne Wilson, PharmD 902-473-5418 sjawilson@gmail.com Canada, Ontario University Health Network Not yet recruiting Toronto, Ontario, Canada, M5G 2C4 Contact: Marisa Batistella, PharmD 416-340-4800 ext 3207 marisa.battistella@uhn.ca Contact: Melissa Lefebvre, MBiotech 4168589786 melissa.lefebvre@uhnresearch.ca 收起 << | |
NCT01902186 | HIV Infection ... 展开 >> Osteopenia 收起 << | Phase 4 | Terminated(Low enrollment) | - | Italy ... 展开 >> University of Milano Milano, Italy University of Torino Torino, Italy 收起 << |
NCT02132728 | Metabolic Syndrome | Not Applicable | Completed | - | Brazil ... 展开 >> Clinical Hospital of Ribeirao Preto Ribeirão Preto, São Paulo, Brazil, 14049-900 收起 << |
NCT03388411 | - | Recruiting | October 12, 2018 | Korea, Republic of ... 展开 >> Hallym University Kangnam Sacred Heart Hospital Recruiting Seoul, Korea, Republic of, 07440 Contact: Saeam Shin, M.D. 82-2-829-5695 saeam0304@hallym.or.kr 收起 << | |
NCT01496469 | Hypertension | Phase 2 | Completed | - | - |
NCT01314586 | Hypercholesterolemia | Not Applicable | Completed | - | United States, Iowa ... 展开 >> Nutrition & Wellness Research Center Ames, Iowa, United States, 50011 收起 << |
NCT01496469 | - | Completed | - | - | |
NCT01883167 | Healthy | Phase 1 | Completed | - | United States, Michigan ... 展开 >> Kalamazoo, Michigan, United States, 49007 收起 << |
NCT01466166 | - | Completed | - | - | |
NCT00885989 | Healthy | Phase 1 | Completed | - | United Kingdom ... 展开 >> Site 1 London, United Kingdom 收起 << |
NCT02710461 | Subjects With Abdominal Obesit... 展开 >>y 收起 << | Not Applicable | Completed | - | Spain ... 展开 >> Institute of Food Science, Technology and Nutrition, National Research Council (ICTAN-CSIC) Madrid, Spain, 28040 收起 << |
NCT01137474 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT01137474 | - | Completed | - | - | |
NCT01715987 | - | Terminated | - | United States, California ... 展开 >> Asian Pacific Liver Center at St. Vincent Medical Center Los Angeles, California, United States, 90057 United States, New York New Discovery LLC New York, New York, United States, 11355 收起 << | |
NCT01363791 | - | Unknown | March 2016 | Canada, Ontario ... 展开 >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Micheal's Hospital Toronto, Ontario, Canada, M5C 2N8 收起 << | |
NCT01021241 | Gout Hyperuri... 展开 >>cemia 收起 << | Phase 1 | Unknown | March 2010 | United States, Florida ... 展开 >> MRA Clinical Research Miami, Florida, United States, 33143 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 收起 << |
NCT02741700 | Gout Low Medi... 展开 >>cation Adherence Health Related Quality of Life 收起 << | Not Applicable | Recruiting | February 28, 2021 | United States, Alabama ... 展开 >> Birmingham VA Medical Center, Birmingham, AL Recruiting Birmingham, Alabama, United States, 35233 Contact: Jasvinder A Singh, MD MPH 205-933-8101 ext 2280 jasvinder.singh@va.gov Contact: Holly M Deal, MBA (205) 933-8101 ext 5301 holly.deal@va.gov Principal Investigator: Jasvinder A Singh, MD MPH United States, Missouri St. Louis VA Medical Center John Cochran Division, St. Louis, MO Recruiting Saint Louis, Missouri, United States, 63106 Contact: Amy M Joseph Amy.Joseph@va.gov Contact: Ziyad Al-Aly, MD (314) 289-6485 Ziyad.Al-Aly@va.gov Sub-Investigator: Amy M. Joseph United States, Pennsylvania Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Joan M Von Feldt, MD MSEd 215-823-5800 Joan.VonFeldt@va.gov Contact: Said A Ibrahim, MD MPH MBA (215) 823-5847 said.ibrahim2@va.gov Sub-Investigator: Joan M. Von Feldt, MD MSEd Sub-Investigator: Sally Pullman-Mooar, MD 收起 << |
NCT01412658 | Drug Safety | Phase 1 | Completed | - | United States, Texas ... 展开 >> Baylor University Center for Exercise, Nutrition, and Preventive Health Research Waco, Texas, United States, 76706 收起 << |
NCT03482284 | Dietary Habits ... 展开 >> Endotoxemia 收起 << | Not Applicable | Active, not recruiting | September 15, 2018 | - |
NCT01200485 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT03388515 | Gout | Phase 1 | Recruiting | January 31, 2020 | China, Zhejiang ... 展开 >> The First Affilicated Hospital Zhejiang University Recruiting Hangzhou, Zhejiang, China Contact: Jian zhong Shen tu, Doctor 0571-87236560 stjz@zju.edu.cn Principal Investigator: Jian zhong Shen tu, Doctor 收起 << |
NCT01814917 | Chronic Kidney Disease ... 展开 >> Dialysis Hyperphosphatemia Paediatric 收起 << | Phase 3 | Terminated(This study has been... 展开 >> terminated because of insufficient patient recruitment.) 收起 << | - | United Kingdom ... 展开 >> Investigational site London, United Kingdom 收起 << |
NCT00811889 | Chronic Kidney Disease ... 展开 >> Type 2 Diabetes Diabetic Nephropathy 收起 << | Phase 2 | Completed | - | - |
NCT03092908 | Nephrolithiasis | Not Applicable | Recruiting | December 31, 2022 | China, Guangdong ... 展开 >> The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Guohua Zeng, Ph.D. +86 13802916676 gzgyzgh@vip.sina.com Principal Investigator: Guohua Zeng, M.D. Sub-Investigator: Wei Zhu, Ph.D. 收起 << |
NCT02336594 | - | Completed | - | - | |
NCT01138241 | - | Completed | - | Thailand ... 展开 >> HIV-NAT, Thai Red Cross AIDS Research Centre Bangkok, Thailand, 10330 收起 << | |
NCT03207659 | Urolithiasis | Not Applicable | Recruiting | December 2018 | China, Guangdong ... 展开 >> Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510230 Contact: Guohua Zeng, Ph.D & MD. +86 13802916676 gzgyzgh@vip.sina.com Principal Investigator: Guohua Zeng, Ph.D & MD. Sub-Investigator: Chao Cai, PH.D & MD 收起 << |
NCT01265264 | Gout Hyperuri... 展开 >>cemia Arthritis Joint Disease 收起 << | Phase 2 | Completed | - | - |
NCT02336594 | Gout | Phase 1 | Completed | - | United States, Texas ... 展开 >> Austin, Texas, United States, 78744 收起 << |
NCT03527277 | Cardiovascular Risk Factor ... 展开 >> Type2 Diabetes Mellitus Insulin Sensitivity Metabolic Syndrome 收起 << | Not Applicable | Recruiting | March 31, 2023 | United States, California ... 展开 >> University of California, Davis Recruiting Davis, California, United States, 95616 Contact: Kimber Stanhope, Ph.D. 530-752-3720 klstanhope@ucdavis.edu Contact: Vivien Lee, B.S. 530-752-2714 vilee@ucdavis.edu 收起 << |
NCT03599700 | - | Not yet recruiting | December 31, 2021 | Egypt ... 展开 >> Clinical Hematology Unit Active, not recruiting Assiut, Egypt, 22413749 收起 << | |
NCT02891954 | Diabetes Mellitus, Type 2 | Phase 1 | Enrolling by invitation | June 30, 2023 | - |
NCT03405350 | Osteoarthritis ... 展开 >> Degenerative Disc Disease 收起 << | Not Applicable | Completed | - | - |
NCT03543774 | Hypercholesterolemia ... 展开 >> Chronic Kidney Diseases 收起 << | Phase 4 | Recruiting | September 15, 2019 | Vietnam ... 展开 >> Hue University of Medicine and Pharmacy Recruiting Hue, Thua Thien Hue, Vietnam, 0234 Contact: Nguyen Thanh Thao 84.234.3822873 hcmp@huemed-univ.edu.vn Contact: Nguyen Thanh Thao 84.234.3822873 thaonrad@gmail.com Principal Investigator: Duong Thi Ngoc Lan, Master Sub-Investigator: Le Van An, A/Professor 收起 << |
NCT03235336 | - | Recruiting | December 2018 | China, Sichuan ... 展开 >> Sichuan Hospital Recruiting Chengdu, Sichuan, China Contact: Shufa Dr chns@unc.edu 收起 << | |
NCT02219516 | Gout | Phase 1 | Completed | - | United States, Colorado ... 展开 >> Lakewood, Colorado, United States, 80228 United States, Florida Orlando, Florida, United States, 32809 United States, Minnesota Minneapolis, Minnesota, United States, 55404 United States, Tennessee Knoxville, Tennessee, United States, 37920 收起 << |
NCT02147002 | Chronic Kidney Disease ... 展开 >> Cardiovascular Complications 收起 << | Not Applicable | Unknown | December 2014 | Poland ... 展开 >> 1Katedra i Klinika Nefrologii, Nadciśnienia Tętniczego i Chorób Wewnętrznych, Bydgoszcz Recruiting Bydgoszcz, Kujawsko-pomorskie, Poland, 85-094 Contact: Agnieszka Pluta, dr 693716980 ext 0048 agnieszkapluta@poczta.onet.pl Principal Investigator: Paweł Stróżecki, dr 收起 << |
NCT01310673 | Gout Gout Acu... 展开 >>te 收起 << | Phase 4 | Completed | - | United States, Vermont ... 展开 >> White River Junction VA Medical Center White River Junction, Vermont, United States, 05009 收起 << |
NCT01100580 | Urinary Stones ... 展开 >> Hypertension Overweight Obesity 收起 << | Not Applicable | Unknown | May 2012 | Italy ... 展开 >> University of Parma Not yet recruiting Parma, Italy, 43100 Contact: Loris Borghi, Prof +390521703375 loris.borghi@unipr.it Principal Investigator: Loris Borghi, Prof 收起 << |
NCT02219516 | - | Completed | - | - | |
NCT02996539 | - | Completed | - | China, Yunnan ... 展开 >> Internal medicine department, Kunming First People's Hospital Kunming, Yunnan, China, 650000 收起 << | |
NCT02018237 | Nonalcoholic Fatty Liver Disea... 展开 >>se Obesity 收起 << | Not Applicable | Completed | - | United States, Missouri ... 展开 >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 收起 << |
NCT02524678 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of 收起 << |
NCT02214589 | Prevention of Procedural Pain ... 展开 >> Reduction of Procedural Pain Biochemical Effects of Oral Sucrose 收起 << | Not Applicable | Recruiting | July 2019 | United States, California ... 展开 >> Loma Linda University Children's Hospital Recruiting Loma Linda, California, United States, 92354 Contact: Danilyn M Angeles, PhD 909-558-7563 dangeles@llu.edu 收起 << |
NCT03206411 | - | Recruiting | November 30, 2018 | Egypt ... 展开 >> Assiut University Recruiting Assiut, Egypt 收起 << | |
NCT01157936 | Systolic and Diastolic Blood P... 展开 >>ressure Levels Uric Acid Levels Metabolic Syndrome Parameters Hepatic Enzymes 收起 << | Phase 2 | Completed | - | Mexico ... 展开 >> Insituto Nacional de Cardiología Ignacio Chávez Mexico, Mexico, 14080 收起 << |
NCT01775098 | Gout | Not Applicable | Withdrawn(because of a lack of... 展开 >> funding) 收起 << | - | - |
NCT01698489 | - | Active, not recruiting | April 2020 | United States, Maryland ... 展开 >> Johns Hopkins University Baltimore, Maryland, United States, 21287 收起 << | |
NCT03105583 | - | Enrolling by invitation | October 2017 | - | |
NCT01788358 | Hypertension | Phase 3 | Completed | - | - |
NCT01788358 | - | Completed | - | - | |
NCT01409408 | Hypertension ... 展开 >>Diabetes Mellitus 收起 << | Phase 4 | Withdrawn(Due to preliminary r... 展开 >>esults of Altitude Trial.) 收起 << | December 2013 | Brazil ... 展开 >> Hospital Universitario Pedro Ernesto Rio de Janeiro, Brazil, 20551030 收起 << |
NCT03766308 | Type 2 Diabetes Mellitus | Not Applicable | Active, not recruiting | May 31, 2019 | China, Hubei ... 展开 >> Tongji Hospital, Tongji Medical College, Huazhong University of Science and technology Wuhan, Hubei, China 收起 << |
NCT03386890 | - | Recruiting | December 31, 2018 | China, Beijing ... 展开 >> Beijing Friendship Hospital Recruiting Beijing, Beijing, China, 100000 Contact: Qianyi Wang 86-13811629824 wangqy1001@hotmail.com 收起 << | |
NCT00655824 | Arthritis, Rheumatoid | Phase 2 | Terminated(The clinical develo... 展开 >>pment of intravenously administered ofatumumab in RA will no longer be pursued, so this study was prematurely terminated by the Sponsor.) 收起 << | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90095 United States, Florida GSK Investigational Site Fort Lauderdale, Florida, United States, 33334 United States, New York GSK Investigational Site New York, New York, United States, 10003 United States, Pennsylvania GSK Investigational Site Duncansville, Pennsylvania, United States, 16635 Denmark GSK Investigational Site Glostrup, Denmark, 2600 GSK Investigational Site Hellerup, Denmark, 2900 GSK Investigational Site Koebenhavn, Denmark, 2100 Hungary GSK Investigational Site Szombathely, Hungary, 9700 Poland GSK Investigational Site Warszawa, Poland, 02-256 United Kingdom GSK Investigational Site Ipswich, United Kingdom, IP4 5PD 收起 << |
NCT01362244 | Nasal Polyps | Phase 2 | Completed | - | Belgium ... 展开 >> GSK Investigational Site Gent, Belgium, 9000 Netherlands GSK Investigational Site Amsterdam, Netherlands, 1105 AZ United Kingdom GSK Investigational Site Cambridge, United Kingdom GSK Investigational Site London, United Kingdom, EC1M 6BQ GSK Investigational Site London, United Kingdom, SE1 1YR GSK Investigational Site London, United Kingdom, SW3 6NP GSK Investigational Site London, United Kingdom, WC1X 8DA 收起 << |
NCT00655824 | - | Terminated(The clinical develo... 展开 >>pment of intravenously administered ofatumumab in RA will no longer be pursued, so this study was prematurely terminated by the Sponsor.) 收起 << | - | - | |
NCT01362244 | - | Completed | - | - | |
NCT02345161 | - | Completed | - | - | |
NCT02069197 | Obesity Diabe... 展开 >>tes Obstructive Sleep Apnea 收起 << | Phase 2 | Recruiting | September 2020 | United States, Maryland ... 展开 >> Mid-Atlantic Epilepsy and Sleep Center, LLC Recruiting Bethesda, Maryland, United States, 20817 Contact: Ivana Tyrlikova, MD 301-530-9744 tyrlikovai@epilepsydc.com Contact: Arcady Barber, MSCN 301-530-9744 barbera@epilepsydc.com 收起 << |
NCT00550459 | - | Completed | - | - | |
NCT02345161 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT00550459 | Hyponatremia | Phase 3 | Completed | - | United States, California ... 展开 >> Sarah. S. Olelewe, MD Hawthorne, California, United States, 90250 Progressive Clinical Research Vista, California, United States, 92083 United States, Colorado Pikes Peak Cardiology Colorado Springs, Colorado, United States, 80907 United States, Florida Innovative Research of West FL Largo, Florida, United States, 33770 Coastal Nephrology Assoc. Research Center Punta Gorda, Florida, United States, 33950 United States, Georgia Rockdale Medical Research Associates Conyers, Georgia, United States, 30094 United States, Louisiana Otis Barnum, DO Natchitoches, Louisiana, United States, 71457 United States, North Dakota Lillestol Research, LLC Fargo, North Dakota, United States, 58106 United States, South Carolina Carolina Research Associates Columbia, South Carolina, United States, 29201 United States, Tennessee Wayne O. Wells, MD Lebanon, Tennessee, United States, 37087 United States, Texas Memorial Clinical Associates Houston, Texas, United States, 77043 United States, Virginia Mitchell Rosner, MD Charlottesville, Virginia, United States, 22908 收起 << |
NCT01808313 | Vascular Disease | Phase 3 | Completed | - | China, Heilongjiang ... 展开 >> GSK Investigational Site Harbin, Heilongjiang, China, 150001 China, Hubei GSK Investigational Site Wuhan, Hubei, China, 430022 China, Hunan GSK Investigational Site Hunan, Hunan, China, 410008 China, Jilin GSK Investigational Site Changchun, Jilin, China, 130021 China, Shaanxi GSK Investigational Site Xian, Shaanxi, China, 710032 China, Shandong GSK Investigational Site Jinan, Shandong, China, 250012 China GSK Investigational Site Beijing, China, 100032 GSK Investigational Site Beijing, China, 100034 GSK Investigational Site Beijing, China, 100037 GSK Investigational Site Beijing, China, 100038 GSK Investigational Site Shanghai, China, 200001 GSK Investigational Site Shanghai, China, 200433 收起 << |
NCT01160224 | Asthma | Phase 2 | Completed | - | Canada, Alberta ... 展开 >> GSK Investigational Site Calgary, Alberta, Canada, T2N 4Z6 Canada, Ontario GSK Investigational Site Hamilton, Ontario, Canada, L8N 4A6 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2X 2P4 GSK Investigational Site Montreal, Quebec, Canada, H4J 1C5 Canada GSK Investigational Site Quebec, Canada, G1V 4G5 收起 << |
NCT01808313 | - | Completed | - | - | |
NCT01205451 | Spasticity, Post-Stroke | Phase 3 | Completed | - | China, Guangdong ... 展开 >> GSK Investigational Site Guangzhou, Guangdong, China China, Heilongjiang GSK Investigational Site Haerbin, Heilongjiang, China, 150001 China, Hubei GSK Investigational Site Wuhan, Hubei, China, 430060 China, Jiangsu GSK Investigational Site Nanjing, Jiangsu, China, 210029 GSK Investigational Site Suzhou, Jiangsu, China, 215004 China, Liaoning GSK Investigational Site Shenyang, Liaoning, China, 110001 China, Sichuan GSK Investigational Site Chengdu, Sichuan, China, 610041 China GSK Investigational Site Beijing, China, 100050 GSK Investigational Site Beijing, China, 100068 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Hangzhou, China, 310016 GSK Investigational Site Shanghai, China, 200025 GSK Investigational Site Shanghai, China, 200040 收起 << |
NCT00608491 | - | Completed | - | - | |
NCT01899768 | Cough | Phase 2 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site Manchester, Lancashire, United Kingdom, M23 9LT GSK Investigational Site Belfast, United Kingdom, BT9 7AB 收起 << |
NCT00608491 | Heart Failure | Phase 3 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic Arizona Phoenix, Arizona, United States, 85054 United States, Georgia Morehouse School of Medicine Atlanta, Georgia, United States, 30310 United States, Minnesota Minnesota Heart Failure Network Minneapolis, Minnesota, United States, 55415 Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Utah University of Utah Health Sciences Center Murray, Utah, United States, 84107 United States, Vermont University of Vermont - Fletcher Allen Health Care Burlington, Vermont, United States, 05401 Canada, Quebec Montreal Heart Institute Montreal, Quebec, Canada, H1T - 1C8 收起 << |
NCT01494610 | Asthma | Phase 2 | Completed | - | Australia, New South Wales ... 展开 >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 New Zealand GSK Investigational Site Wellington, New Zealand, 6021 收起 << |
NCT00577135 | Heart Failure | Phase 3 | Completed | - | United States, Georgia ... 展开 >> Morehouse School of Medicine Atlanta, Georgia, United States, 30310 United States, Massachusetts Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 United States, Minnesota Minnesota Heart Failure Network Minneapolis, Minnesota, United States, 55415 Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Utah University of Utah Health Sciences Center Murray, Utah, United States, 84107 United States, Vermont University of Vermont - Fletcher Allen Health Care Burlington, Vermont, United States, 05401 Canada, Quebec Montreal Heart Institute Montreal, Quebec, Canada, H1T - 1C8 收起 << |
NCT01899768 | - | Completed | - | - | |
NCT00577135 | - | Completed | - | - | |
NCT00442572 | Hepatitis B, Chronic | Phase 2 | Completed | - | Bulgaria ... 展开 >> Mhat St. Ivan Rilski; Clinic of Gastroenterology Sofia, Bulgaria, 1612 收起 << |
NCT01290887 | Eosinophilic Asthma | Phase 3 | Terminated(Business decision) | - | - |
NCT00442572 | - | Completed | - | - | |
NCT01494610 | - | Completed | - | - | |
NCT00543647 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... 展开 >> Site 1 London, United Kingdom 收起 << |
NCT01290887 | - | Terminated(Business decision) | - | - | |
NCT02464345 | Binge Eating Disorder ... 展开 >> Bulimia Nervosa Eating Disorder 收起 << | Phase 2 Phase 3 | Unknown | December 2018 | Brazil ... 展开 >> Universidade Federal de Sao Paulo (UNIFESP) Recruiting Sao Paulo, SP, Brazil Contact: Angelica Claudino, MD, Ph.D 50842187 收起 << |
NCT01205451 | - | Completed | - | - | |
NCT02767869 | Metabolic Syndrome X | Phase 2 | Completed | - | Mexico ... 展开 >> Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 45037 收起 << |
NCT01304992 | Hypercholesterolemia | Not Applicable | Completed | - | Germany ... 展开 >> Friedrich Schiller University Jena, Department of Nutritional Physiology Jena, Thuringia, Germany, 07743 收起 << |
NCT02608710 | Gout | Phase 1 | Completed | - | United States, Texas ... 展开 >> Austin, Texas, United States, 78744 收起 << |
NCT01361022 | Healthy | Phase 1 | Completed | - | Taiwan ... 展开 >> 263.511.1 Boehringer Ingelheim Investigational Site Taipei, Taiwan 收起 << |
NCT02203890 | - | Completed | - | Guatemala ... 展开 >> Center for Studies of Sensory Impairment Aging and Metabolism Guatemala, Quetzaltenango, Guatemala, 09001 收起 << | |
NCT01195662 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT03664167 | Gout, Arthritis, Obesity | Not Applicable | Not yet recruiting | June 1, 2019 | Denmark ... 展开 >> Department of Rheumatology, the Parker Institute, Frederiksberg and Bispebjerg Hospital Not yet recruiting Frederiksberg, Copenhagen, Denmark, 2000 Contact: Line Rustad Contact: Lars Erik Kristensen, MD, phd lars.erik.kristensen@regionh.dk 收起 << |
NCT01195662 | - | Completed | - | - | |
NCT01602562 | Herpes Simplex | Phase 3 | Completed | - | Japan ... 展开 >> GSK Investigational Site Aichi, Japan, 446-8602 GSK Investigational Site Aichi, Japan, 453-8511 GSK Investigational Site Aichi, Japan, 466-8560 GSK Investigational Site Hiroshima, Japan, 734-8551 GSK Investigational Site Hyogo, Japan, 650-0047 GSK Investigational Site Hyogo, Japan, 654-0081 GSK Investigational Site Kagoshima, Japan, 890-8520 GSK Investigational Site Kanagawa, Japan, 259-1143 GSK Investigational Site Osaka, Japan, 594-1101 GSK Investigational Site Saitama, Japan, 339-8551 GSK Investigational Site Tokyo, Japan, 162-8655 收起 << |
NCT00547521 | Rheumatoid Arthritis (RA) | Phase 3 | Completed | - | - |
NCT03539926 | Cystinuria | Not Applicable | Active, not recruiting | February 2019 | Spain ... 展开 >> Fundacio Puigvert Barcelona, Spain, 08025 收起 << |
NCT00547521 | - | Completed | - | - | |
NCT01921374 | Other Diseases or Conditions | Not Applicable | Completed | - | Brazil ... 展开 >> University Federal of São Paulo São Paulo, Brazil, 04024001 收起 << |
NCT01437540 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 3 | Completed | - | - |
NCT01437540 | - | Completed | - | - | |
NCT01747330 | - | Completed | - | - | |
NCT03621215 | Gout Flare Go... 展开 >>ut Attack 收起 << | Not Applicable | Not yet recruiting | January 2021 | United Kingdom ... 展开 >> Food and Nutrition Group, Sheffield Hallam University Not yet recruiting Sheffield, United Kingdom, S1 1WB Contact: Tony Lynn, PhD 0114 2252065 T.Lynn@shu.ac.uk Contact: Margo Barker, PhD 01142560765 Margo.Barker@shu.ac.uk Principal Investigator: Margo Barker, PhD Principal Investigator: Tony Lynn, PhD Sub-Investigator: Kirstie Lamb, MMedSci 收起 << |
NCT03348267 | Skeletal Muscle Damage ... 展开 >> Muscle Inflammation Muscle Recovery Soccer Performance 收起 << | Not Applicable | Completed | - | Greece ... 展开 >> Exercise Biochemistry Laboratory, School of Physical Education & Sports Sciences, University of Thessaly Tríkala, Greece, 42100 收起 << |
NCT01602562 | - | Completed | - | - | |
NCT01321112 | Gene Expression ... 展开 >> Immunosuppression Conversion Liver Transplantation 收起 << | Not Applicable | Unknown | March 2014 | Chile ... 展开 >> Gastroenterology Department, Pontificia Universidad Catolica de Chile Recruiting Santiago, Santiago, RM, Chile, 8330024 Contact: Carlos E Benitez, MD 56-02-3543820 ext 3880 cbenitezc@med.puc.cl 收起 << |
NCT01668654 | Epilepsy | Phase 3 | Terminated(FDA placed a clinic... 展开 >>al hold on the Pediatric Program requiring retigabine discontinuation in subjects; early termination allows for timely reporting of results.) 收起 << | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90027 United States, Florida GSK Investigational Site Gulf Breeze, Florida, United States, 32561 GSK Investigational Site Port Charlotte, Florida, United States, 33952 GSK Investigational Site Wellington, Florida, United States, 33414 United States, Minnesota GSK Investigational Site Saint Paul, Minnesota, United States, 55102-2534 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Tennessee GSK Investigational Site Memphis, Tennessee, United States, 38105 United States, Texas GSK Investigational Site Austin, Texas, United States, 78723 GSK Investigational Site Dallas, Texas, United States, 75230-2507 收起 << |
NCT00401453 | Diabetes Mellitus Type 2 ... 展开 >> Insulin Resistance 收起 << | Phase 3 | Completed | - | Germany ... 展开 >> Fifth Medical Clinic Mannheim, Baden-Wuerttemberg, Germany, 68167 收起 << |
NCT01747330 | Pancreatic Exocrine Insufficie... 展开 >>ncy 收起 << | Phase 3 | Completed | - | Russian Federation ... 展开 >> Site Reference ID/Investigator# 80716 Barnaul, Russian Federation, 656019 Site Reference ID/Investigator# 80693 Moscow, Russian Federation, 117997 Site Reference ID/Investigator# 80698 Novosibirsk, Russian Federation, 630091 Site Reference ID/Investigator# 80713 Novosibirsk, Russian Federation Site Reference ID/Investigator# 80715 Orenburg, Russian Federation, 460000 Site Reference ID/Investigator# 80694 St. Petersburg, Russian Federation, 194156 Site Reference ID/Investigator# 80714 Tomsk, Russian Federation, 634050 Site Reference ID/Investigator# 80697 Voronezh, Russian Federation, 394036 Site Reference ID/Investigator# 80696 Yaroslavl, Russian Federation, 150003 收起 << |
NCT00310375 | - | Completed | - | - | |
NCT01668654 | - | Terminated(FDA placed a clinic... 展开 >>al hold on the Pediatric Program requiring retigabine discontinuation in subjects; early termination allows for timely reporting of results.) 收起 << | - | - | |
NCT00937326 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT00310375 | Epilepsy | Phase 3 | Completed | - | - |
NCT03030456 | Aging Oxidati... 展开 >>ve Stress 收起 << | Not Applicable | Enrolling by invitation | February 2017 | - |
NCT03462121 | Mild to Moderate Dementia Due ... 展开 >>to Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease 收起 << | Phase 2 | Recruiting | April 30, 2019 | Canada, Ontario ... 展开 >> Kawartha Centre - Redefining Healthy Aging Recruiting Peterborough, Ontario, Canada, K9H 2P4 Contact: Jennifer K Ingram, MD FRCPC 705-749-3906 Contact: Krista Gillis 05-930-2667 (24 Hr.) Principal Investigator: Jennifer K Ingram, MD Toronto Memory Program Recruiting Toronto, Ontario, Canada, M3B 2S7 Principal Investigator: Sharon Cohen, MD Gerontion Research Inc., The Center for Memory & Aging Recruiting Toronto, Ontario, Canada, M4G 3E8 Principal Investigator: Giovanni Marotta, MD Canada, Quebec Recherches Neuro-Hippocampe Inc. d/b/a Clinique de la Memoire de l'Outaouais Recruiting Gatineau, Quebec, Canada, J8T 8J1 Principal Investigator: Richard Bergeron, MD Diex Recherche Sherbrooke Inc. Recruiting Sherbrooke, Quebec, Canada, J1L 0H8 Principal Investigator: Marcel Germain, MD 收起 << |
NCT03182543 | Exercise-induced Oxidative Str... 展开 >>ess 收起 << | Not Applicable | Completed | - | - |
NCT00310388 | Epilepsy | Phase 3 | Terminated(No longer any benef... 展开 >>it in collecting data since retigabine has been withdrawn from market.) 收起 << | - | - |
NCT02496494 | CYCLOSPORINE/TACROLIMUS | Phase 4 | Unknown | December 2015 | Korea, Republic of ... 展开 >> Kyungpook National University Hospital Recruiting Daegu, Korea, Republic of Contact: Chan-Duck Kim drcdkim@knu.ac.kr 收起 << |
NCT01495000 | Osteoporosis, Postmenopausal | Phase 3 | Completed | - | India ... 展开 >> GSK Investigational Site Ahmedabad, India, 380015 GSK Investigational Site Bangalore, India, 560043 GSK Investigational Site Bangalore, India, 560052 GSK Investigational Site Bangalore, India, 560054 GSK Investigational Site Delhi, India, 110060 GSK Investigational Site Mangalore, India, 575002 GSK Investigational Site Nagpur, India, 440010 GSK Investigational Site Nagpur, India, 440012 GSK Investigational Site Pune, India, 411030 GSK Investigational Site Trivandrum, India, 695011 GSK Investigational Site Vadodra, India, 390007 收起 << |
NCT00937326 | - | Completed | - | - | |
NCT01495000 | - | Completed | - | - | |
NCT02469298 | Virus Diseases | Phase 2 | Completed | - | - |
NCT00945282 | - | Completed | - | - | |
NCT00604825 | - | Completed | - | - | |
NCT00945282 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 2 | Completed | - | Argentina ... 展开 >> GSK Investigational Site Buenos Aires, Argentina, B1602DBG 收起 << |
NCT00310388 | - | Terminated(No longer any benef... 展开 >>it in collecting data since retigabine has been withdrawn from market.) 收起 << | - | - | |
NCT00604825 | Menopausal and Female Climacte... 展开 >>ric States 收起 << | Phase 2 | Completed | - | - |
NCT01713920 | Hypertension | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> The Catholic University of Korea Bucheon St. Mary's Hospital Bucheon, Korea, Republic of The Catholic University of Korea Seoul St. Mary's Hospital Seoul, Korea, Republic of 收起 << |
NCT03093103 | Nephropathy | Phase 2 | Recruiting | December 31, 2018 | Switzerland ... 展开 >> Service de Néphrologie Recruiting Lausanne, Vaud, Switzerland, 1011 Contact: Guler Gok-sogut, Ass-med 41 79 556 20 05 guler-gok-sogut@chuv.ch Contact: Marie-Eve Muller, MD 41 79 556 59 46 Marie-Eve.Muller@chuv.ch Sub-Investigator: Anne Zanchi, MD Principal Investigator: Michel Burnier, Prof 收起 << |
NCT00996840 | Lung Injury, Acute | Phase 2 | Completed | - | United States, Kentucky ... 展开 >> GSK Investigational Site Lexington, Kentucky, United States, 40536-0293 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 GSK Investigational Site Winston-Salem, North Carolina, United States, 27157 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232-7110 收起 << |
NCT02469298 | - | Completed | - | - | |
NCT01453296 | Asthma | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Cypress, California, United States, 90630 GSK Investigational Site Huntington Beach, California, United States, 92647 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80206 United States, Illinois GSK Investigational Site Normal, Illinois, United States, 61761 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 收起 << |
NCT01453296 | - | Completed | - | - | |
NCT02737267 | Body Weight Changes | Not Applicable | Unknown | December 2017 | Spain ... 展开 >> Centre for Nutrition Research, University of Navarra Pamplona, Navarra, Spain, 31008 收起 << |
NCT03441308 | Overweight and Obesity | Not Applicable | Active, not recruiting | December 31, 2021 | - |
NCT00996840 | - | Completed | - | - | |
NCT00515502 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | Germany ... 展开 >> GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Berlin, Germany, 14050 GSK Investigational Site Hamburg, Germany, 22291 收起 << |
NCT01364623 | Female Sexual Dysfunction | Phase 1 | Completed | - | United States, Texas ... 展开 >> Premier Research International LLC Austin, Texas, United States, 78705 收起 << |
NCT02705807 | Cardiovascular Disease | Phase 4 | Completed | - | Japan ... 展开 >> GSK Investigational Site Okayama, Japan, 701-1192 收起 << |
NCT02705807 | - | Completed | - | - | |
NCT02282683 | Heart Failure ... 展开 >> Hyperuricemia 收起 << | Phase 2 Phase 3 | Recruiting | December 2017 | China, Hebei ... 展开 >> The First Hospital of Hebei Medical University Recruiting Shijiazhuang, Hebei, China, 050031 Contact: Kunshen Liu, M.D. 86 311 85617033 ksliud@sohu.com 收起 << |
NCT02649400 | - | Unknown | - | Brazil ... 展开 >> Federal University of Sao Paulo Sao Paulo, Brazil, 04024002 收起 << | |
NCT01597635 | - | Completed | - | - | |
NCT01453023 | - | Completed | - | - | |
NCT01332292 | Asthma | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Cypress, California, United States, 90630 GSK Investigational Site Huntington Beach, California, United States, 92647 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80206 United States, Illinois GSK Investigational Site Normal, Illinois, United States, 61761 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 收起 << |
NCT00515502 | - | Completed | - | - | |
NCT01332292 | - | Completed | - | - | |
NCT00416130 | Breast Cancer | Phase 1 Phase 2 | Unknown | January 2015 | Singapore ... 展开 >> National University Hospital Singapore, Singapore, 149547 National Cancer Centre Singapore, Singapore, 169610 收起 << |
NCT02337933 | Metabolic Syndrome X | Phase 2 | Completed | - | Mexico ... 展开 >> Instituto de Terapéutica Experimental y Clínica Guadalajara, Jalisco, Mexico, 44140 收起 << |
NCT02129231 | Oxidative Stress ... 展开 >> Diabetic Polyneuropathy 收起 << | Phase 2 | Completed | - | Mexico ... 展开 >> Cardiovascular Research Unit Guadalajara, Jalisco, Mexico, 44340 收起 << |
NCT01597635 | Lung Injury, Acute | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Sacramento, California, United States, 95817 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60611 United States, Massachusetts GSK Investigational Site Springfield, Massachusetts, United States, 01199 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109 United States, New York GSK Investigational Site New York, New York, United States, 10003 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 GSK Investigational Site Greensboro, North Carolina, United States, 27403 GSK Investigational Site Winston-Salem, North Carolina, United States, 27517 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43215 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97239 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19107 United States, South Carolina GSK Investigational Site Charleston, South Carolina, United States, 29425 Canada, British Columbia GSK Investigational Site Vancouver, British Columbia, Canada, V5Z 1M9 GSK Investigational Site Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Nova Scotia GSK Investigational Site Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario GSK Investigational Site Kingston, Ontario, Canada, K7L 2V7 Canada, Quebec GSK Investigational Site Greenfield Park, Quebec, Canada, J4V 2H1 GSK Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 收起 << |
NCT01370811 | Sialorrhoea | Phase 2 | Completed | - | United States, Michigan ... 展开 >> QUEST Research Institute Bingham Farms, Michigan, United States, 48025 收起 << |
NCT01691794 | HIV, Pediatric | Phase 4 | Completed | - | United States, Arizona ... 展开 >> Phoenix Children'S Hospital Phoenix, Arizona, United States, 85016 United States, Georgia Grady Health System Ponce Family And Youth Clinic Atlanta, Georgia, United States, 30322 United States, Texas Children'S Medical Center Of Dallas Dallas, Texas, United States, 75235 Argentina Local Institution Buenos Aires, Bs As, Buenos Aires, Argentina, 1141 Local Institution Buenos Aires, Argentina, 1181 Local Institution Buenos Aires, Argentina, 1425 Brazil Local Institution Salvador, Bahia, Brazil, 40110-160 Local Institution Salvador, Bahia, Brazil, 40110 Local Institution Porto Alegre, RIO Grande DO SUL, Brazil, 90035-903 Local Institution Porto Alegre, Rio Grande Do Sul, Brazil, 90035 Local Institution Sao Paulo, SP, Brazil, 01416-901 Local Institution Sao Paulo, Brazil, 01246 Chile Local Institution Santiago, Metropolitana, Chile, 8207257 Local Institution Santiago, Metropolitana, Chile, 8380418 Mexico Local Institution Guadalajara, Jalisco, Mexico, 44280 Local Institution Monterrey, Nuevo LEON, Mexico, 64000 Local Institution Merida, Yucatan, Mexico, 97000 Local Institution Puebla, Mexico, 72000 Peru Local Institution Lima, Peru, 1 Local Institution Lima, Peru, LIMA 10 Russian Federation Local Institution Moscow, Russian Federation, 129110 Local Institution St. Petersburg, Russian Federation, 190103 South Africa Local Institution Port Elizabeth, Eastern CAPE, South Africa, 6001 Local Institution Bloemfontein, FREE State, South Africa, 9301 Local Institution Soweto, Gauteng, South Africa, 2013 Local Institution Cape Town, Western CAPE, South Africa, 7505 Local Institution Cape Town, Western CAPE, South Africa, 7530 收起 << |
NCT02170012 | Healthy Elderly | Phase 1 | Terminated(The study was prema... 展开 >>turely terminated on 17th December 2014 due to safety concerns.) 收起 << | - | United States, Florida ... 展开 >> Miami Research Associates, Inc. South Miami, Florida, United States, 33143 MRA Clinical Research, LLC South Miami, Florida, United States, 33143 收起 << |
NCT01294436 | Type2 Diabetes ... 展开 >> High Blood Sugar 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> Research Site Nagoya, Aichi, Japan Research Site Owariasahi, Aichi, Japan Research Site Toyohashi, Aichi, Japan Research Site Hirosaki, Aomori, Japan Research Site Niihama, Ehime, Japan Research Site Itoshima, Fukuoka, Japan Research Site Yukuhashi, Fukuoka, Japan Research Site Annaka, Gunma, Japan Research Site OTA, Gunma, Japan Research Site Aki-gun, Hiroshima, Japan Research Site Sapporo, Hokkaido, Japan Research Site Sanuki, Kagawa, Japan Research Site Takamatsu, Kagawa, Japan Research Site Kamakura, Kanagawa, Japan Research Site Kawasaki, Kanagawa, Japan Research Site Yokohamashi, Kanagawa, Japan Research Site Yokohama, Kanagawa, Japan Research Site Zushi, Kanagawa, Japan Research Site Sendai, Miyagi, Japan Research Site Matsumoto, Nagano, Japan Research Site Suita, Osaka, Japan Research Site Otsu, Shiga, Japan Research Site Atami, Shizuoka, Japan Research Site Komatsushima, Tokushima, Japan Research Site Chiyoda, Tokyo, Japan Research Site Chuo, Tokyo, Japan Research Site Mitaka, Tokyo, Japan Research Site OTA, Tokyo, Japan Research Site Shibuya, Tokyo, Japan Research Site Shinjuku, Tokyo, Japan Research Site Taito, Tokyo, Japan Research Site Takaoka, Toyama, Japan Research Site UBE, Yamaguchi, Japan Research Site Fukuoka, Japan Research Site Hiroshima, Japan Research Site Kochi, Japan Research Site Osaka, Japan Research Site Shizuoka, Japan Research Site Toyama, Japan 收起 << |
NCT02151617 | Healthy | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 收起 << |
NCT01453023 | Asthma | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Huntington Beach, California, United States, 92647 收起 << |
NCT02695186 | - | Unknown | June 2016 | Greece ... 展开 >> General Hospital of Filiates Recruiting Filiates, Epirus, Greece, 46300 Contact: Georgios Pappas-Gogos, MD, MSc +302663360227 pappasg8@gmail.com Principal Investigator: Georgios Pappas-Gogos, MD, MSc Principal Investigator: Spyridon Gogos, MD Principal Investigator: Panagiota Aggeli, MD Principal Investigator: Alexandros Tselepis, MD, PhD 收起 << | |
NCT00422318 | Heart Failure ... 展开 >> Hyperuricemia 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> Tottori University Hospital Yonago, Japan, 683-8504 收起 << |
NCT03230526 | Parkinson Disease | Phase 2 | Recruiting | April 20, 2022 | France ... 展开 >> CHU de Nantes Recruiting Nantes, France Contact: Anne Gaëlle Corbille Principal Investigator: Anne Gaëlle Corbille Centre Eugène Marquis Not yet recruiting Rennes, France Contact: Florence Lejeune Principal Investigator: Florence Lejeune CHU de Rennes Not yet recruiting Rennes, France Contact: Marc Verin Principal Investigator: Marc Verin CHU de Tours Recruiting Tours, France Contact: Jean-Luc HOUETO Principal Investigator: Jean-Luc HOUETO 收起 << |
NCT00812617 | Healthy | Not Applicable | Completed | - | Japan ... 展开 >> Hiroshima University Hiroshima, Japan, 734-8551 收起 << |
NCT03076463 | Subjects at Cardiometabolic Ri... 展开 >>sk 收起 << | Not Applicable | Completed | - | Spain ... 展开 >> Institute of Food Science, Technology and Nutrition (ICTAN-CSIC) Madrid, Spain, 28040 收起 << |
NCT01691794 | - | Completed | - | - | |
NCT00124982 | - | Completed | - | - | |
NCT01294436 | - | Completed | - | - | |
NCT00124982 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT03183193 | Non-Alcoholic Fatty Liver Dise... 展开 >>ase Obese Overweight 收起 << | Not Applicable | Recruiting | December 2019 | Spain ... 展开 >> Centre for Nutrition Research, University of Navarra Recruiting Pamplona, Navarra, Spain, 31008 Contact: M. Angeles Zulet, PhD +34948425600 ext 806317 mazulet@unav.es Contact: Itziar Abete, PhD +34948425600 ext 806357 iabetego@unav.es 收起 << |
NCT03216057 | Hypertriglyceridemia ... 展开 >> Pediatric Obesity 收起 << | Not Applicable | Completed | - | - |
NCT03659890 | Healthy | Not Applicable | Recruiting | September 2019 | United Kingdom ... 展开 >> University of Exeter - St Luke's Campus Recruiting Exeter, Devon, United Kingdom, EX2 4TH Contact: Mariana Coelho 07521759471 m.coelho@exeter.ac.uk 收起 << |
NCT01209078 | Skin Infections, Bacterial | Phase 2 | Completed | - | United States, Alabama ... 展开 >> GSK Investigational Site Anniston, Alabama, United States, 36207 United States, California GSK Investigational Site Chula Vista, California, United States, 91911 GSK Investigational Site La Mesa, California, United States, 91942 GSK Investigational Site Long Beach, California, United States, 90813 GSK Investigational Site Oceanside, California, United States, 92056 United States, Hawaii GSK Investigational Site Honolulu, Hawaii, United States, 96813 United States, Pennsylvania GSK Investigational Site West Reading, Pennsylvania, United States, 19611 收起 << |
NCT01295671 | Cardiovascular Disease, Obesit... 展开 >>y 收起 << | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 收起 << |
NCT02114892 | - | Completed | - | - | |
NCT01295671 | - | Completed | - | - | |
NCT02114892 | Metabolic Syndrome X | Phase 2 | Completed | - | Mexico ... 展开 >> Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 45037 收起 << |
NCT03615534 | Atherogenic Dyslipidemia ... 展开 >> Obesity Associated Disorder 收起 << | Phase 4 | Completed | - | Iraq ... 展开 >> Al Kindy College of Medicine, University of Baghdad Baghdad, Iraq, 10045 Lewai S Abdulaziz Baghdad, Iraq, 10045 收起 << |
NCT03766399 | Asthma | Phase 1 | Recruiting | December 5, 2019 | United Kingdom ... 展开 >> Research Site Recruiting Harrow, United Kingdom, HA1 3UJ Research Site Not yet recruiting Manchester, United Kingdom, M23 9GP 收起 << |
NCT03615534 | - | Completed | - | - | |
NCT00234988 | Obesity | Phase 4 | Completed | - | United States, Illinois ... 展开 >> Global Medical Information - Abbott North Chicago, Illinois, United States, 60064 收起 << |
NCT01572792 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 3 | Completed | - | - |
NCT01209078 | - | Completed | - | - | |
NCT01725126 | - | Completed | - | - | |
NCT01725126 | Obesity | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, Kansas GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 << |
NCT01951404 | End Stage Renal Disease ... 展开 >> Left Ventricular Hypertrophy 收起 << | Phase 4 | Completed | - | United Kingdom ... 展开 >> NHS Greater Glasgow and Clyde Glasgow, La, United Kingdom, G12 8TA NHS Tayside Dundee, Tayside, United Kingdom, DD9 1SY NHS Ayrshire and Arran Crosshouse, United Kingdom, KA2OBE 收起 << |
NCT01572792 | - | Completed | - | - | |
NCT01578239 | Carcinoid Tumor of the Small B... 展开 >>owel Neuroendocrine Tumour 收起 << | Phase 3 | Active, not recruiting | February 2021 | - |
NCT01578239 | - | Active, not recruiting | - | - | |
NCT03441711 | - | Recruiting | June 2022 | United States, Tennessee ... 展开 >> Regional One Health Center for High Risk Pregnancies Recruiting Memphis, Tennessee, United States, 38120 Contact: Giancarlo Mari, M.D. 901-448-2531 gmari@uthsc.edu Contact: , M.D. 收起 << | |
NCT01481584 | Men | Not Applicable | Completed | - | Germany ... 展开 >> Friedrich Schiller University Jena, Department of Nutritional Physiology Jena, Thuringia, Germany, 07743 收起 << |
NCT01908257 | Healthy | Phase 1 | Completed | - | United States, California ... 展开 >> Cypress, California, United States, 90630 收起 << |
NCT01334242 | Healthy | Phase 1 | Completed | - | United States, Texas ... 展开 >> Lexicon Investigational Site San Antonio, Texas, United States, 78209 收起 << |
NCT03435276 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... 展开 >> Research Site Harrow, United Kingdom, HA1 3UJ 收起 << |
NCT03496558 | Pregnant Woman With Single Pre... 展开 >>gnancy Pregnant Woman With no Assisted Reproduction 收起 << | Not Applicable | Recruiting | February 2020 | Spain ... 展开 >> Universidad de Granda Recruiting Granada, Spain, 18071 Contact: María José Aguilar Cordero, Professor 657841751 ext +34 mariajaguilar@telefonica.net 收起 << |
NCT02689882 | Metabolic Disturbance | Phase 1 | Completed | - | United States, Washington ... 展开 >> University of Washington Seattle, Washington, United States, 98195 收起 << |
NCT01450709 | - | Unknown | October 2012 | United States, New York ... 展开 >> Parkside Dialysis Clinic at Downstate Medical Center Recruiting Brooklyn, New York, United States, 11226 Principal Investigator: Subodh J Saggi, M.D., MPH 收起 << | |
NCT02000856 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Not Applicable | Completed | - | Sweden ... 展开 >> Uppsala University Hospital Uppsala, Sweden 收起 << |
NCT01450670 | - | Unknown | July 2012 | United States, Pennsylvania ... 展开 >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Principal Investigator: Stephanie DeLoach, M.D. Sub-Investigator: Bonita Falkner, M.D. 收起 << | |
NCT00590538 | Cystic Fibrosis | Phase 1 Phase 2 | Terminated(12/15/2008 Voluntar... 展开 >>ily placed on inactive status-requested by the PI) 收起 << | - | United States, Pennsylvania ... 展开 >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT00590538 | - | Terminated(12/15/2008 Voluntar... 展开 >>ily placed on inactive status-requested by the PI) 收起 << | - | - | |
NCT01099579 | - | Completed | - | - | |
NCT01068717 | - | Completed | - | - | |
NCT01925287 | Pharmacokinetics of Novel Curc... 展开 >>umin Formulations Safety of Novel Curcumin Formulations 收起 << | Early Phase 1 | Completed | - | Germany ... 展开 >> University of Hohenheim Stuttgart, Germany, 70599 收起 << |
NCT01099579 | HIV Infections | Phase 3 | Completed | - | Brazil ... 展开 >> Local Institution Sao Paolo, SAO Paulo, Brazil, 01246-900 Chile Local Institution Santiago, Metropolitana, Chile, 8380418 Local Institution Santiago, Metropolitana, Chile Mexico Local Institution Df, Distrito Federal, Mexico, 06720 Local Institution Guadalajara, Jalisco, Mexico, 44160 Local Institution Guadalajara, Jalisco, Mexico, 44280 Local Institution Merida, Yucatan, Mexico, 97000 Local Institution Oaxaca, Mexico, 71256 Local Institution Puebla, Mexico, 72000 Peru Local Institution Lima, Peru, 1 Local Institution Lima, Peru South Africa Local Institution Bloemfontein, FREE State, South Africa, 9301 Local Institution Coronationville, Gauteng, South Africa, 2092 Local Institution Soweto, Gauteng, South Africa, 2001 Local Institution Congella, KWA ZULU Natal, South Africa, 4013 Local Institution Cape Town, Western CAPE, South Africa, 7505 Thailand Local Institution Bangkok, Thailand, 10330 Local Institution Bangkok, Thailand, 10700 收起 << |
NCT00410410 | - | Completed | - | - | |
NCT00410410 | Ulcerative Colitis | Phase 3 | Completed | - | - |
NCT00664521 | - | Completed | - | - | |
NCT01457950 | Osteoporosis, Postmenopausal | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> GSK Investigational Site Busan, Korea, Republic of, 602-739 GSK Investigational Site Daegu, Korea, Republic of GSK Investigational Site Gwangju, Korea, Republic of, 501-757 GSK Investigational Site Seoul, Korea, Republic of, 100-380 GSK Investigational Site Seoul, Korea, Republic of, 110-744 GSK Investigational Site Seoul, Korea, Republic of, 120-752 GSK Investigational Site Seoul, Korea, Republic of, 135-710 GSK Investigational Site Seoul, Korea, Republic of, 137-701 GSK Investigational Site songpa-gu, Seoul, Korea, Republic of, 138-736 GSK Investigational Site Suwon, Korea, Republic of, 443-721 收起 << |
NCT01068717 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Texas ... 展开 >> Ppd Development, Lp Austin, Texas, United States, 78744 收起 << |
NCT01457950 | - | Completed | - | - | |
NCT01289132 | Essential Hypertension | Phase 2 | Completed | - | - |
NCT00664521 | Rheumatoid Arthritis | Phase 2 | Completed | - | France ... 展开 >> Research Site Nice, France Research Site Paris, France Research Site Strasbourg, France Netherlands Research Site Amsterdam, Netherlands Sweden Research Site Malmö, Sweden Research Site Stockholm, Sweden United Kingdom Research Site Newcastle, United Kingdom Research Site Norwich, United Kingdom 收起 << |
NCT00593606 | Parkinson's Disease | Phase 3 | Completed | - | - |
NCT00593606 | - | Completed | - | - | |
NCT00712933 | - | Completed | - | - | |
NCT00712933 | Systemic Lupus Erythematosus | Phase 3 | Completed | - | - |
NCT01513902 | Juvenile Idiopathic Arthritis | Phase 1 | Completed | - | United States, Minnesota ... 展开 >> Explorer Clinic, University of Minnesota Children's Hospital Minneapolis, Minnesota, United States, 55454 Clinical and Translational Science Institute Masonic Clinical Research Unit (Administration Only) Minneapolis, Minnesota, United States, 55455 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Oregon Randall Children's Hospital at Legacy Emanuel Portland, Oregon, United States, 97227 Germany PRI - Pediatric Rheumatology Research Institute GmbH Bad Bramstedt, Germany, 24576 Hamburger Zentrum fuer Kinder-und Jugendrheumatologie SchoenKlinik Hamburg Eilbek Hamburg, Germany, 22081 Asklepios Klinik Sankt Augustin Gmbh St. Augustin, Germany, 53757 Poland Wojewodzki Specjalistyczny Szpital Dzieciecy im. Sw. Ludwika w Krakowie Krakow, Poland, 31-503 Klinika Kardiologii i Reumatologii Dzieciecej Lodz, Poland, 91-738 Slovakia Narodny ustav reumatickych chorob Piestany, Slovakia, 921 12 收起 << |
NCT00724867 | Systemic Lupus Erythematosus | Phase 3 | Completed | - | - |
NCT00724867 | - | Completed | - | - | |
NCT02145442 | Overweight Ob... 展开 >>esity 收起 << | Phase 2 Phase 3 | Completed | - | Cuba ... 展开 >> National Institute of Endocrinology Plaza de la Revolución, Havana, Cuba, 10400 收起 << |
NCT03672786 | Genetic Change ... 展开 >> Athlete 收起 << | Not Applicable | Completed | - | Spain ... 展开 >> Universidad de Granada Granada, Spain, 18071 收起 << |
NCT03450759 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... 展开 >> Research Site London, United Kingdom, HA1 3UJ 收起 << |
NCT01596309 | Cardiovascular Risk Factors | Not Applicable | Completed | - | Spain ... 展开 >> Department of Nutrition, Food Science, Physiology and Toxicology. University of Navarra Pamplona, Navarra, Spain, 31008 收起 << |
NCT00583362 | Systemic Lupus Erythematosus | Phase 2 | Completed | - | - |
NCT03541005 | Overweight and Obesity | Phase 3 | Recruiting | December 1, 2019 | Cuba ... 展开 >> National Institute of Endocrinology Recruiting Havana, La Habana, Cuba, 10400 Contact: Eduardo Cabrera Rode, Dr. diabetes@infomed.sld.cu Sub-Investigator: Ileana Cubas Dueñas, Dr. Sub-Investigator: Ana I. Conesa González, Dr. Sub-Investigator: José Hernández, Dr. Principal Investigator: Judith Parlá Sardiñas, Dr. Sub-Investigator: Silvia Marín Julia, Dr. Sub-Investigator: Yuri Arnold Domínguez, Dr. Sub-Investigator: Antonio D. Reyes Rodríguez, PD Sub-Investigator: Aimee Álvarez Álvarez, MD Sub-Investigator: Ragmila Echevarría Valdés, BSc Sub-Investigator: Janet Rodríguez Acosta, BSc Sub-Investigator: Liudmila Jorge Espinosa, CPhT Sub-Investigator: Kenia Enrique Lugo, BNurs Sub-Investigator: Masiel Peña Roque, BNurs Sub-Investigator: Rocío Montes de Oca Somoano, Dr. 收起 << |
NCT00583362 | - | Completed | - | - | |
NCT01513902 | - | Completed | - | - | |
NCT03687476 | Niemann-Pick Disease, Type C | Phase 2 | Not yet recruiting | October 30, 2022 | - |
NCT03645434 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 2 | Recruiting | September 23, 2019 | Germany ... 展开 >> Research Site Not yet recruiting Berlin, Germany, 14050 Research Site Withdrawn Frankfurt, Germany, 60596 Research Site Not yet recruiting Grosshansdof, Germany, 22927 Research Site Not yet recruiting Wiesbaden, Germany, 65187 United Kingdom Research Site Recruiting London, United Kingdom, HA1 3UJ Research Site Not yet recruiting Manchester, United Kingdom, M23 9QZ 收起 << |
NCT01784848 | Systemic Hypertension ... 展开 >> Obesity 收起 << | Not Applicable | Active, not recruiting | May 2021 | Brazil ... 展开 >> Instituto Dante Pazzanese de Cardiologia São Paulo, SP, Brazil, 04004-060 Instituto do Coração - Hospital das Clínicas de São Paulo São Paulo, SP, Brazil, 04004-060 Hospital do Coração - Research Institute Sao Paulo, Brazil, 04005-000 收起 << |
NCT03397888 | Hepatic Impairment | Phase 1 | Completed | - | United States, Florida ... 展开 >> Clinical Pharmacology of Miami Hialeah, Florida, United States, 33014 收起 << |
NCT02113241 | Metabolic Syndrome X | Phase 4 | Completed | - | Mexico ... 展开 >> Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 44340 收起 << |
NCT01119846 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, Arizona ... 展开 >> GSK Investigational Site Phoenix, Arizona, United States, 85013 United States, California GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27705 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43212 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 United States, Washington GSK Investigational Site Tacoma, Washington, United States, 98418 收起 << |
NCT03306667 | Hepatic Insufficiency ... 展开 >> Healthy 收起 << | Phase 1 | Completed | - | Japan ... 展开 >> Mochida Investigational sites Tokyo, Japan 收起 << |
NCT02956811 | Type 2 Diabetes ... 展开 >> Left Ventricular Hypertrophy 收起 << | Phase 4 | Active, not recruiting | March 2019 | United Kingdom ... 展开 >> Ninewells Hospital Dundee, United Kingdom 收起 << |
NCT02482402 | Chronic Left Ventricular Failu... 展开 >>re Pulmonary Hypertension 收起 << | Phase 2 | Withdrawn(Delay in recruitment... 展开 >>) 收起 << | - | Germany ... 展开 >> Klinik für Thorax- und Kardiovaskularchirurgie Bad Oeynhausen, Germany, 32545 Thoraxclinic at the University of Heidelberg Heidelberg, Germany, 69126 收起 << |
NCT01684332 | Postprandial ... 展开 >>Hyperglycemia, Postprandial Feeding Behaviors Antioxidant Lipid Profile 收起 << | Not Applicable | Completed | - | Spain ... 展开 >> Department of Nutrition, Food Science and Physiology Pamplona, Navarra, Spain, 31008 收起 << |
NCT00510146 | - | Completed | - | - | |
NCT00510146 | Depression, Bipolar | Phase 3 | Completed | - | China ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100088 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China, 410008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chengdu, China, 610041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510370 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China, 310003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Harbin, China, 150001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kunming, China, 650032 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200030 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wu Han, China, 430060 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Xi'An, China, 710032 Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hiroshima, Japan, 731-0501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shiga, Japan, 525-0037 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 170-0002 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seongnam-Si, Korea, Republic of, 463-707 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 110-744 收起 << |
NCT02890966 | Gout; Hyperuricemia | Phase 1 | Completed | - | China, Chongqing ... 展开 >> The South West Hospital Chongqing, Chongqing, China, 400042 收起 << |
NCT01119846 | - | Completed | - | - | |
NCT03706690 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Recruiting | January 31, 2025 | - |
NCT03118713 | Type 2 Diabetes Mellitus | Phase 4 | Active, not recruiting | January 2019 | Korea, Republic of ... 展开 >> Site 13 Busan, Korea, Republic of Site 02 Deagu, Korea, Republic of Site 11 Guri-si, Korea, Republic of Site 01 Seoul, Korea, Republic of Site 05 Seoul, Korea, Republic of Site 07 Seoul, Korea, Republic of Site 09 Seoul, Korea, Republic of Site 12 Suwon-si, Korea, Republic of 收起 << |
NCT03320941 | Obesity | Phase 2 | Completed | - | Japan ... 展开 >> Novartis Investigative Site Matsudo city, Chiba, Japan, 271 0077 Novartis Investigative Site Chikushino-city, Fukuoka, Japan, 818-0036 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 810-0066 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 819-0006 Novartis Investigative Site Kitakyushu-city, Fukuoka, Japan, 807-0857 Novartis Investigative Site Kakogawa-city, Hyogo, Japan, 675-0101 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 231-0023 Novartis Investigative Site Kumamoto City, Kumamoto, Japan, 860-0863 Novartis Investigative Site Kumamoto-city, Kumamoto, Japan, 860-8039 Novartis Investigative Site Kyoto city, Kyoto, Japan, 600-8898 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 615-8125 Novartis Investigative Site Nagasaki city, Nagasaki, Japan, 850 0045 Novartis Investigative Site Higashiosaka-city, Osaka, Japan, 577-0802 Novartis Investigative Site Higashiosaka-city, Osaka, Japan, 577-0803 Novartis Investigative Site Ageo-city, Saitama, Japan, 362-8588 Novartis Investigative Site Kawaguchi-sity, Saitama, Japan, 332 0021 Novartis Investigative Site Tokorozawa-city, Saitama, Japan, 359-0042 Novartis Investigative Site Tokorozawa, Saitama, Japan Novartis Investigative Site Hachioji-city, Tokyo, Japan, 192-0046 Novartis Investigative Site Kiyose-city, Tokyo, Japan, 204-0021 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0021 Novartis Investigative Site Hyogo, Japan, 674-0081 收起 << |
NCT02374619 | Muscle Damage ... 展开 >> Oxidative Stress 收起 << | Not Applicable | Completed | - | - |
NCT01984749 | Hyperuricemia | Not Applicable | Unknown | - | - |
NCT03438617 | Type 2 Diabetes Mellitus | Not Applicable | Active, not recruiting | July 31, 2018 | China, Shanghai ... 展开 >> Shanghai Sixth People's Hospital Shanghai, Shanghai, China, 200235 An Ting Community Health Center Shanghai, Shanghai, China Cao He Jing Community Health Center Shanghai, Shanghai, China Cao Yang Community Health Center Shanghai, Shanghai, China Hong Mei Community Health Center Shanghai, Shanghai, China Kang Jian Community Health Center Shanghai, Shanghai, China Long Hua Community Health Center Shanghai, Shanghai, China Nan Jing Xi Road Community Health Center Shanghai, Shanghai, China Tao Pu Community Health Center Shanghai, Shanghai, China Tian Lin Community Health Center Shanghai, Shanghai, China Zhen Ru Community Health Center Shanghai, Shanghai, China 收起 << |
NCT02330341 | Glucose Intolerance | Phase 2 | Completed | - | Mexico ... 展开 >> Manuel González Ortiz Guadalajara, Jalisco, Mexico, 44140 收起 << |
NCT03437525 | Type 2 Diabetes Treated With I... 展开 >>nsulin 收起 << | Not Applicable | Active, not recruiting | April 30, 2018 | China, Shanghai ... 展开 >> Shanghai Sixth People's Hospital Shanghai, Shanghai, China, 200235 An Ting Community Health Center Shanghai, Shanghai, China Cao He Jing Community Health Center Shanghai, Shanghai, China Cao Yang Community Health Center Shanghai, Shanghai, China Hong Mei Community Health Center Shanghai, Shanghai, China Kang Jian Community Health Center Shanghai, Shanghai, China Long Hua Community Health Center Shanghai, Shanghai, China Nan Jing Xi Road Community Health Center Shanghai, Shanghai, China Tao Pu Community Health Center Shanghai, Shanghai, China Tian Lin Community Health Center Shanghai, Shanghai, China Zhen Ru Community Health Center Shanghai, Shanghai, China 收起 << |
NCT00555321 | - | Terminated | - | - | |
NCT00546754 | Hypertension | Phase 3 | Completed | - | - |
NCT00546754 | - | Completed | - | - | |
NCT00555321 | Immunosuppression in Solid Org... 展开 >>an Transplant 收起 << | Phase 2 | Terminated | - | - |
NCT01729728 | - | Completed | - | - | |
NCT01729728 | Postoperative Pain ... 展开 >> Acute Pain 收起 << | Phase 2 | Completed | - | United States, Utah ... 展开 >> Jean Brown Research Salt Lake City, Utah, United States, 84124 收起 << |
NCT02498652 | Gout | Phase 2 | Completed | - | United States, California ... 展开 >> Anaheim, California, United States, 92801 United States, Florida DeLand, Florida, United States, 32720 South Miami, Florida, United States, 33143 United States, Texas Dallas, Texas, United States, 75231 收起 << |
NCT03418779 | IgA Nephropathy at High Risk o... 展开 >>f Developing ESRD 收起 << | Phase 2 Phase 3 | Recruiting | August 31, 2021 | China, Beijing ... 展开 >> Guang anmen Hospital, China Academy of Chinese Medical Sciences Recruiting Beijing, Beijing, China, 100053 Contact: Shen Li 010-88001057 lishen58173@163.com Contact: Jinpu Li +86 18642168989 收起 << |
NCT02231333 | Non-alcoholic Steatohepatitis | Not Applicable | Unknown | June 2016 | India ... 展开 >> Institute of Liver & Biliary Sciences Recruiting New Delhi, Delhi, India, 110070 Contact: Dr Devraj K, MD 011-46300000 drdevurgowda@gmail.com 收起 << |
NCT01681303 | Chronic Kidney Disease ... 展开 >> AST-120 收起 << | Phase 4 | Completed | - | Taiwan ... 展开 >> Department of Nephrology, Chang Gung Memorial Hospital Keelung, Taiwan, 204 收起 << |
NCT02498652 | - | Completed | - | - | |
NCT03523026 | Metabolic Syndrome ... 展开 >> Coronary Artery Disease 收起 << | Not Applicable | Recruiting | December 30, 2018 | Turkey ... 展开 >> Kıymet Muammer Recruiting Istanbul, Fatih/Istanbul, Turkey, 34096 Contact: Kıymet Muammer, MSc PT 0090212 4592000 ext 29530 kiymetmuammar@yahoo.com Contact: Fatma Karantay Mutluay, Professor 0090216 4448544 fmutluay@medipol.edu.tr 收起 << |
NCT02354339 | Metabolic Syndrome X | Phase 2 | Completed | - | Mexico ... 展开 >> Instituto de Terapéutica Experimental y Clínica Guadalajara, Jalisco, Mexico, 44340 收起 << |
NCT01290458 | Muscle Damage ... 展开 >> Oxidative Stress Hemolysis 收起 << | Not Applicable | Completed | - | Greece ... 展开 >> University of Thessaly Trikala, Greece, 42100 收起 << |
NCT02205476 | - | Terminated(B5301001 study did ... 展开 >>not meet its predefined efficacy endpoints, the long term follow up study B5301012 was terminated in 1/6/2015. No safety concerns identified.) 收起 << | - | - | |
NCT03596567 | Renal Impairment | Phase 1 | Completed | - | United States, Florida ... 展开 >> University of Miami Division of Clinical Pharmacology Miami, Florida, United States, 33136 University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 United States, Minnesota Prism Clinical Research LLC Saint Paul, Minnesota, United States, 55114 收起 << |
NCT02817256 | Complications of Other Bariatr... 展开 >>ic Procedure 收起 << | Not Applicable | Unknown | November 2018 | United Arab Emirates ... 展开 >> Faculty of Medicine and Health Sciences UAE University Al Ain, AB, United Arab Emirates Faculty of Medicine and Health Sciences Al Ain, United Arab Emirates 收起 << |
NCT00261443 | Bipolar Disorder | Phase 4 | Completed | - | - |
NCT01925547 | Metabolic Syndrome, Protection... 展开 >> Against 收起 << | Phase 2 | Completed | - | Germany ... 展开 >> Institute of Biological Chemistry and Nutrition, University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 收起 << |
NCT03416127 | Diabetes Mellitus, Type 2 | Phase 2 | Not yet recruiting | May 1, 2019 | Mexico ... 展开 >> Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Not yet recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: MANUEL GONZALEZ, PhD +523310585200 ext 34212 uiec@prodigy.net.mx Contact: KARINA PEREZ RUBIO, PhD +523310585200 ext 34212 karina2410@hotmail.com 收起 << |
NCT03444142 | Diabetes Mellitus, Type 2 | Phase 4 | Recruiting | December 30, 2018 | Mexico ... 展开 >> Instituto de terapeutica Experimental y Clinica. Centro universitario de Ciencias de la Salud. Universidad de Guadalajara Recruiting Guadalajara, Jalisco, Mexico, 44340 收起 << |
NCT00261443 | - | Completed | - | - | |
NCT03006471 | PreDiabetes P... 展开 >>rehypertension 收起 << | Phase 4 | Active, not recruiting | December 2018 | Mexico ... 展开 >> Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 44340 收起 << |
NCT03682627 | Kidney Transplantation | Not Applicable | Not yet recruiting | December 2020 | Germany ... 展开 >> Division of Visceral Transplantation, Department of General, Visceral and Transplantation Surgery, University of Heidelberg Heidelberg, Baden-Württemberg, Germany, 69120 收起 << |
NCT03592667 | Hypertension | Phase 4 | Enrolling by invitation | May 2019 | Mexico ... 展开 >> Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 44340 收起 << |
NCT02700334 | Prediabetes I... 展开 >>mpaired Fasting Glucose Impaired Glucose Tolerance 收起 << | Phase 4 | Completed | - | Mexico ... 展开 >> Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 44340 收起 << |
NCT03710460 | Obesity | Phase 4 | Recruiting | June 30, 2019 | Mexico ... 展开 >> Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: Manuel Gonzalez, PhD +52-10-58-52-00 ext 34212 uiec@prodigy.net.mx Contact: Esperanza Martinez, PhD +52-10-58-52-00 ext 34212 esperanzamartnezabundi@yahoo.com 收起 << |
NCT02205476 | Hypertrophic Scars Resulting F... 展开 >>rom Prior Breast Scar Revision Surgery 收起 << | Phase 2 | Terminated(B5301001 study did ... 展开 >>not meet its predefined efficacy endpoints, the long term follow up study B5301012 was terminated in 1/6/2015. No safety concerns identified.) 收起 << | - | United States, Florida ... 展开 >> Stephan Baker MD PA Coral Gables, Florida, United States, 33146 Bayside Ambulatory Center Miami, Florida, United States, 33133 United States, Georgia Kavali Plastic Surgery and Skin Renewal Center Atlanta, Georgia, United States, 30328 Primeter outpatient surgery center Atlanta, Georgia, United States, 30328 United States, Missouri Body Aesthetic Research Center Saint Louis, Missouri, United States, 63141 收起 << |
NCT01018017 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | Germany ... 展开 >> GSK Investigational Site Neuss, Nordrhein-Westfalen, Germany, 41460 收起 << |
NCT03444233 | Non-Alcoholic Fatty Liver Dise... 展开 >>ase Obesity 收起 << | Phase 4 | Completed | - | - |
NCT03612778 | Kidney Transplant; Complicatio... 展开 >>ns 收起 << | Not Applicable | Recruiting | September 2019 | Slovenia ... 展开 >> University Medical Centre Recruiting Ljubljana, Slovenia Contact: Jernej Pajek, PhD 收起 << |
NCT00115063 | Obesity | Phase 4 | Terminated(ethical issues of c... 展开 >>ontinuing control group without treatment) 收起 << | - | United States, Louisiana ... 展开 >> Pennington Management of Clinical Trials Baton Rouge, Louisiana, United States, 70808 收起 << |
NCT00646776 | - | Completed | - | - | |
NCT00115063 | - | Terminated(ethical issues of c... 展开 >>ontinuing control group without treatment) 收起 << | - | - | |
NCT02210156 | Respiratory Tract Infection | Not Applicable | Completed | - | Mexico ... 展开 >> Omnilife Guadalajara, Jalisco, Mexico, 44500 收起 << |
NCT00767520 | - | Completed | - | - | |
NCT02775175 | Healthy Volunteers | Not Applicable | Completed | - | Germany ... 展开 >> Department of Internal and Integrative Medicine, Kliniken Essen-Mitte Essen, Germany, 45276 收起 << |
NCT00646776 | Antivirals/HIV | Phase 1 | Completed | - | United States, New Jersey ... 展开 >> Bristol-Myers Squibb Clinical Pharmacology Unit Hamilton, New Jersey, United States, 08690 收起 << |
NCT01817036 | Vitamin D Deficiency | Phase 1 | Completed | - | China, Shanghai ... 展开 >> Institute for Nutritional Sciences, Chinese Academy of Sciences Shanghai, Shanghai, China, 200031 收起 << |
NCT01899703 | Cholestasis, Intrahepatic | Phase 2 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site Birmingham, West Midlands, United Kingdom, B15 2WB GSK Investigational Site Cambridge, United Kingdom GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 4LP 收起 << |
NCT00639756 | Metabolic Syndrome | Phase 2 | Completed | - | Spain ... 展开 >> Renal Unit, Mateo Orfila Hospital Menorca, Balearic Islands, Spain, 07703 收起 << |
NCT00207090 | - | Completed | - | - | |
NCT00767520 | Breast Cancer | Phase 2 | Completed | - | United States, California ... 展开 >> Compassionate Cancer Care Medical Group, Inc Fountain Valley, California, United States, 92708 Compassionate Cancer Care Medical Group Inc Riverside, California, United States, 92501 United States, Pennsylvania Pennsylvania Oncology/Hematology Associates Philadelphia, Pennsylvania, United States, 19106 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 Czech Republic Local Institution Hradec Kralove, Czech Republic, 500 05 Local Institution Prague 5, Czech Republic, 150 06 France Local Institution Lille, France, 59000 Local Institution Paris Cedex 13, France, 75651 Local Institution Saint-Cloud Cedex, France, 92211 Ireland Local Institution Dublin, Ireland, 24 Poland Local Institution Gdansk, Poland, 80-462 Local Institution Gdansk, Poland, 80-952 Local Institution Lodz, Poland, 93-509 Local Institution Opole, Poland, 45-060 Spain Local Institution Madrid, Spain, 28033 Local Institution Madrid, Spain, 28041 Local Institution Torrevieja, Spain, 03186 Sweden Local Institution Vasteras, Sweden, 72189 United Kingdom Local Institution Chelmsford, Essex, United Kingdom, CM1 7ET Local Institution London, Greater London, United Kingdom, NW1 2BU Local Institution Coventry, Warwickshire, United Kingdom, CV22DX 收起 << |
NCT00207090 | Advanced Solid Tumors ... 展开 >> Neoplasms 收起 << | Phase 1 | Completed | - | United States, Ohio ... 展开 >> The Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 收起 << |
NCT00457002 | Venous Thrombosis ... 展开 >> Pulmonary Embolism 收起 << | Phase 3 | Completed | - | - |
NCT01424514 | - | Completed | - | - | |
NCT00457002 | - | Completed | - | - | |
NCT03771729 | CKD | Early Phase 1 | Not yet recruiting | June 15, 2019 | - |
NCT03272230 | Apathy Fronto... 展开 >>temporal Dementia Parkinson Disease Depressive Symptoms 收起 << | Not Applicable | Recruiting | July 31, 2019 | France ... 展开 >> ICM / Pitié-Salpêtrière Hospital AP-HP / CIC Recruiting Paris, France, 75013 Contact: Armelle Ramettilacroux, Master armelle.ramettilacroux@icm-institute.org 收起 << |
NCT03351530 | - | Enrolling by invitation | February 9, 2019 | Taiwan ... 展开 >> General Biologicals Corporation Hsinchu, Taiwan 收起 << | |
NCT00263302 | Heart Failure, Congestive | Phase 1 | Suspended | - | China, Hebei ... 展开 >> Kunshen Liu Shijiazhuang, Hebei, China, 050031 The First Hospital of Hebei Medical University Shijiazhuang, Hebei, China, 050031 收起 << |
NCT01424514 | Rhinitis | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> GSK Investigational Site Mississauga, Ontario, Canada, L4W 1N2 收起 << |
NCT02343107 | Abdominal Obesity ... 展开 >> Type 2 Diabetes 收起 << | Not Applicable | Completed | - | France ... 展开 >> Groupe Hospitalier Pitié Salpetrière Paris, France, 75013 收起 << |
NCT01316887 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT01316887 | - | Completed | - | - | |
NCT02261376 | Healthy | Phase 1 | Completed | - | United Kingdom ... 展开 >> Hammersmith Medicines Research Ltd London, United Kingdom, NW10 7EW 收起 << |
NCT02014467 | Osteoporosis, Postmenopausal | Phase 3 | Completed | - | China, Sichuan ... 展开 >> GSK Investigational Site Chengdu, Sichuan, China, 610041 GSK Investigational Site Chengdu, Sichuan, China, 610072 China GSK Investigational Site Beijing, China, 100035 GSK Investigational Site Beijing, China, 100050 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Chengdu, China, 610083 GSK Investigational Site Shanghai, China, 200040 GSK Investigational Site Shanghai, China, 200233 收起 << |
NCT00603278 | Asthma | Phase 2 | Completed | - | - |
NCT01934192 | - | Terminated | - | - | |
NCT00603278 | - | Completed | - | - | |
NCT03593785 | Hypercholesterolemia | Phase 1 | Recruiting | July 23, 2019 | United States, California ... 展开 >> Research Site Recruiting Glendale, California, United States, 91206 收起 << |
NCT00603382 | Asthma | Phase 2 | Completed | - | - |
NCT01934192 | Gastroparesis | Phase 2 | Terminated | - | United States, Colorado ... 展开 >> GSK Investigational Site Aurora, Colorado, United States, 80045 United States, Georgia GSK Investigational Site Augusta, Georgia, United States, 30909 United States, Kentucky GSK Investigational Site Louisville, Kentucky, United States, 40202 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 Australia, New South Wales GSK Investigational Site Randwick, New South Wales, Australia, 2031 Australia, Queensland GSK Investigational Site Southport, Queensland, Australia, 4215 Australia, South Australia GSK Investigational Site Adelaide, South Australia, Australia, 5000 GSK Investigational Site Woodville, South Australia, Australia, 5011 Canada, Alberta GSK Investigational Site Calgary, Alberta, Canada, T1Y 6J4 GSK Investigational Site Calgary, Alberta, Canada, T2N 2T9 Canada, Ontario GSK Investigational Site Hamilton, Ontario, Canada, L8L 2X2 GSK Investigational Site Kingston, Ontario, Canada, K7L 2V7 GSK Investigational Site Ottawa, Ontario, Canada, K1H 8L6 GSK Investigational Site Ottawa, Ontario, Canada, K1Y 4E9 GSK Investigational Site Toronto, Ontario, Canada, M5G 1X5 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2X 3J4 GSK Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 GSK Investigational Site Sherbrooke, Quebec, Canada, J1H 5N4 Canada GSK Investigational Site Quebec, Canada, G1J 1Z4 收起 << |
NCT00603746 | Asthma | Phase 2 | Completed | - | - |
NCT02014467 | - | Completed | - | - | |
NCT02158481 | Vascular Diseases ... 展开 >> Impaired Glucose Tolerance 收起 << | Not Applicable | Completed | - | United Kingdom ... 展开 >> Aspect Clinical Ledbury, United Kingdom 收起 << |
NCT00603382 | - | Completed | - | - | |
NCT00796991 | Advanced Melanoma | Phase 1 | Completed | - | United States, California ... 展开 >> The Angeles Clinic & Research Inst. Los Angeles, California, United States, 90025 United States, Florida H Lee Moffit Cancer Cnt And Res Inst Tampa, Florida, United States, 33612 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 United States, North Carolina Blumenthal Cancer Center, Carolinas Medical Center Charlotte, North Carolina, United States, 28204 收起 << |
NCT00796991 | - | Completed | - | - | |
NCT00603746 | - | Completed | - | - | |
NCT01262898 | - | Completed | - | - | |
NCT01586364 | - | Completed | - | - | |
NCT00643201 | Venous Thrombosis | Phase 3 | Completed | - | - |
NCT01585948 | - | Active, not recruiting | December 2017 | Greece ... 展开 >> Cardiology Department, University Hospital of Ioannina Ioannina, Greece, 45110 收起 << | |
NCT01262898 | Gastroparesis | Phase 2 | Completed | - | - |
NCT01586364 | Atrophy Vagin... 展开 >>al Diseases 收起 << | Phase 3 | Completed | - | - |
NCT03768245 | Obesity Diabe... 展开 >>tes Mellitus, Type 2 Cardiovascular Function Kidney Diseases Liver Diseases Physical Fitness 收起 << | Not Applicable | Completed | - | Mexico ... 展开 >> Hospital Regional Adolfo Lopez Matelos Mexico City, Distrito Federal, Mexico, 01620 收起 << |
NCT00311311 | Atherosclerosis ... 展开 >> Kidney Failure 收起 << | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | United States, New York ... 展开 >> Pfizer Investigational Site Rochester, New York, United States, 14642 Canada, Alberta Pfizer Investigational Site Calgary, Alberta, Canada, T2N 2T9 Pfizer Investigational Site Edmonton, Alberta, Canada, T6G 2B7 Canada, Ontario Pfizer Investigational Site Hamilton, Ontario, Canada, L8N 4A6 Pfizer Investigational Site London, Ontario, Canada, N6A 5A5 Pfizer Investigational Site Toronto, Ontario, Canada, M5B 1W8 Pfizer Investigational Site Toronto, Ontario, Canada, M5C 2T2 Canada, Quebec Pfizer Investigational Site Montreal, Quebec, Canada, H1T 2M4 收起 << |
NCT03384290 | Healthy Subjects | Phase 1 | Active, not recruiting | November 2018 | Australia, Victoria ... 展开 >> Nucleus Network Limited Melbourne, Victoria, Australia, 3004 收起 << |
NCT00643201 | - | Completed | - | - | |
NCT00311311 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT02497937 | Heart Failure | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> GSK Investigational Site Minneapolis, Minnesota, United States, 55415 GSK Investigational Site Rochester, Minnesota, United States, 55905 收起 << |
NCT00502996 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT00502996 | - | Completed | - | - | |
NCT02497937 | - | Completed | - | - | |
NCT03574805 | Asthma | Phase 1 | Recruiting | October 20, 2019 | Australia, South Australia ... 展开 >> CMAX Recruiting Adelaide, South Australia, Australia, 500 Contact: Kate Richardson 61 8 7088 7900 Kathryn.Richardson@cmax.com.au Principal Investigator: Thomas Polasek, MD Australia, Victoria Nucleus Network Limited Recruiting Melbourne, Victoria, Australia, 3004 Contact: Jessica Faggian 61 3 9076 8900 j.faggian@nucleusnetwork.com.au Principal Investigator: Oscar Walsh, MD Australia Linear Recruiting Perth, Australia Contact: Nicola Norton, RN 61 0 414 416 034 nnorton@linear.org.au Contact: Simon Scott, BSc, MPharmMed 61 0 432 149 680 sscott@linear.org.au Principal Investigator: Lara Hatchuel, MD 收起 << |
NCT01271218 | Knee Osteoarthritis | Phase 4 | Completed | - | United States, Texas ... 展开 >> Exercise & Sport Nutrition Lab College Station, Texas, United States, 78843 收起 << |
NCT02751424 | Infections, Bacterial | Phase 1 | Terminated(Study data is curre... 展开 >>ntly under review.) 收起 << | - | Australia, South Australia ... 展开 >> GSK Investigational Site Adelaide, South Australia, Australia, 5000 收起 << |
NCT01549626 | Adult Women O... 展开 >>verweight Obese 收起 << | Not Applicable | Completed | - | Brazil ... 展开 >> Clementino Fraga Filho University Hospital Rio de Janeiro, Brazil, 21.941-913 收起 << |
NCT01223365 | Chronic Pain | Phase 3 | Completed | - | - |
NCT01382212 | End-Stage Renal Disease ... 展开 >> Secondary Hyperparathyroidism 收起 << | Phase 3 | Completed | - | - |
NCT01223365 | - | Completed | - | - | |
NCT01439971 | - | Completed | - | - | |
NCT01382212 | - | Completed | - | - | |
NCT03217604 | Healthy Volunteers | Phase 1 | Completed | - | Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 << |
NCT02099968 | Hypertension ... 展开 >>Metabolic Syndrome 收起 << | Not Applicable | Completed | - | Germany ... 展开 >> Immanuel Hospital Berlin, Department of Internal and Complementary Medicine Berlin, Germany, 45276 Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen Essen, Germany, 45276 收起 << |
NCT00394394 | Hypertension | Phase 2 | Completed | - | Brazil ... 展开 >> Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 收起 << |
NCT02751424 | - | Terminated(Study data is curre... 展开 >>ntly under review.) 收起 << | - | - | |
NCT02595684 | Obesity | Phase 4 | Completed | - | Mexico ... 展开 >> Instituto de Terapéutica Experimental y Clínica Guadalajara, Jalisco, Mexico, 44140 收起 << |
NCT01439971 | Hemophilia A | Phase 1 | Completed | - | United States, California ... 展开 >> University of California San Diego Medical Center San Diego, California, United States, 92103-8651 United States, Connecticut New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Oregon Doernbecher Children's Hospital Portland, Oregon, United States, 97239 OHSU Investigational Pharmacy Portland, Oregon, United States, 97239 Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Pennsylvania CTRC Philadelphia, Pennsylvania, United States, 19104 Penn Comprehensive Hemophilia Program - Center for Blood Disorders Philadelphia, Pennsylvania, United States, 19104 Belgium Pfizer Clinical Research Unit Bruxelles, Belgium, B-1070 Hungary Semmelweis Egyetem Altalanos Orvostudomanyi Kar/ I.sz. Belgyogyaszati Klinika Budapest, Hungary, 1083 Italy Dipartimento di Medicina Clinica 1-Centro Regionale per le Malattie del Sangue Castelfranco Veneto (TV), Italy, 31033 Servizio Farmacia- Ospedale Castelfranco Veneto Castelfranco Veneto - Treviso, Italy, 31033 Centro Emofilia e Trombosi "Angelo Bianchi Bonomi" U.O.S. Dipartimentale per la Diagnosi e la Terapi Milano, Italy, 20122 Servizio Farmacia Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Milano, Italy, 20122 Centro Malattie Emorragiche e Trombotiche - Ematologia Vicenza, Italy, 36100 Farmacia Ospedaliera Ospedale San Bortolo Vicenza, Italy, 36100 New Zealand Christchurch Clinical Studies Trust Christchurch, New Zealand, 08011 South Africa Phoenix Pharma (Pty) Ltd Port Elizabeth, Eastern Cape, South Africa, 6001 Turkey Ege University Tip Fakultesi Izmir, Turkey, 35100 United Kingdom Royal Free Hampstead NHS Trust, Royal Free Hospital London, United Kingdom, NW3 2QG Haematology Department London, United Kingdom, W12 0HS Central Manchester Universtiy Hospitals NHS Foundation Trust Manchester, United Kingdom, M13 9WL 收起 << |
NCT00298272 | Rheumatoid Arthritis | Phase 2 | Terminated(Sponsor decided to ... 展开 >>end long term extension phase for business reasons unrelated to safety.) 收起 << | - | United States, Alabama ... 展开 >> Research Site Huntsville, Alabama, United States, 35801 United States, Arizona Research Site Paradise Valley, Arizona, United States, 85253 United States, California Research Site Palm Desert, California, United States, 92260 United States, Florida Research Site Jupiter, Florida, United States, 33458 Research Site Sarasota, Florida, United States, 34239 United States, Idaho Research Site Boise, Idaho, United States, 83702 United States, Michigan Research Site Kalamazoo, Michigan, United States, 49048 United States, Missouri Research Site St. Louis, Missouri, United States, 63141 United States, Ohio Research site Chardon, Ohio, United States, 44024 Research Site Mayfield Village, Ohio, United States, 44143 United States, Oklahoma Research Site Oklahoma City, Oklahoma, United States, 73103 Research Site Tulsa, Oklahoma, United States, 74135 United States, Pennsylvania Research Site Duncansville, Pennsylvania, United States, 16635 United States, Texas Research Site Dallas, Texas, United States, 75231 Research Site Houston, Texas, United States, 77074 Research Site San Antonio, Texas, United States, 78217 United States, Utah Research Site Salt Lake City, Utah, United States, 84132 United States, Vermont Research Site Burlington, Vermont, United States, 05401 收起 << |
NCT01483781 | Diabetes Mellitus, Type 2 ... 展开 >> Plasma Volume 收起 << | Phase 1 | Completed | - | Germany ... 展开 >> Neuss, Germany 收起 << |
NCT00298272 | - | Terminated(Sponsor decided to ... 展开 >>end long term extension phase for business reasons unrelated to safety.) 收起 << | - | - | |
NCT03429478 | Music Therapy ... 展开 >> Cholecystitis/Cholelithiasis Inflammatory Response Surgical Injury 收起 << | Not Applicable | Recruiting | November 1, 2019 | India ... 展开 >> Prof. Brij Bushan Agarwal Recruiting Delhi, India, 110058 Contact: Neeraj Dhamija, DNB Surgery +919811377332 neerajdhamija@icloud.com 收起 << |
NCT03394664 | Obesity | Not Applicable | Recruiting | July 2021 | United States, Massachusetts ... 展开 >> Warren Conference Center and Inn Recruiting Ashland, Massachusetts, United States, 01721 收起 << |
NCT03714438 | Glucose Tolerance | Phase 2 | Completed | - | Mexico ... 展开 >> Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara Guadalajara, Jalisco, Mexico, 44340 收起 << |
NCT02323100 | Cystic Fibrosis | Phase 1 Phase 2 | Recruiting | April 2020 | United States, Alabama ... 展开 >> University of Alabama at Birmingham Not yet recruiting Birmingham, Alabama, United States, 35294-0006 Contact: Steven M Rowe, MD, MSPH 205-934-9640 smrowe@uab.edu Principal Investigator: Steven M Rowe, MD, MSPH United States, Colorado National Jewish Health Recruiting Denver, Colorado, United States, 80206 Contact: Connie StClair 303-270-2321 shiven@njhealth.org Principal Investigator: Noah Lechtzin, MD Sub-Investigator: Peter Mogazel, MD, PhD United States, Pennsylvania Children's Hospital of Philadelphia Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Ron Rubenstein, MD, PhD 215-590-1281 rrubenst@mail.med.upenn.edu Principal Investigator: Ron Rubenstein, MD, PhD 收起 << |
NCT00424593 | - | Completed | - | - | |
NCT02616510 | - | Completed | - | Netherlands ... 展开 >> University Medical Center Utrecht Utrecht, Netherlands 收起 << | |
NCT02000817 | Diabetes Mellitus, Type 1 | Phase 2 | Completed | - | Belgium ... 展开 >> GSK Investigational Site Brussels, Belgium, 1090 GSK Investigational Site Bruxelles, Belgium, 1070 GSK Investigational Site Edegem, Belgium, 2650 GSK Investigational Site Gent, Belgium, 9000 GSK Investigational Site Leuven, Belgium, 3000 GSK Investigational Site Liège, Belgium, 4000 收起 << |
NCT01376388 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 802-0083 GSK Investigational Site Gunma, Japan, 371-0048 GSK Investigational Site Hiroshima, Japan, 732-0052 GSK Investigational Site Hiroshima, Japan, 732-0057 GSK Investigational Site Hokkaido, Japan, 064-0915 GSK Investigational Site Hokkaido, Japan, 080-0805 GSK Investigational Site Hyogo, Japan, 665-0827 GSK Investigational Site Hyogo, Japan, 670-0849 GSK Investigational Site Ibaraki, Japan, 300-0053 GSK Investigational Site Kagawa, Japan, 763-8502 GSK Investigational Site Kanagawa, Japan, 239-0821 GSK Investigational Site Kyoto, Japan, 615-8087 GSK Investigational Site Oita, Japan, 870-0921 GSK Investigational Site Oita, Japan, 876-0047 GSK Investigational Site Osaka, Japan, 576-0016 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Osaka, Japan, 590-0064 GSK Investigational Site Shizuoka, Japan, 436-0022 GSK Investigational Site Tokyo, Japan, 105-0004 GSK Investigational Site Tokyo, Japan, 185-0014 GSK Investigational Site Tokyo, Japan, 187-0024 GSK Investigational Site Wakayama, Japan, 641-8510 GSK Investigational Site Yamanashi, Japan, 400-0031 收起 << |
NCT00105989 | Depressive Disorder, Major | Phase 3 | Completed | - | United States, California ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Newport Beach, California, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sherman Oaks, California, United States United States, Maryland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baltimore, Maryland, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gaithersburg, Maryland, United States United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brooklyn, New York, United States France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Angouleme, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Douai, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fains, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Rochelle, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nimes, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Roubaix, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Strasbourg, France Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ellwangen, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hildesheim, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leipzig, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munchen, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wurzburg, Germany Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Catania, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ferrara, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Firenze, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Parma, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Roma, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Torino, Italy Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St. Petersburg, Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Village Nikolskoe, Russian Federation Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halmstad, Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lund, Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Malmo, Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stockholm, Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sundsvall, Sweden 收起 << |
NCT00424593 | Back Pain Without Radiation | Phase 3 | Completed | - | Brazil ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Curitiba, Brazil, 80060240 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p San Paulo, Brazil, 04027-000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Sao Paulo, Brazil, 04026-000 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Amiens, France, 80054 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Marseille, France, 13008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Paris, France, 75014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Saint Affrique, France, 12400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Saint-Etienne, France, 42055 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Ellwangen, Germany, 73479 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Graefelfing, Germany, 82166 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Hamburg, Germany, 22143 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Wiesbaden, Germany, 65191 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Mexico City, Mexico, 06700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Monterrey, Mexico, 64460 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p San Pedro Garza Garcia, Mexico, 66260 Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Amsterdam, Netherlands, 1105 AZ For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Rotterdam, Netherlands, 3039 BD 收起 << |
NCT00536471 | Major Depressive Disorder | Phase 4 | Completed | - | - |
NCT01025115 | Metabolic Syndrome | Phase 3 | Completed | - | Cuba ... 展开 >> National Institute of Endocrinology Havana City, Havana, Cuba, 10400 收起 << |
NCT03304938 | Diabetes Mellitus, Type 2 ... 展开 >> Sleep Disturbance 收起 << | Not Applicable | Recruiting | February 18, 2018 | Iran, Islamic Republic of ... 展开 >> Shiraz University of Medical Sciences Recruiting Shiraz, Fars, Iran, Islamic Republic of Contact: Zeinab Nasiri Lari, M.D. 09173139409 dr.znasiri@gmail.com 收起 << |
NCT01376388 | - | Completed | - | - | |
NCT00536471 | - | Completed | - | - | |
NCT01244984 | - | Completed | - | - | |
NCT01244984 | Asthma | Phase 3 | Completed | - | Japan ... 展开 >> GSK Investigational Site Chiba, Japan, 277-0863 GSK Investigational Site Fukuoka, Japan, 802-0083 GSK Investigational Site Fukuoka, Japan, 816-0813 GSK Investigational Site Gifu, Japan, 501-6062 GSK Investigational Site Gunma, Japan, 373-0021 GSK Investigational Site Hiroshima, Japan, 730-0844 GSK Investigational Site Hiroshima, Japan, 732-0062 GSK Investigational Site Hiroshima, Japan, 739-0402 GSK Investigational Site Hyogo, Japan, 665-0827 GSK Investigational Site Hyogo, Japan, 670-0046 GSK Investigational Site Hyogo, Japan, 672-8064 GSK Investigational Site Ibaraki, Japan, 302-0022 GSK Investigational Site Kanagawa, Japan, 231-8682 GSK Investigational Site Kanagawa, Japan, 253-0041 GSK Investigational Site Kyoto, Japan, 601-1495 GSK Investigational Site Kyoto, Japan, 615-8087 GSK Investigational Site Miyagi, Japan, 983-0824 GSK Investigational Site Miyagi, Japan, 983-8520 GSK Investigational Site Nagano, Japan, 390-0303 GSK Investigational Site Nagano, Japan, 390-8510 GSK Investigational Site Okayama, Japan, 700-0862 GSK Investigational Site Okayama, Japan, 701-0304 GSK Investigational Site Okayama, Japan, 714-0081 GSK Investigational Site Osaka, Japan, 545-8586 GSK Investigational Site Osaka, Japan, 569-1192 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Tokyo, Japan, 105-0004 GSK Investigational Site Tokyo, Japan, 134-0083 GSK Investigational Site Tokyo, Japan, 185-0014 GSK Investigational Site Toyama, Japan, 937-0066 收起 << |
NCT01702363 | - | Completed | - | - | |
NCT00408993 | Diabetic Neuropathies | Phase 3 | Completed | - | China ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100101 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China, 410011 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Harbin, China, 150086 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjin, China, 210012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200233 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wu Han, China, 430022 收起 << |
NCT00573794 | Ulcerative Colitis | Phase 3 | Completed | - | - |
NCT01702363 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 811-1347 GSK Investigational Site Gunma, Japan, 371-0048 GSK Investigational Site Hokkaido, Japan, 080-0805 GSK Investigational Site Hyogo, Japan, 670-0849 GSK Investigational Site Ibaraki, Japan, 300-0053 GSK Investigational Site Ibaraki, Japan, 302-0022 GSK Investigational Site Ishikawa, Japan, 920-8610 GSK Investigational Site Kanagawa, Japan, 239-0821 GSK Investigational Site Kyoto, Japan, 601-1495 GSK Investigational Site Miyagi, Japan, 983-0824 GSK Investigational Site Nagano, Japan, 391-0011 GSK Investigational Site Oita, Japan, 870-0921 GSK Investigational Site Oita, Japan, 876-0047 GSK Investigational Site Osaka, Japan, 530-0001 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Shizuoka, Japan, 436-0022 GSK Investigational Site Tokyo, Japan, 103-0027 GSK Investigational Site Tokyo, Japan, 153-8934 GSK Investigational Site Tokyo, Japan, 192-0903 GSK Investigational Site Yamanashi, Japan, 400-0031 收起 << |
NCT00408993 | - | Completed | - | - | |
NCT00105989 | - | Completed | - | - | |
NCT03516721 | Obesity Adole... 展开 >>scent Obesity 收起 << | Not Applicable | Completed | - | Belgium ... 展开 >> Jessa Ziekenhuis Hasselt, Belgium, 3500 收起 << |
NCT01602549 | Gastroparesis | Phase 2 | Completed | - | Australia, New South Wales ... 展开 >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Germany GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89081 GSK Investigational Site Bochum, Nordrhein-Westfalen, Germany, 44791 GSK Investigational Site Bonn, Nordrhein-Westfalen, Germany, 53105 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 50937 GSK Investigational Site Jena, Thueringen, Germany, 07747 GSK Investigational Site Berlin, Germany, 13088 Sweden GSK Investigational Site Uppsala, Sweden, SE-751 85 United Kingdom GSK Investigational Site Cambridge, United Kingdom, C2B 2PY GSK Investigational Site Newcastle Upon Tyne, United Kingdom, NE4 5PL GSK Investigational Site Norwich, United Kingdom, NR4 7UY 收起 << |
NCT01301456 | Diabetes Mellitus ... 展开 >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida Elite Research Institute Miami, Florida, United States, 33169 Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Miramar, Florida, United States, 33025 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30308 United States, Nebraska ICON Clinical Pharmacology, LLC Omaha, Nebraska, United States, 68154 United States, Pennsylvania CRI Worldwide, LLC Philadelphia, Pennsylvania, United States, 19139 United States, Texas Healthcare Discoveries LLC d/b/a ICON Development Solutions San Antonio, Texas, United States, 78209 收起 << |
NCT00573794 | - | Completed | - | - | |
NCT01453049 | Diabetes Mellitus, Type 2 | Phase 3 | Terminated(US FDA/EMA/SFDA dec... 展开 >>isions to rosiglitazone-containing medicines, ethic) 收起 << | - | China, Hubei ... 展开 >> GSK Investigational Site Wuhan, Hubei, China, 430030 China, Jiangsu GSK Investigational Site Suzhou, Jiangsu, China, 215004 China, Liaoning GSK Investigational Site Dalian, Liaoning, China, 116027 China, Zhejiang GSK Investigational Site Hangzhou, Zhejiang, China, 310003 GSK Investigational Site Hangzhou, Zhejiang, China, 310009 China GSK Investigational Site Beijing, China, 100029 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Chongqing, China, 400016 GSK Investigational Site Shanghai, China, 200080 GSK Investigational Site Shenyang, China, 110003 GSK Investigational Site Tianjin, China, 300052 GSK Investigational Site Wuhan, China, 430022 收起 << |
NCT01602549 | - | Completed | - | - | |
NCT01453049 | - | Terminated(US FDA/EMA/SFDA dec... 展开 >>isions to rosiglitazone-containing medicines, ethic) 收起 << | - | - | |
NCT01721317 | Seizures | Phase 4 | Terminated(After reevaluation ... 展开 >>of the benefit risk profile of ezogabine/retigabine, GSK does not believe the early adjunctive treatment study population is appropriate.) 收起 << | - | United States, California ... 展开 >> GSK Investigational Site Fresno, California, United States, 93710 GSK Investigational Site Newport Beach, California, United States, 92658 GSK Investigational Site Newport Beach, California, United States, 92663 GSK Investigational Site Santa Monica, California, United States, 90404 United States, Colorado GSK Investigational Site Colorado Springs, Colorado, United States, 80907 United States, Florida GSK Investigational Site Pensacola, Florida, United States, 32514 GSK Investigational Site Port Charlotte, Florida, United States, 33952 United States, Illinois GSK Investigational Site Peoria, Illinois, United States, 61637 United States, Maryland GSK Investigational Site Bethesda, Maryland, United States, 20817 United States, Minnesota GSK Investigational Site Golden Valley, Minnesota, United States, 55422 United States, New Jersey GSK Investigational Site Hackensack, New Jersey, United States, 07601 GSK Investigational Site Livingston, New Jersey, United States, 07039 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 United States, Texas GSK Investigational Site Arlington, Texas, United States, 76017 GSK Investigational Site Dallas, Texas, United States, 75251 GSK Investigational Site Kingwood, Texas, United States, 77339 GSK Investigational Site San Antonio, Texas, United States, 78229 GSK Investigational Site Temple, Texas, United States, 76508 United States, Washington GSK Investigational Site Spokane, Washington, United States, 99204 Greece GSK Investigational Site Athens, Greece, 10676 GSK Investigational Site Thessaloniki, Greece, 57010 收起 << |
NCT01721317 | - | Terminated(After reevaluation ... 展开 >>of the benefit risk profile of ezogabine/retigabine, GSK does not believe the early adjunctive treatment study population is appropriate.) 收起 << | - | - | |
NCT01301456 | - | Completed | - | - | |
NCT01494584 | Epilepsy | Phase 2 | Terminated(Terminated after pl... 展开 >>acing the study on hold at the request of the FDA) 收起 << | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90027 United States, Florida GSK Investigational Site Gulf Breeze, Florida, United States, 32561 GSK Investigational Site Port Charlotte, Florida, United States, 33952 GSK Investigational Site Wellington, Florida, United States, 33414 United States, Minnesota GSK Investigational Site Saint Paul, Minnesota, United States, 55102-2534 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Tennessee GSK Investigational Site Memphis, Tennessee, United States, 38105 United States, Texas GSK Investigational Site Austin, Texas, United States, 78723 GSK Investigational Site Dallas, Texas, United States, 75230-2507 收起 << |
NCT02299375 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | - |
NCT01494584 | - | Terminated(Terminated after pl... 展开 >>acing the study on hold at the request of the FDA) 收起 << | - | - | |
NCT00408876 | - | Completed | - | - | |
NCT00408876 | Back Pain Without Radiation | Phase 3 | Completed | - | United States, Florida ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Fort Myers, Florida, United States, 33912 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Orlando, Florida, United States, 32806 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph South Miami, Florida, United States, 33143 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Tampa, Florida, United States, 33606 收起 << |
NCT00406848 | Major Depressive Disorder | Phase 4 | Completed | - | - |
NCT02299375 | - | Completed | - | - | |
NCT00767806 | Chronic Low Back Pain | Phase 3 | Completed | - | United States, Arizona ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chandler, Arizona, United States, 85225 United States, Connecticut For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cromwell, Connecticut, United States, 06416 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Deland, Florida, United States, 32720 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jacksonville, Florida, United States, 32216 United States, Massachusetts For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brighton, Massachusetts, United States, 02135 United States, Oklahoma For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oklahoma City, Oklahoma, United States, 73109 United States, Oregon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Portland, Oregon, United States, 97210 Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sa Coma, Brazil, 04230000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. São Paulo, Brazil, 04026-000 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aalen, Germany, 73430 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alzenau, Germany, 63755 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 10629 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ellwangen, Germany, 73479 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 20255 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wiesbaden, Germany, 65189 Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rotterdam, Netherlands, 3039 BD Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Krakow, Poland, 30-349 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lublin, Poland, 20-093 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland, 61-289 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Szczecin, Poland, 70-376 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation, 119992 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08025 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bilboa, Spain, 48013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Getafe, Spain, 28905 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Coruña, Spain, 15006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28009 收起 << |
NCT00406848 | - | Completed | - | - | |
NCT00711009 | Human Immunodeficiency Virus I... 展开 >>nfection 收起 << | Phase 3 | Completed | - | - |
NCT01932203 | Cerebral Small Vessel Disease | Phase 4 | Unknown | October 2018 | Korea, Republic of ... 展开 >> Myongji Hospital Goyang-si, Gyeonggi-do, Korea, Republic of, 412-270 National Health Insurance Corporation Ilsan Hospital Goyang-si, Gyeonggi-do, Korea, Republic of Dongtan Sacred Heart Hospital, Hallym University College of Medicine Hwaseong-si, Gyeonggi-do, Korea, Republic of Wonkwang University Iksan Hospital Iksan, Jeollabuk-do, Korea, Republic of Hallym University Medical Center Anyang, Korea, Republic of Bucheon St.Mary's Hospital Bucheon, Korea, Republic of Soonchunhyang University Bucheon Hospital Bucheon, Korea, Republic of Eulji University School of Medicine Daejeon, Korea, Republic of Konyang University Hospital Daejeon, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Inha University Hospital Incheon, Korea, Republic of, 400-711 Gachon University Gil Medical Incheon, Korea, Republic of Dong-A University Hospital Pusan, Korea, Republic of Pusan National University Hospital Pusan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Chungang University Hospital Seoul, Korea, Republic of Ewha Womans University Mokdong Hospital Seoul, Korea, Republic of Kyung Hee University Hospital Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of 收起 << |
NCT02064881 | Type 2 Diabetes | Phase 2 Phase 3 | Recruiting | August 2020 | Mexico ... 展开 >> Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán Recruiting México, Distrito Federal, Mexico, 14000 Contact: Francisco Gómez, Doctor 55133891 gomezperezfco@gmail.com Contact: Paloma Almeda, Doctor 56554523 palomaalmeda@yahoo.com Principal Investigator: Francisco J Gómez, Doctor 收起 << |
NCT00767806 | - | Completed | - | - | |
NCT03010514 | - | Recruiting | October 2019 | China ... 展开 >> Beijing Anzhen Hospital Recruiting Beijing, China, 100029 Contact: ke-xu Yang 86-010-64426153 EC@anzhenGCP.com 收起 << | |
NCT02621060 | Impaired Glucose Tolerance | Phase 2 | Unknown | February 2017 | Mexico ... 展开 >> Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara Recruiting Guadalajara, Jalisco, Mexico, 44340 收起 << |
NCT00168831 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT02545777 | Acute Gouty Arthritis | Phase 2 | Unknown | - | China, Beijing ... 展开 >> No.3 Hospital Affiliated to Beijing University of Chinese Medicine Recruiting Beijing, Beijing, China, 100029 Contact: Lou Xi Nen, Doctor 13601181885 13601181885@163.com Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine Recruiting Beijing, Beijing, China, 100700 Contact: Zhao Jiu Li, Doctor 84013229 dzmk@163.net 收起 << |
NCT01262781 | - | Completed | - | United States, California ... 展开 >> San Francisco General Hospital San Francisco, California, United States, 94110 收起 << | |
NCT02956655 | Type 2 Diabetes Mellitus | Not Applicable | Unknown | - | China, Guangdong ... 展开 >> The First Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Jian Qin, Doctor 020-87330751 himybox@yeah.net 收起 << |
NCT00168831 | - | Completed | - | - | |
NCT00168844 | - | Completed | - | - | |
NCT00711009 | - | Completed | - | - | |
NCT00775437 | Juvenile Idiopathic Arthritis | Phase 3 | Completed | - | - |
NCT02780908 | Hypoxia Altit... 展开 >>ude Sickness Tolerance 收起 << | Not Applicable | Unknown | December 2018 | Slovenia ... 展开 >> Jozef Stefan Institute Recruiting Ljubljana, Slovenia, 1000 Contact: Tadej Debevec, PhD +38641278954 tadej.debevec@ijs.si Contact: Igor B. Mekjavic, PhD +386 1 477 3358 igor.mekjavic@ijs.si University Children's Hospital Ljubljana Department of Pediatric Neurology Recruiting Ljubljana, Slovenia, 1000 Contact: Damjan Osredkar, MD PhD +386.1.522.9273 damjan.osredkar@kclj.si Contact: Minca Mramor, MD PhD +386.1.522.9286 minca.mramor@gmail.com 收起 << |
NCT01623453 | - | Terminated(Difficulty recruiti... 展开 >>ng subjects) 收起 << | - | Korea, Republic of ... 展开 >> DaeHang Hospital Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of 收起 << | |
NCT00168844 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT00775437 | - | Completed | - | - | |
NCT02929498 | Myelodysplastic Syndrome | Phase 2 | Recruiting | May 15, 2019 | United States, Pennsylvania ... 展开 >> GSK Investigational Site Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT01485887 | Major Depressive Disorder | Phase 3 | Completed | - | Japan ... 展开 >> Nippon Medical School Chiba Hokusoh Hospital Inzai, Chiba, Japan, 270-1694 Nakamoto Clinic Noda City, Chiba, Japan, 278-0033 Stress Care Yoshimura Clinic Fukuoka-shi, Fukuoka, Japan, 810-0041 Hatakeyama Clinic Kitakyushu, Fukuoka, Japan, 802-0064 Shiranui Hospital Omuta, Fukuoka, Japan, 836-0004 Fujikawa Clinic Hatsukaichi, Hiroshima, Japan, 738-0023 Takahashi Psychiatric Clinic Ashiya, Hyogo, Japan, 659-0093 Ikeuchi Psycho Induced Internal Med.Clinic Kobe, Hyogo, Japan, 655-0037 National Hospital Organization Kanazawa Medical Center Kanazawa, Ishikawa, Japan, 920-8650 Medical Corporation Seishinkai Kishiro Mental Clinic Kawasaki, Kanagawa, Japan, 214-0014 Yutaka Clinic Sagamihara-shi, Kanagawa, Japan, 252-0303 Tawara Clinic Yokohama, Kanagawa, Japan, 221-0835 Shioiri Mental Clinic Yokosuka city, Kanagawa, Japan, 238-0042 Shibamoto Clinic Osakasayama-shi, Osaka, Japan, 589-0011 Suzuki Hospital Adachi-ku, Tokyo, Japan, 120-0033 Sangenjaya Nakamura Mental Clinic Setagaya-ku, Tokyo, Japan, 154-0004 Omotesando Mental Clinic Shibuya-ku, Tokyo, Japan, 150-0001 Maynds Tower Mental Clinic Shibuya-ku, Tokyo, Japan, 151-0053 Tokyo Kosei Nenkin Hospital Shinjuku-ku, Tokyo, Japan, 162-8543 Himorogi Psychiatric Institute Toshima-ku, Tokyo, Japan, 170-0002 Tenjin Mental Clinic Fukuoka, Japan, 810-0004 Stress Care Yoshimura Clinic Fukuoka, Japan, 810-0041 Kuranari Psychiatry Clinic Fukuoka, Japan, 810-0801 Medical Corporation Toyokokai Tawara Clinic Kanagawa, Japan, 221-0835 Sagaarashiyama-Tanaka Clinic Kyoto, Japan, 616-8421 收起 << |
NCT01485887 | - | Completed | - | - | |
NCT01928940 | Solid Tumours | Phase 2 | Completed | - | Japan ... 展开 >> GSK Investigational Site Shizuoka, Japan, 411-8777 GSK Investigational Site Tokyo, Japan, 104-0045 收起 << |
NCT02015988 | Acute Coronary Syndrome ... 展开 >> Diabetes Mellitus, Type 2 Hypertriglyceridemia 收起 << | Phase 4 | Unknown | May 2017 | Ukraine ... 展开 >> State Institution "Dnipropetrovsk Medical Academy of Health Ministry of Ukraine" Dnipropetrovsk, Ukraine 收起 << |
NCT02177812 | Leukaemia, Myelocytic, Acute | Phase 1 | Terminated(The risk benefit in... 展开 >> relapsed refractory AML does not favor continuation of the study.) 收起 << | - | United States, Georgia ... 展开 >> GSK Investigational Site Augusta, Georgia, United States, 30912 United States, New York GSK Investigational Site Bronx, New York, United States, 10461 GSK Investigational Site Bronx, New York, United States, 10467 GSK Investigational Site New York, New York, United States, 10065 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 Australia, Victoria GSK Investigational Site Melbourne, Victoria, Australia, 3004 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M5G 2M9 GSK Investigational Site Toronto, Ontario, Canada, M5G 2M 收起 << |
NCT01928940 | - | Completed | - | - | |
NCT03544281 | Multiple Myeloma | Phase 2 | Recruiting | November 28, 2022 | United States, Alabama ... 展开 >> GSK Investigational Site Recruiting Birmingham, Alabama, United States, 35294 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT02728414 | Diabetes Mellitus, Type 2 | Not Applicable | Recruiting | December 2017 | China, Shanghai ... 展开 >> Shanghai 10th People's Hospital Recruiting Shanghai, Shanghai, China, 200072 Contact: Cuiling Zhu, MD 18817951953l 1263856671@qq.com Principal Investigator: Renyuan Gao, MD 收起 << |
NCT02733484 | Obesity | Not Applicable | Recruiting | December 2017 | China, Shanghai ... 展开 >> Shanghai 10th People's Hospital Recruiting Shanghai, Shanghai, China, 200072 Contact: Cuiling Zhu, MD 18817951953 1263856671@qq.com Contact: Renyuan Gao, MD renyuangao@126.com Principal Investigator: Huanlong Qin, PhD Principal Investigator: Shen Qu, PhD 收起 << |
NCT00408421 | Osteoarthritis Knee Pain | Phase 3 | Completed | - | United States, Arizona ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chandler, Arizona, United States, 85225 United States, California For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beverly Hills, California, United States, 90211 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Northridge, California, United States, 91325 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Walnut Creek, California, United States, 94598 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Deland, Florida, United States, 32720 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fort Myers, Florida, United States, 33916 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. S. Miami, Florida, United States, 33143 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stuart, Florida, United States, 34996 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States, 60611 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Morton Grove, Illinois, United States, 60053 United States, Massachusetts For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Billerica, Massachusetts, United States, 01821 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Waltham, Massachusetts, United States, 02453 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Westborough, Massachusetts, United States, 01581 United States, Nevada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Reno, Nevada, United States, 89502 United States, New Jersey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edison, New Jersey, United States, 08817 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stratford, New Jersey, United States, 08084 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toms River, New Jersey, United States, 08755 United States, Oklahoma For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tulsa, Oklahoma, United States, 74135 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lake Jackson, Texas, United States, 77566 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Waco, Texas, United States, 76708 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wichita Falls, Texas, United States, 76309 Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hato Rey, Puerto Rico, 00917 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Juan, Puerto Rico, 00935 Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brasov, Romania, 500365 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bucharest, Romania, 70266 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cluj-Napoca, Romania, 400132 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Iasi, Romania, 700656 收起 << |
NCT01417624 | Heart Failure | Phase 3 | Unknown | June 2013 | United Kingdom ... 展开 >> Royal Brompton Hospital Recruiting London, United Kingdom, SW3 6NP Principal Investigator: Rakesh Sharma, MRCP PhD Sub-Investigator: Kaushik Guha, MBBS MRCP Sub-Investigator: Martin R Cowie, MD FRCP FESC Sub-Investigator: Raad Mohiaddin, MD PhD FRCP Sub-Investigator: Ranil de Silva, PhD FRCP 收起 << |
NCT03515122 | - | Enrolling by invitation | December 2019 | Sweden ... 展开 >> Rehabilitation medicine Research Group Lund, Sweden 收起 << | |
NCT02888691 | Type 1 Diabetes | Not Applicable | Completed | - | Denmark ... 展开 >> Hvidovre University Hospital Hvidovre, Denmark, 2650 收起 << |
NCT03422172 | HIV Infections | Phase 1 | Active, not recruiting | April 28, 2020 | China, Zhejiang ... 展开 >> GSK Investigational Site Hangzhou, Zhejiang, China, 310000 China GSK Investigational Site Beijing, China, 100069 GSK Investigational Site Shanghai, China, 201508 收起 << |
NCT01705210 | - | Completed | - | Netherlands ... 展开 >> Maastricht University Medical Center Maastricht, Netherlands, 6202 AZ 收起 << | |
NCT01222949 | Malaria, Falciparum | Phase 1 | Completed | - | Australia ... 展开 >> CMAX, a division of IDT Australia Limited Adelaide, Australia, SA 5000 Nucleus Network Limited Melbourne, Australia, VIC 3004 收起 << |
NCT01222962 | Malaria, Falciparum | Phase 1 | Completed | - | Australia ... 展开 >> CMAX, a division of IDT Australia Limited Adelaide, Australia, SA 5000 收起 << |
NCT03460795 | Liver Cirrhosis | Phase 1 Phase 2 | Not yet recruiting | September 1, 2020 | China, Jiangsu ... 展开 >> Nanjing Medical University Not yet recruiting Nanjing, Jiangsu, China, 210029 Contact: Ling Lu, M.D, PH. D. 86-025-68136053 lvling@njmu.edu.cn 收起 << |
NCT01222078 | Diabetes Mellitus, Type 1 | Phase 2 | Terminated(A Phase 3 study rec... 展开 >>ently reported and demonstrated that the dose of otelixizumab in OTX113390 is not effective.) 收起 << | - | France ... 展开 >> GSK Investigational Site Paris Cedex 18, France, 75877 Germany GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89081 GSK Investigational Site Leipzig, Sachsen, Germany, 04103 收起 << |
NCT03593707 | Healthy Volunteers | Phase 1 | Suspended(Sponsor elected to v... 展开 >>oluntarily pause study.) 收起 << | February 12, 2019 | Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 << |
NCT01222078 | - | Terminated(A Phase 3 study rec... 展开 >>ently reported and demonstrated that the dose of otelixizumab in OTX113390 is not effective.) 收起 << | - | - | |
NCT03743519 | Patellofemoral Pain | Not Applicable | Not yet recruiting | April 1, 2020 | - |
NCT00787137 | - | Terminated(poor recruitment) | - | - | |
NCT02292771 | Obstetric Labour, Premature | Phase 3 | Terminated(The study was stopp... 展开 >>ed due to the feasibility of recruiting the study in a timely manner) 收起 << | - | - |
NCT00146328 | - | Completed | - | - | |
NCT00146328 | HIV Infections | Phase 2 Phase 3 | Completed | - | - |
NCT00408421 | - | Completed | - | - | |
NCT01549210 | - | Completed | - | Italy ... 展开 >> Dept of Rheumatology - IRCCS San Matteo Foundation Pavia, Italy, 27100 收起 << | |
NCT00736099 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00787137 | Arthritis, Psoriatic | Phase 1 | Terminated(poor recruitment) | - | Serbia ... 展开 >> Professor Nemanja Damjanov Belgrade, Serbia 收起 << |
NCT00742508 | - | Completed | - | - | |
NCT00742508 | Heart Failure, Congestive | Phase 1 | Completed | - | Japan ... 展开 >> GSK Investigational Site Chiba, Japan, 296-8602 GSK Investigational Site Ehime, Japan, 794-0006 GSK Investigational Site Hiroshima, Japan, 737-0023 GSK Investigational Site Hokkaido, Japan, 060-0033 GSK Investigational Site Hokkaido, Japan, 063-0005 GSK Investigational Site Kanagawa, Japan, 210-0852 GSK Investigational Site Kanagawa, Japan, 238-8558 GSK Investigational Site Mie, Japan, 511-0068 GSK Investigational Site Nagano, Japan, 397-8555 GSK Investigational Site Nagasaki, Japan, 859-3615 GSK Investigational Site Oita, Japan, 879-5593 GSK Investigational Site Osaka, Japan, 565-8565 GSK Investigational Site Saga, Japan, 843-0393 GSK Investigational Site Saitama, Japan, 364-8501 GSK Investigational Site Shizuoka, Japan, 410-2295 GSK Investigational Site Shizuoka, Japan, 411-8611 GSK Investigational Site Shizuoka, Japan, 427-8502 GSK Investigational Site Shizuoka, Japan, 430-8502 GSK Investigational Site Tokyo, Japan, 141-0001 GSK Investigational Site Tokyo, Japan, 142-8666 GSK Investigational Site Tokyo, Japan, 153-8515 GSK Investigational Site Tokyo, Japan, 196-0003 GSK Investigational Site Wakayama, Japan, 640-8158 收起 << |
NCT02377466 | Obstetric Labour, Premature | Phase 3 | Terminated(Asset terminated by... 展开 >> PIB) 收起 << | - | - |
NCT02292771 | - | Terminated(The study was stopp... 展开 >>ed due to the feasibility of recruiting the study in a timely manner) 收起 << | - | - | |
NCT00623597 | HIV Infections | Phase 2 | Completed | - | Argentina ... 展开 >> Buenos Aires, Argentina, 1202 Buenos Aires, Argentina, 1425 Santa Fe, Argentina, 3000 Spain Madrid, Spain, 28046 Madrid, Spain, 28905 Valencia, Spain, 46009 Thailand Bangkok, Thailand, 10400 Khon Kaen, Thailand, 40002 Pathumwan, Thailand, 10330 Payathai, Thailand, 10400 收起 << |
NCT00736099 | - | Completed | - | - | |
NCT02533817 | Healthy | Not Applicable | Completed | - | - |
NCT03563846 | Lactose Intolerance | Phase 1 | Completed | - | United States, Florida ... 展开 >> Syneos Health Miami, Florida, United States, 33136 收起 << |
NCT02377466 | - | Terminated(Asset terminated by... 展开 >> PIB) 收起 << | - | - | |
NCT00623597 | - | Completed | - | - | |
NCT02045797 | Infections, Bacterial | Phase 2 | Completed | - | - |
NCT02564055 | Dermatitis, Atopic | Phase 2 | Completed | - | - |
NCT02045797 | - | Completed | - | - | |
NCT02564042 | Psoriasis | Phase 2 | Completed | - | - |
NCT02279641 | Gout | Phase 1 | Completed | - | United States, Kansas ... 展开 >> Overland Park, Kansas, United States, 66212 收起 << |
NCT02880852 | Systemic Lupus Erythematosus | Phase 1 | Completed | - | China ... 展开 >> GSK Investigational Site Shanghai, China GSK Investigational Site Suzhou, China, 215004 收起 << |
NCT01356602 | Acute Gouty Arthritis | Phase 3 | Completed | - | - |
NCT02279641 | - | Completed | - | - | |
NCT01265498 | Nonalcoholic Fatty Liver Disea... 展开 >>se (NAFLD) Nonalcoholic Steatohepatitis (NASH) 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> University of California, San Diego San Diego, California, United States, 92103 University of California, San Francisco San Francisco, California, United States, 94143 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Missouri St. Louis University Saint Louis, Missouri, United States, 63104 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44109 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 收起 << |
NCT02880852 | - | Completed | - | - | |
NCT02564055 | - | Completed | - | - | |
NCT03684122 | Parkinson Disease | Phase 1 Phase 2 | Recruiting | April 2019 | Jordan ... 展开 >> Cell Therapy Center, University of Jordan Recruiting Amman, Jordan, 11942 Contact: Fatima Jamali, PhD 009625355000 ext 23960 ftmjamali@gmail.com 收起 << |
NCT01431638 | Acute Gouty Arthritis | Phase 3 | Completed | - | - |
NCT01710722 | Obesity | Not Applicable | Completed | - | United States, Louisiana ... 展开 >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 收起 << |
NCT01356602 | - | Completed | - | - | |
NCT01156220 | Healthy Male and Female Volunt... 展开 >>eers 收起 << | Phase 4 | Unknown | June 2012 | Germany ... 展开 >> Clinical Trial Center North Not yet recruiting Hamburg, Germany, 20246 Contact: Alen Jambrecina, Dr. med. +49 40 7410 51603 a.jambrecina@uke.de 收起 << |
NCT02564042 | - | Completed | - | - | |
NCT01265498 | - | Completed | - | - | |
NCT01552590 | Hyponatremia and Extracellular... 展开 >> Fluid in Cirrhotic 收起 << | Phase 4 | Unknown | January 2013 | Korea, Republic of ... 展开 >> Hallym Univ. Chuncheon Sacred Heart Hospital Recruiting Bucheon, Korea, Republic of Contact: KiTae Suk, Assistant professor Principal Investigator: KiTae Suk, Assistant professor Soonchunhyang Univ. Bucheon Hospital Recruiting Bucheon, Korea, Republic of Contact: YoungSeok Kim, Associate professor Principal Investigator: YoungSeok Kim, Associate professor Wonju Christian Hospital Recruiting Wonju, Korea, Republic of Contact: SoonKoo Baik, Professor Principal Investigator: SoonKoo Baik, Professor 收起 << |
NCT01594567 | - | Unknown | December 2015 | Canada, Ontario ... 展开 >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 收起 << | |
NCT01608620 | - | Unknown | September 2016 | Canada, Ontario ... 展开 >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 收起 << | |
NCT02057731 | - | Completed | - | United States, Florida ... 展开 >> University of Florida Gainesville, Florida, United States, 32608 收起 << | |
NCT01777256 | Systemic Lupus Erythematosus | Phase 2 | Terminated(This study met a pr... 展开 >>otocol defined futility criterion and will be terminated following completion of the Follow Up Visit on the last subject randomised.) 收起 << | - | - |
NCT01671124 | - | Unknown | November 2013 | Taiwan ... 展开 >> Taipei Mecical University Hospital Recruiting Taipei, Taiwan, 100 Contact: Yu-Ru Guo, master 886227361661 ext 6549 dinyty@hotmail.com Sub-Investigator: Chih-Chiang Chiu, Ph.D Sub-Investigator: Hsin-Chien Lee, Ph.D Principal Investigator: Shih-Yi Huang, Ph.D 收起 << | |
NCT03015948 | Gout | Phase 1 | Completed | - | Australia, New South Wales ... 展开 >> Atridia Pty Limited Sydney, New South Wales, Australia, 2000 收起 << |
NCT01460797 | Obesity | Not Applicable | Completed | - | Brazil ... 展开 >> School of Health Sciences, University of Brasília Brasília, DF, Brazil, 70910-900 收起 << |
NCT02147041 | Diabetes Mellitus ... 展开 >> Hyperlipidemia 收起 << | Phase 2 Phase 3 | Unknown | August 2014 | Taiwan ... 展开 >> Taipei City Hospital Taipei, Taiwan 收起 << |
NCT00077636 | Hepatitis C, Chronic | Phase 4 | Completed | - | - |
NCT00077636 | - | Completed | - | - | |
NCT02310750 | - | Completed | - | - | |
NCT02205333 | Advanced Solid Tumors ... 展开 >> Aggressive B-cell Lymphomas 收起 << | Phase 1 Phase 2 | Terminated(The study was termi... 展开 >>nated early at the sponsor's discretion.) 收起 << | - | United States, Arizona ... 展开 >> Research Site Scottsdale, Arizona, United States, 85259 United States, California Research Site Sacramento, California, United States, 95817 Research Site Santa Monica, California, United States, 90404 United States, District of Columbia Research Site Washington, D.C., District of Columbia, United States, 20007 United States, Florida Research Site Tampa, Florida, United States, 33612 United States, Illinois Research Site Chicago, Illinois, United States, 60611 United States, Michigan Research Site Detroit, Michigan, United States, 48202 United States, Nevada Research Site Las Vegas, Nevada, United States, 89169 United States, New Jersey Research Site Hackensack, New Jersey, United States, 7601 United States, North Carolina Research Site Huntersville, North Carolina, United States, 28078 United States, Oregon Research Site Portland, Oregon, United States, 97213 United States, Tennessee Research Site Memphis, Tennessee, United States, 38120 United States, Texas Research Site Houston, Texas, United States, 77030 收起 << |
NCT02014272 | Healthy Volunteers | Phase 1 | Completed | - | Singapore ... 展开 >> Pfizer Investigational Site Singapore, Singapore, 188770 收起 << |
NCT02310750 | Plaque Psoriasis | Phase 1 | Completed | - | United States, California ... 展开 >> Anaheim Clinical Trials, LLC Anaheim, California, United States, 92801 收起 << |
NCT02014272 | - | Completed | - | - | |
NCT02262754 | Chronic Low Back Pain | Phase 2 | Completed | - | - |
NCT02228395 | Healthy | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 收起 << |
NCT02205333 | - | Terminated(The study was termi... 展开 >>nated early at the sponsor's discretion.) 收起 << | - | - | |
NCT01449110 | Cardiovascular Diseases | Phase 2 | Completed | - | Spain ... 展开 >> University Hospital Morales Meseguer Murcia, Spain, 30008 收起 << |
NCT02228395 | - | Completed | - | - | |
NCT02262754 | - | Completed | - | - | |
NCT00419146 | Schizophrenia ... 展开 >> Schizophreniform Disorders Schizoaffective Disorder Psychotic Disorders 收起 << | Phase 2 Phase 3 | Completed | - | Norway ... 展开 >> Aker University Hospital Oslo, Norway, 0320 收起 << |
NCT01369225 | Alzheimer's Disease | Phase 1 | Completed | - | United States, Florida ... 展开 >> MD Clinical Hallandale Beach, Florida, United States, 33009 Munroe Regional Medical Center Ocala, Florida, United States, 34471 Renstar Medical Research Ocala, Florida, United States, 34471 Trinity Care Solutions Ocala, Florida, United States, 34471 Advanced Imaging of Ocala Ocala, Florida, United States, 34481 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30308 United States, Maryland Foers Medical Arts Pharmacy Bethesda, Maryland, United States, 20814 CBH Health, LLC Rockville, Maryland, United States, 20850 United States, Michigan Borgess Medical Center Kalamazoo, Michigan, United States, 49048 Borgess Research Institute Kalamazoo, Michigan, United States, 49048 KNI Southwest Michigan Imaging Center, LLC Kalamazoo, Michigan, United States, 49048 United States, Missouri Millennium Psychiatric Associates, LLC Creve Coeur, Missouri, United States, 63141 DePaul Health Center-MRI Department St. Louis, Missouri, United States, 63044 United States, New Jersey Memory Enhancement Center of America, Inc. Eatontown, New Jersey, United States, 07724 Central Jersey Radiology Oakhurst, New Jersey, United States, 07755 Korea, Republic of Seoul National University Hospital, Department Neurology Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Inha University Hospital, Department of Neurology Incheon, Korea, Republic of, 400-711 Samsung Medical Center, Department of Neurology Seoul, Korea, Republic of, 1350710 Korea University Anam Hospital IRB Seoul, Korea, Republic of, 136-705 ASAN Medical Center Seoul, Korea, Republic of, 138-736 Konkuk University Medical Center, Department of Neurology Seoul, Korea, Republic of, 143914 收起 << |
NCT02443740 | Healthy | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 收起 << |
NCT02224664 | Parkinson`s Disease | Phase 1 | Completed | - | United States, California ... 展开 >> Orange Coast Memorial Medical Center Fountain Valley, California, United States, 92708 The Parkinson's and Movement Disorder Institute Fountain Valley, California, United States, 92708 Collaborative Neuroscience Network, LLC Long Beach, California, United States, 90806 United States, Colorado Rocky Mountain Movement Disorders Center Englewood, Colorado, United States, 80113 Davita Clinical Research Center Lakewood, Colorado, United States, 80228 United States, Florida MD Clinical Hallandale Beach, Florida, United States, 33009 Compass Research, LLC Orlando, Florida, United States, 32806 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30331 United States, Massachusetts Massachusetts General Hospital -- FOR DRUG SHIPMENT ONLY Boston, Massachusetts, United States, 02114 Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Quest Research Institute Farmington Hills, Michigan, United States, 48334 United States, New Jersey PRA International Marlton, New Jersey, United States, 08053 United States, North Carolina Carolina Phase I Research, LLC Raleigh, North Carolina, United States, 27612 United States, Oklahoma Lynn Health Science Institute Oklahoma City, Oklahoma, United States, 73112 United States, Texas Neurology Consultants of Dallas, PA Dallas, Texas, United States, 75231 Walnut Hill Medical Center Dallas, Texas, United States, 75231 Belgium Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 << |
NCT02443740 | - | Completed | - | - | |
NCT01673178 | Diabetes Melliuts, Type 2 | Phase 1 | Completed | - | United States, California ... 展开 >> Anaheim Clinical Trials, LLC Anaheim, California, United States, 92801 Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Diablo Clinical Research, Inc. Walnut Creek, California, United States, 94598 United States, Florida Avail Clinical Research, LLC DeLand, Florida, United States, 32720 Elite Research Institute Miami, Florida, United States, 33169 Miami Research Associates, Inc. South Miami, Florida, United States, 33143 MRA Clinical Research, LLC South Miami, Florida, United States, 33143 United States, Kentucky Central Kentucky Research Associates, Inc. Lexington, Kentucky, United States, 40509 L-MARC Research Center Louisville, Kentucky, United States, 40213 United States, Minnesota Prism Research Saint Paul, Minnesota, United States, 55114 United States, North Carolina High Point Clinical Trials Center, LLC High Point, North Carolina, United States, 27265 Carolina Phase 1 Research Raleigh, North Carolina, United States, 27612 Wake Internal Medicine Consultants Raleigh, North Carolina, United States, 27612 United States, Ohio Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45227 Community Research Cincinnati, Ohio, United States, 45255 Mercy Hospital Pharmacy Cincinnati, Ohio, United States, 45255 United States, Texas Covance Clinical Research Unit Dallas, Texas, United States, 75247 收起 << |
NCT02224664 | - | Completed | - | - | |
NCT01806896 | Huntington's Disease | Phase 2 | Completed | - | France ... 展开 >> Centre d'Investigation Clinique (CIC)/ Institut du Cerveau et de la Möelle Epinière (ICM) Paris Cedex 13, France, 75651 收起 << |
NCT01806896 | - | Completed | - | - | |
NCT02259244 | Obesity | Not Applicable | Completed | - | - |
NCT00983437 | - | Terminated(Study has been stop... 展开 >>ped by sponsor decision) 收起 << | - | - | |
NCT01369225 | - | Completed | - | - | |
NCT03680105 | Critical Limb Ischemia | Phase 1 | Recruiting | March 2019 | United States, Texas ... 展开 >> ICON Early Phase Services Recruiting San Antonio, Texas, United States, 78209 Contact: Dennis A Ruff, MD 收起 << |
NCT03493191 | Acute Pain | Phase 1 | Recruiting | September 2018 | Australia ... 展开 >> Linear Clinical Research Limited Recruiting Nedlands, Australia Contact: Sarah Powell +61 (0) 411 062 165 spowell@linear.org.au 收起 << |
NCT01673178 | - | Completed | - | - | |
NCT01258712 | Rheumatoid Arthritis (RA) | Phase 3 | Completed | - | Taiwan ... 展开 >> Buddhist Dalin Tzu Chi General Hospital Chiayi, Taiwan Chang Gung Memorial Hospital -Kaohsiung Kaohsiung, Taiwan Kaohsiung Medical University Hospital Kaohsiung, Taiwan Kaohsiung Veterans General Hospital Kaohsiung, Taiwan Chung Shan Medical University Hospital Taichung, Taiwan Taichung Veterans General Hospital Taichung, Taiwan National Cheng Kung University Hospital Tainan, Taiwan Cathay General Hospital Taipei, Taiwan National Taiwan University Hospital Taipei, Taiwan Taipei Veterans General Hospital Taipei, Taiwan Tri-Service General Hospital Taipei, Taiwan Chang Gung Memorial Hospital - Linkou Taoyuan, Taiwan 收起 << |
NCT00983437 | Traumatic Brain Injury | Phase 3 | Terminated(Study has been stop... 展开 >>ped by sponsor decision) 收起 << | - | - |
NCT00703755 | Patients With Metabolic Syndro... 展开 >>me 收起 << | Phase 2 | Completed | - | - |
NCT02956577 | - | Completed | - | Denmark ... 展开 >> Cardiovascular Research Unit, OUH Svendborg Hospital Svendborg, Denmark, 5700 收起 << | |
NCT01922739 | Low Back Pain | Phase 3 | Completed | - | - |
NCT01899755 | Psoriasis | Phase 1 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site London, United Kingdom, NW10 7EW 收起 << |
NCT01922739 | - | Completed | - | - | |
NCT03686722 | Diabetes Mellitus, Type 2 ... 展开 >> Hepatitis C Drug Interactions 收起 << | Phase 1 | Completed | - | Egypt ... 展开 >> Drug research centre Cairo, Egypt 收起 << |
NCT00903201 | Cystic Fibrosis | Phase 2 | Completed | - | - |
NCT00903201 | - | Completed | - | - | |
NCT02992106 | Endothelial Dysfunction ... 展开 >> Childhood Obesity 收起 << | Not Applicable | Enrolling by invitation | August 2020 | Belgium ... 展开 >> University Hospital of Brussels Brussels, Belgium, 1090 收起 << |
NCT03433248 | Type2 Diabetes | Phase 4 | Recruiting | December 1, 2020 | Netherlands ... 展开 >> VU University Medical Center Recruiting Amsterdam, Noord-Holland, Netherlands, 1081HV Contact: Michaël JB van Baar, MD +31 20 444 4709 m.vanbaar@vumc.nl Contact: Daniël H van Raalte, MD PhD +31 20 444 0534 d.vanraalte@vumc.nl Principal Investigator: Mark HH Kramer, MD PhD Principal Investigator: Daniël H van Raalte, MD PhD 收起 << |
NCT02358668 | Pre-Diabetes | Phase 2 | Completed | - | Hong Kong ... 展开 >> The Chinese University of Hong Kong Shatin, Hong Kong 收起 << |
NCT00546052 | Hypertension ... 展开 >>Metabolic Disorder 收起 << | Phase 3 | Completed | - | - |
NCT02795754 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 << |
NCT01173120 | Rheumatoid Arthritis (RA) | Phase 3 | Completed | - | - |
NCT01396187 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, California ... 展开 >> Pfizer Investigational Site Chula Vista, California, United States, 91911 United States, Florida Pfizer Investigational Site Miami, Florida, United States, 33169 Pfizer Investigational Site South Miami, Florida, United States, 33143 United States, Kansas Pfizer Investigational Site Overland Park, Kansas, United States, 66212 United States, Texas Pfizer Investigational Site San Antonio, Texas, United States, 78229 收起 << |
NCT01173120 | - | Completed | - | - | |
NCT02090621 | Hepatic Insufficiency | Phase 2 | Completed | - | Spain ... 展开 >> Jose Antonio Pons, MD Murcia, El Palmar, Spain, 30120 收起 << |
NCT02358668 | - | Completed | - | - | |
NCT01396187 | - | Completed | - | - | |
NCT01637675 | Pulmonary Hypertension ... 展开 >> Pulmonary Arterial Hypertension Cardiovascular Diseases Lung Diseases Tanshinone IIA Sulfonate 收起 << | Phase 2 Phase 3 | Unknown | December 2014 | China, Guangdong ... 展开 >> The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Jian Wang, MD +8615013388183 jwang31@jhmi.edu 收起 << |
NCT02845622 | Cardiovascular Diseases ... 展开 >> Glucose Metabolism Disorders 收起 << | Not Applicable | Completed | - | Italy ... 展开 >> San Donato Hospital San Donato Milanese, Italy, 20097 收起 << |
NCT00546052 | - | Completed | - | - | |
NCT01916239 | Colorectal Cancer | Phase 1 Phase 2 | Completed | - | Spain ... 展开 >> Hospital General Universitario Reina Sofía Murcia, Spain, 30003 收起 << |
NCT02729662 | Autosomal Dominant Polycystic ... 展开 >>Kidney Disease 收起 << | Not Applicable | Active, not recruiting | September 30, 2021 | Japan ... 展开 >> Kyorin University Hospital Mitaka, Tokyo, Japan, 181-8611 收起 << |
NCT03458650 | Healthy | Phase 1 | Completed | - | China, Shanghai ... 展开 >> Huashan Hospital, Fudan University Shanghai, Shanghai, China, 200040 收起 << |
NCT00402168 | Renal Transplant | Phase 2 | Completed | - | - |
NCT02427347 | Abdominal Obesity ... 展开 >> Metabolic Syndrome 收起 << | Not Applicable | Completed | - | China, Beijing ... 展开 >> Department of Acupuncture and Moxibustion, Dongfang Hospital, Beijing University of Chinese Medicine Beijing, Beijing, China, 100078 收起 << |
NCT03198585 | Heart Failure With Reduced Eje... 展开 >>ction Fraction 收起 << | Phase 2 | Recruiting | October 2019 | Denmark ... 展开 >> Herlev and Gentofte University Hospital Recruiting Copenhagen, Denmark, 2730 Contact: Jesper Jensen, MD +45 38686258 jesper.jensen.06@regionh.dk Principal Investigator: Morten Schou, MD Sub-Investigator: Jesper Jensen, MD Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Massar Omar, MD +45 608400609 massar.omar@rsyd.dk Principal Investigator: Jacob E Moller, MD Sub-Investigator: Massar Omar, MD 收起 << |
NCT00402168 | - | Completed | - | - | |
NCT03061851 | Diabetes Mellitus, Type 2 | Not Applicable | Recruiting | December 2018 | China, Shandong ... 展开 >> Qingdao University Hospital Recruiting Qingdao, Shandong, China Contact: Nailong Yang 0086-18661806185 nailongyang@163.com 收起 << |
NCT00272779 | HIV Infections | Phase 3 | Completed | - | - |
NCT03050229 | Nocturnal Hypertension ... 展开 >> T2DM (Type 2 Diabetes Mellitus) 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> Fukuoka University Chikushi Hospital Fukuoka, Japan Kotake Hospital Fukuoka, Japan Onga Hospital Fukuoka, Japan Ishiguro Clinic Gifu, Japan Higashiagatsuma-machi National Health Insurance Clinic Gunma, Japan Katsuya Iin Hyogo, Japan Minamisanriku Hospital Miyagi, Japan Shibuya Clinic Saitama, Japan International University of Health and Welfare Hospital Tochigi, Japan Jichi Medical University hospital Tochigi, Japan Utsunomiya higashi hospital Tochigi, Japan Kato Clinic Tokyo, Japan 收起 << |
NCT01894165 | Molybdenum Cofactor Deficiency... 展开 >> (MoCD) Rare Autosomal Recessive Disorder Deficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase) 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> Parexel Baltimore EPCU Baltimore, Maryland, United States, 21225 收起 << |
NCT03449199 | Diabetic Kidney Disease | Phase 2 | Recruiting | June 30, 2019 | - |
NCT01072175 | Cancer | Phase 2 | Completed | - | United States, California ... 展开 >> Novartis Investigative Site Los Angeles, California, United States, 90025 Novartis Investigative Site San Francisco, California, United States, 94115 United States, Colorado Novartis Investigative Site Aurora, Colorado, United States, 80045 United States, Connecticut Novartis Investigative Site New Haven, Connecticut, United States, 06520 United States, Florida Novartis Investigative Site Tampa, Florida, United States, 33612 United States, Maryland Novartis Investigative Site Lutherville-Timonium, Maryland, United States, 21093 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02114 Novartis Investigative Site Boston, Massachusetts, United States, 02215 United States, Minnesota Novartis Investigative Site Rochester, Minnesota, United States, 55905 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37203 Novartis Investigative Site Nashville, Tennessee, United States, 37232 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030-4009 Australia, New South Wales Novartis Investigative Site Westmead, New South Wales, Australia, 2145 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3084 收起 << |
NCT03446053 | Healthy Volunteers ... 展开 >> Anti-Bacterial Agents Methicillin-Resistant Staphylococcus Aureus Methicillin-Sensitive Staphylococcus Aureus Infection 收起 << | Phase 1 | Recruiting | October 2019 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: In Jin Jang, M.D., Ph. D 82-2-740-8290 ijjang@snu.ac.kr Contact: Jun Gi Hwang Hwang, M.D 82-2-742-9252 hjk17@snu.ac.kr Principal Investigator: In Jin Jang, M.D., Ph. D Sub-Investigator: Jun Gi Hwang, M.D 收起 << |
NCT00204230 | Immunosuppressive Agents ... 展开 >> Kidney Failure, Chronic Kidney Transplantation 收起 << | Not Applicable | Terminated | - | - |
NCT02433717 | Schizophrenia ... 展开 >> Schizoaffective Disorder 收起 << | Phase 4 | Unknown | February 2016 | Taiwan ... 展开 >> Department of Psychiatry, National Taiwan University Hospital Not yet recruiting Taipei, Test2, Taiwan, test3 Contact: Yi-Ting Lin +886-972-653-797 p98421013@ntu.edu.tw Sub-Investigator: Ming H. Hsieh Sub-Investigator: Yi-Lin Chien Sub-Investigator: Chih-Min Liu Sub-Investigator: Tzung-Jeng Hwang Sub-Investigator: Chen-Chung Liu National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Yi-Ting Lin, MD +886-2-23123456 ext 67990 p98421013@ntu.edu.tw Principal Investigator: Yi-Ting Lin, MD Sub-Investigator: Chin-Min Liu, MD, PhD Sub-Investigator: Ming H Hsieh, MD, PhD Sub-Investigator: Tzung-Jeng Hwang, MD, PhD Sub-Investigator: Chen-Chung Liu, MD, PhD Principal Investigator: Yi-Ling Chien, MD, PhD 收起 << |
NCT00272779 | - | Completed | - | - | |
NCT00823199 | - | Completed | - | - | |
NCT02972905 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 1 | Completed | - | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 813-0017 收起 << |
NCT02594514 | - | Completed | - | Brazil ... 展开 >> HCFUMSP Sao Paulo, SP, Brazil, 0543-010 收起 << | |
NCT02377427 | Asthma | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site San Diego, California, United States, 92123 United States, North Carolina GSK Investigational Site Chapel Hill, North Carolina, United States, 27599-7310 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73112 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 United States, Wisconsin GSK Investigational Site Madison, Wisconsin, United States, 53792-9988 Japan GSK Investigational Site Fukuoka, Japan, 811-1394 GSK Investigational Site Hiroshima, Japan, 720-8520 GSK Investigational Site Hiroshima, Japan, 721-8511 GSK Investigational Site Wakayama, Japan, 646-8558 Poland GSK Investigational Site Lodz, Poland, 90-329 GSK Investigational Site Tarnow, Poland, 33-100 GSK Investigational Site Wroclaw, Poland, 53-201 United Kingdom GSK Investigational Site Glasgow, United Kingdom, G514TF GSK Investigational Site Leicester, United Kingdom, LE27LX GSK Investigational Site Liverpool, United Kingdom, L12 2AP GSK Investigational Site London, United Kingdom, SE5 9RS GSK Investigational Site London, United Kingdom, SW3 6NP GSK Investigational Site Oxford, United Kingdom, OX3 9DU GSK Investigational Site Sheffield, United Kingdom, S10 2TH 收起 << |
NCT00823199 | Schizophrenia | Not Applicable | Completed | - | - |
NCT02377427 | - | Completed | - | - | |
NCT02122211 | Men Carrying 2 Minor Alleles f... 展开 >>or Choline Dehydrogenase rs12676 Male Infertility 收起 << | Phase 1 | Completed | - | United States, North Carolina ... 展开 >> UNC Nutrition Research Institute Kannapolis, North Carolina, United States, 28081 收起 << |
NCT01072175 | - | Completed | - | - | |
NCT02625207 | Healthy Subjects | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 收起 << |
NCT01806506 | Morbid Obesity ... 展开 >> Metabolic Syndrome X Diabetes Mellitus Dyslipidemia Hypertension 收起 << | Not Applicable | Unknown | - | Poland ... 展开 >> Department of General, Transplant and Liver Surgery, Public Central Teaching Hospital, Medical University of Warsaaw Warsaw, Poland, 02-097 收起 << |
NCT01982734 | Pharmacokinetics of New Curcum... 展开 >>in Formulations Safety of New Curcumin Formulations 收起 << | Early Phase 1 | Completed | - | Germany ... 展开 >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 收起 << |
NCT02625207 | - | Completed | - | - | |
NCT02944097 | Safety After Oral Intake ... 展开 >> Pharmacokinetics After Oral Intake 收起 << | Early Phase 1 | Completed | - | Germany ... 展开 >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 收起 << |
NCT02197130 | Huntington's Disease | Phase 2 | Completed | - | - |
NCT02663089 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 1 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site London, United Kingdom, NW10 7EW 收起 << |
NCT02197130 | - | Completed | - | - | |
NCT03140397 | Safety After Oral Intake ... 展开 >> Pharmacokinetics After Oral Intake Immune Cells Activity 收起 << | Early Phase 1 | Completed | - | Germany ... 展开 >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 Eberhard Karls University Tuebingen Tübingen, Baden-Württemberg, Germany, 72076 收起 << |
NCT03286777 | Safety of Native vs. Micellar ... 展开 >>6-PN After Oral Intake Pharmacokinetics of Native vs. Micellar 6-PN After Oral Intake PBMC Activity After Native vs. Micellar 6-PN Oral Intake 收起 << | Not Applicable | Completed | - | Germany ... 展开 >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 Eberhard Karls University Tuebingen Tübingen, Baden-Württemberg, Germany, 72076 收起 << |
NCT02460783 | Alzheimer's Disease ... 展开 >> Obesity Diabetes Mellitus 收起 << | Phase 2 | Recruiting | July 1, 2019 | United States, Maryland ... 展开 >> National Institute of Aging, Clinical Research Unit Recruiting Baltimore, Maryland, United States, 21224 收起 << |
NCT02832414 | Sleep Apnea, Obstructive ... 展开 >> Obesity 收起 << | Not Applicable | Recruiting | - | Spain ... 展开 >> Hospital Universitari de Bellvitge Recruiting L'Hospitalet de Llobregat, Barcelona, Spain Contact: Carmen Monasterio 收起 << |
NCT03739242 | Hypercholesterolemia | Not Applicable | Completed | - | Italy ... 展开 >> Policlinico S.Orsola - Malpighi Medicina Interna Borghi Bologna, Italy, 40138 收起 << |
NCT02226354 | Healthy | Phase 1 | Completed | - | Canada, New Brunswick ... 展开 >> Université de Moncton Moncton, New Brunswick, Canada, E1A 3E9 收起 << |
NCT02540759 | Healthy | Phase 1 | Completed | - | Canada, New Brunswick ... 展开 >> Université de Moncton Moncton, New Brunswick, Canada, E1A 3E9 收起 << |
NCT01022060 | Recurrent Calcic Urolithiasis | Phase 3 | Completed | - | Cuba ... 展开 >> Institute of Nephrology Havana City, Havana, Cuba, 10400 收起 << |
NCT00978224 | Chronic Inflammatory Syndrome | Phase 3 | Suspended(Decision of the inve... 展开 >>stigator) 收起 << | September 2011 | Cuba ... 展开 >> Institute of Nephrology "Dr. Abelardo Buch López" Havana, Cuba, 10400 收起 << |
NCT01142726 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT02944084 | Safety After Oral Intake ... 展开 >> Pharmacokinetics After Oral Intake 收起 << | Early Phase 1 | Completed | - | Germany ... 展开 >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 收起 << |
NCT02964715 | Type2 Diabetes ... 展开 >> NAFLD 收起 << | Phase 4 | Recruiting | November 2018 | Malaysia ... 展开 >> University of Malaya Recruiting Kuala Lumpur, Wilayah Persekutuan, Malaysia Contact: Shireene R Vethakkan, MD 0162093355 shireene.vethakkan@gmail.com Sub-Investigator: Wah K Chan, MRCP 收起 << |
NCT02434497 | Homozygous Familial Hyperchole... 展开 >>sterolemia (HoFH) 收起 << | Phase 3 | Completed | - | Belgium ... 展开 >> Research Site Brussels (Woluwé-St-Lambert), Belgium, 1200 Canada, Quebec Research Site Chicoutimi, Quebec, Canada, G7H 7K9 Denmark Research Site Copenhagen, Denmark, DK-2100 Israel Research Site Halfa, Israel, 31096 Malaysia Research Site Kubang Kerian, Malaysia, 16150 Taiwan Research Site Taipei City, Taiwan, 11217 收起 << |
NCT02434497 | - | Completed | - | - | |
NCT02425020 | Dietary Modification | Not Applicable | Completed | - | - |
NCT02109445 | Metastatic Cancer Pancreas | Phase 2 | Terminated(The study was termi... 展开 >>nated on 24JUN15 due to change in strategy of PF-03084014 development.No safety/efficacy concerns were behind the reason of trial termination) 收起 << | - | United States, Colorado ... 展开 >> Anschutz Inpatient Pavilion Aurora, Colorado, United States, 80045 Drug Shipment: Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Cancer Center Aurora, Colorado, United States, 80045 University of Colorado Denver, CTO (CTRC) Aurora, Colorado, United States, 80045 United States, New York University of Rochester Investigational Drug Pharmacy Rochester, New York, United States, 14642 University of Rochester Rochester, New York, United States, 14642 收起 << |
NCT01142726 | - | Completed | - | - | |
NCT01636778 | - | Completed | - | - | |
NCT02109445 | - | Terminated(The study was termi... 展开 >>nated on 24JUN15 due to change in strategy of PF-03084014 development.No safety/efficacy concerns were behind the reason of trial termination) 收起 << | - | - | |
NCT02970838 | Obesity Diabe... 展开 >>tes Type 2 Weight Loss 收起 << | Not Applicable | Completed | - | Germany ... 展开 >> University Medicine Greifswald Greifswald, Germany, 17475 收起 << |
NCT03417674 | Overweight and Obesity | Not Applicable | Active, not recruiting | December 31, 2018 | Germany ... 展开 >> West-German Centre of Diabetes and Health Düsseldorf, Germany, 40591 收起 << |
NCT01728675 | Aging Muscle ... 展开 >>Damage Oxidative Stress 收起 << | Not Applicable | Completed | - | Cyprus ... 展开 >> European University Cyprus Nicosia, Cyprus, 1516 收起 << |
NCT03665636 | Glycogen Storage Disease Type ... 展开 >>I 收起 << | Early Phase 1 | Not yet recruiting | June 2019 | United States, Pennsylvania ... 展开 >> UPMC Children's Hospital of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15210 Contact: Angela Leshinski, MBA, RD, LDN 412-692-5232 angela.leshinski@chp.edu Contact: Elizabeth McCracken, MS, LCGC 412-692-5662 elizabeth.mccracken@chp.edu Principal Investigator: Areeg El-Gharbawy, MD 收起 << |
NCT01636778 | Hepatitis C, Chronic | Phase 2 | Completed | - | Japan ... 展开 >> GSK Investigational Site Aichi, Japan, 467-8602 GSK Investigational Site Fukui, Japan, 918-8503 GSK Investigational Site Fukuoka, Japan, 803-8505 GSK Investigational Site Fukuoka, Japan, 830-0011 GSK Investigational Site Gunma, Japan, 370-0829 GSK Investigational Site Hyogo, Japan, 663-8501 GSK Investigational Site Ibaraki, Japan, 317-0077 GSK Investigational Site Kagawa, Japan, 760-0017 GSK Investigational Site Kagawa, Japan, 760-8557 GSK Investigational Site Kagoshima, Japan, 899-5112 GSK Investigational Site Kanagawa, Japan, 213-8587 GSK Investigational Site Nagasaki, Japan, 856-8562 GSK Investigational Site Oita, Japan, 879-5593 GSK Investigational Site Osaka, Japan, 540-0006 GSK Investigational Site Tokyo, Japan, 105-8470 GSK Investigational Site Wakayama, Japan, 646-8558 收起 << |
NCT00237588 | Hypertension | Phase 4 | Completed | - | Norway ... 展开 >> Cardiovascular and Renal Research Center/ Department of Cardiology, Ullevaal University Hospital Oslo, Norway, 0407 收起 << |
NCT03671733 | Obesity | Phase 3 | Recruiting | September 1, 2020 | China, Hunan ... 展开 >> Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410008 Contact: Jing Wu +86-13574120508 wujing0731@163.com 收起 << |
NCT02119260 | Oedema, Pulmonary | Phase 2 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG GSK Investigational Site London, United Kingdom, NW10 7EW 收起 << |
NCT03627494 | Muscular Dystrophies | Phase 1 | Recruiting | June 30, 2019 | United States, Maryland ... 展开 >> GSK Investigational Site Recruiting Baltimore, Maryland, United States, 21225 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT02581345 | Chronic Plaque Psoriasis ... 展开 >> Psoriasis 收起 << | Phase 3 | Completed | - | - |
NCT02537834 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Japan ... 展开 >> Atsuta-ku, Aichi, Japan, 456-0058 Minato-ku, Aichi, Japan, 455-0018 Kisarazu, Chiba, Japan, 292-0038 Annaka, Gunma, Japan, 379-0116 Naka, Ibaraki, Japan, 311-0113 Sagamihara, Kanagawa, Japan, 252-0302 Kasaoka, Okayama, Japan, 714-0043 Shimono, Tochigi, Japan, 329-0433 Adachi-ku, Tokyo, Japan, 123-0845 Chuo-ku, Tokyo, Japan, 103-0027 Mitaka, Tokyo, Japan, 181-0013 收起 << |
NCT02130193 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | United States, Alabama ... 展开 >> GSK Investigational Site Birmingham, Alabama, United States, 35294 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80206 United States, Iowa GSK Investigational Site Iowa City, Iowa, United States, 52242 United States, Pennsylvania GSK Investigational Site Oaks, Pennsylvania, United States, 19456 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19140 United States, South Carolina GSK Investigational Site Spartanburg, South Carolina, United States, 29303 Germany GSK Investigational Site Frankfurt, Hessen, Germany, 60596 GSK Investigational Site Neu isenburg, Hessen, Germany, 63263 GSK Investigational Site Dueren, Nordrhein-Westfalen, Germany, 52349 GSK Investigational Site Essen, Nordrhein-Westfalen, Germany, 45359 GSK Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39112 GSK Investigational Site Leipzig, Sachsen, Germany, 04207 GSK Investigational Site Leipzig, Sachsen, Germany, 04275 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Berlin, Germany, 10787 GSK Investigational Site Berlin, Germany, 10789 收起 << |
NCT02119260 | - | Completed | - | - | |
NCT00338689 | Infant Development | Not Applicable | Unknown | September 2015 | Belgium ... 展开 >> CHC St. Vincent, Liège / Universite Libre de Bruxelles Liège, Belgium, BE-4000 Germany Ludwig-Maximilians-Universitaet Muenchen, Germany, D 80337 Italy Universita degli Studi di Milano Milan, Italy, I-20122 Poland Children´s Memorial Healzj Institute Warsaw, Poland, P 04736 Spain Universitat Rovira i Virgili Tarragona, Spain, S 43003 收起 << |
NCT02222493 | - | Completed | - | - | |
NCT02581345 | - | Completed | - | - | |
NCT02222493 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT03414294 | Healthy | Phase 1 | Recruiting | February 27, 2020 | Australia, South Australia ... 展开 >> CMAX, Clinical Research Pty Ltd Recruiting Adelaide, South Australia, Australia, 5000 收起 << |
NCT02130193 | - | Completed | - | - | |
NCT03151837 | Diabetes Mellitus, Type 2 | Not Applicable | Completed | - | Taiwan ... 展开 >> Chung Shan Medical University Hospital Taichung, Taiwan, 40201 收起 << |
NCT02691325 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 << |
NCT02512900 | Asthma | Phase 1 | Completed | - | Poland ... 展开 >> Research Site Kielce, Poland, 25-040 Research Site Wrocław, Poland, 51-162 Research Site Wrocław, Poland, 53-201 Research Site Łódź, Poland, 71-329 收起 << |
NCT01856595 | - | Completed | - | - | |
NCT01369550 | Healthy Volunteers ... 展开 >> Markers of Cardiovascular Risk 收起 << | Not Applicable | Completed | - | United States, Florida ... 展开 >> Meridien Research St. Petersburg, Florida, United States, 33709 United States, Illinois Provident Clinical Research & Consulting, Inc. Addison, Illinois, United States 收起 << |
NCT01856595 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, California ... 展开 >> Anaheim Clinical Trials Anaheim, California, United States, 92801 Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida MRA Clinical Research, LLC South Miami, Florida, United States, 33143 收起 << |
NCT02836184 | Hyperphosphatemia | Phase 4 | Unknown | September 2016 | China, Jiangxi ... 展开 >> Jiujiang NO.1 People's Hospital Recruiting Jiujiang, Jiangxi, China, 332000 收起 << |
NCT02512900 | - | Completed | - | - | |
NCT02778477 | Normal Healthy | Phase 1 | Terminated(Preliminary analysi... 展开 >>s of accrued data failed to indicate any meaningful pharmacodynamic response.) 收起 << | - | Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 << |
NCT00315354 | Obesity Insul... 展开 >>in Resistance 收起 << | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 收起 << |
NCT00533897 | - | Completed | - | - | |
NCT00533897 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT02342548 | - | Terminated(Study terminated on... 展开 >> 15DEC2016 due to study A8241021 showing no significant difference on primary endpoint between PF-02545920 & placebo. No safety concerns.) 收起 << | - | - | |
NCT02342548 | Huntington's Disease | Phase 2 | Terminated(Study terminated on... 展开 >> 15DEC2016 due to study A8241021 showing no significant difference on primary endpoint between PF-02545920 & placebo. No safety concerns.) 收起 << | - | - |
NCT02563899 | Hyperhidrosis | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> GSK Investigational Site Raleigh, North Carolina, United States, 27612 United States, Texas GSK Investigational Site Austin, Texas, United States, 78759 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2K 4L5 收起 << |
NCT02229227 | - | Completed | - | - | |
NCT02229227 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01622283 | Rhinitis, Allergic, Perennial ... 展开 >>and Seasonal 收起 << | Phase 1 | Completed | - | Japan ... 展开 >> GSK Investigational Site Kagoshima, Japan, 890-0081 收起 << |
NCT02216097 | - | Terminated(The study stopped b... 展开 >>ased on Pfizer portfolio prioritization and not due to safety and/or efficacy concern or change in benefitrisk assessment of PF-04457845.) 收起 << | - | - | |
NCT00420056 | - | Completed | - | - | |
NCT01347866 | - | Terminated(Refer to Detailed D... 展开 >>escription for documentaion of Termination Statement.) 收起 << | - | - | |
NCT01347866 | Advanced Cancer | Phase 1 | Terminated(Refer to Detailed D... 展开 >>escription for documentaion of Termination Statement.) 收起 << | - | United States, California ... 展开 >> Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095-6984 Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095 UCLA Medical Center Los Angeles, California, United States, 90095 UCLA Oncology Center Los Angeles, California, United States, 90095 Santa Monica - UCLA Medical Center and Orthopaedic Hospital Santa Monica, California, United States, 90404 UCLA Santa Monica Hematology Oncology Santa Monica, California, United States, 90404 United States, Colorado Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Denver (CTRC) Aurora, Colorado, United States, 80045 University of Colorado Hospital Anschutz Inpatient Pavilion Aurora, Colorado, United States, 80045 University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, South Carolina Medical University of South Carolina, Hollings Cancer Center Charleston, South Carolina, United States, 29425 Medical University of South Carolina Charleston, South Carolina, United States, 29425 MUSC, Investigational Drug Services Charleston, South Carolina, United States, 29425 MUSC Health East Cooper Mount Pleasant, South Carolina, United States, 29464 MUSC Specialty Care-North North Charleston, South Carolina, United States, 29406 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Italy Ospedale San Raffaele Milano, Italy, 20132 Spain Hospital General Vall d'Hebron Barcelona, Spain, 08035 收起 << |
NCT00855465 | - | Completed | - | - | |
NCT02216097 | Post-Traumatic Stress Disorder | Phase 2 | Terminated(The study stopped b... 展开 >>ased on Pfizer portfolio prioritization and not due to safety and/or efficacy concern or change in benefitrisk assessment of PF-04457845.) 收起 << | - | United States, New York ... 展开 >> Clinical and Translational Science Institute (CTSI) New York, New York, United States, 10016 NYU CTSI Research Pharmacy (Drug Shipment Address) New York, New York, United States, 10016 NYU School of Medicine New York, New York, United States, 10016 收起 << |
NCT00855465 | Pulmonary Hypertension | Phase 3 | Completed | - | - |
NCT00496769 | Atrial Fibrillation | Phase 3 | Completed | - | - |
NCT03044353 | Amyloidosis | Phase 2 | Suspended(Pending data review.... 展开 >>) 收起 << | September 23, 2021 | United States, Massachusetts ... 展开 >> GSK Investigational Site Boston, Massachusetts, United States, 02115 United Kingdom GSK Investigational Site Cambridge, United Kingdom, CB2 0GG GSK Investigational Site London, United Kingdom, NW10 7EW 收起 << |
NCT03590613 | Autoimmune Diseases | Phase 1 | Active, not recruiting | September 21, 2018 | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 812-0025 收起 << |
NCT00057811 | Childhood Burkitt Lymphoma ... 展开 >> Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Stage I Childhood Large Cell Lymphoma Stage I Childhood Small Noncleaved Cell Lymphoma Stage II Childhood Large Cell Lymphoma Stage II Childhood Small Noncleaved Cell Lymphoma Stage III Childhood Large Cell Lymphoma Stage III Childhood Small Noncleaved Cell Lymphoma Stage IV Childhood Large Cell Lymphoma Stage IV Childhood Small Noncleaved Cell Lymphoma Untreated Childhood Acute Lymphoblastic Leukemia 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Children's Oncology Group Arcadia, California, United States, 91006-3776 收起 << |
NCT01607372 | Asthma and Rhinitis | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> GSK Investigational Site Toronto, Ontario, Canada, M5V 2T3 收起 << |
NCT01920594 | Surgical Procedures | Phase 2 | Completed | - | United States, Alabama ... 展开 >> GSK Investigational Site Birmingham, Alabama, United States, 35233 United States, California GSK Investigational Site Los Angeles, California, United States, 90048 United States, Colorado GSK Investigational Site Aurora, Colorado, United States, 80045 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30322 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109-5864 United States, Minnesota GSK Investigational Site Rochester, Minnesota, United States, 55905 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 GSK Investigational Site Pittsburgh, Pennsylvania, United States, 308902 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 United States, Virginia GSK Investigational Site Charlottesville, Virginia, United States, 22908 GSK Investigational Site Richmond, Virginia, United States, 23298 Canada, Alberta GSK Investigational Site Calgary, Alberta, Canada, T2N 2T9 Canada, Quebec GSK Investigational Site Quebec City, Quebec, Canada, G1V 4G5 收起 << |
NCT00057811 | - | Completed | - | - | |
NCT01920594 | - | Completed | - | - | |
NCT00496769 | - | Completed | - | - | |
NCT00077649 | Hepatitis C, Chronic | Phase 4 | Completed | - | - |
NCT00077649 | - | Completed | - | - | |
NCT01332331 | Hypertension, Pulmonary | Phase 2 | Suspended(Ongoing juvenile rat... 展开 >> toxicology studies.) 收起 << | February 1, 2019 | - |
NCT01342952 | Hypertension, Pulmonary | Phase 2 | Recruiting | October 24, 2024 | - |
NCT03101722 | Presbycusis T... 展开 >>innitus Cognitive Impairment 收起 << | Not Applicable | Enrolling by invitation | December 1, 2021 | China, Shanghai ... 展开 >> Huadong Hospital Shanghai, Shanghai, China, 200040 Jinshan Zhong Ren geriatric care hospital Shanghai, Shanghai, China, 200040 Jiuting Community Health Service Shanghai, Shanghai, China, 200040 收起 << |
NCT00993967 | Freidreich's Ataxia | Phase 3 | Completed | - | Austria ... 展开 >> Universitätsklinik Innsbruck Innsbruck, Austria Belgium Hôpital Erasme - Univeristé Libre de Bruxelles Bruxelles, Belgium, 1070 France Hôpital de la Salpétrière - INSERM U679, Neurologie et Thérapeutique expérimentale Paris, France, 75651 Germany HELIOS Klinikum Berlin Berlin, Germany, 13125 Neurologische Universitätsklinik und Ploklinik - Universitätsklimikum Bonn Bonn, Germany, 53105 Klinik II, Neuropädiatrie und Muskelerkrankungen - Universitätsklinik Freiburg Freiburg, Germany, 79106 Zentrum für Neurologische Medizin Göttingen, Germany, 37073 UKE Hamburg Neuropädiatrie - Zentrum für Frauen, Kinder und Jugendmedizin Hamburg, Germany, 20246 Neurologische Klinik - Klinikum Grosshadern München, Germany, 81377 Neurologische Universitätsklinik und Poliklinik Tübingen, Germany, 72076 Netherlands University medical Center Groningen Groningen, Netherlands, 9700 RB 收起 << |
NCT03027726 | Overweight Children With Type ... 展开 >>2 Diabetes Risk 收起 << | Not Applicable | Completed | - | Spain ... 展开 >> Pediatric Endocrinology Unit of the University Hospital of Araba (HUA) Vitoria-Gasteiz, Araba, Spain, 01009 收起 << |
NCT00993967 | - | Completed | - | - | |
NCT01920555 | Treatment Resistant Depression | Phase 2 | Completed | - | United States, California ... 展开 >> Stanford University Palo Alto, California, United States, 94304 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Texas University of Texas Southwestern Dallas, Texas, United States, 75390 Baylor College of Medicine Houston, Texas, United States, 77030 收起 << |
NCT00424294 | Arthritis, Rheumatoid | Phase 2 | Terminated(See Detailed Descri... 展开 >>ption field) 收起 << | - | - |
NCT01175135 | Schizophrenia | Phase 2 | Completed | - | - |
NCT00853112 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT00759564 | Pneumonia | Phase 1 | Completed | - | United States, Indiana ... 展开 >> Centurion Clinical Research Indianapolis, Indiana, United States, 46260 Belgium Pfizer Clinical Research Unit Bruxelles, Belgium, 1070 收起 << |
NCT01920555 | - | Completed | - | - | |
NCT00777647 | Obesity Metab... 展开 >>olic; Complications Dietary Habits 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Department of Internal Medicine/Endocrinology C, Aarhus University Hospital Aarhus, Denmark, 8000 收起 << |
NCT01175135 | - | Completed | - | - | |
NCT01192191 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 811-2201 GSK Investigational Site Fukuoka, Japan, 819-8555 GSK Investigational Site Fukushima, Japan, 964-0871 GSK Investigational Site Gunma, Japan, 371-0048 GSK Investigational Site Hiroshima, Japan, 732-0057 GSK Investigational Site Hokkaido, Japan, 001-0901 GSK Investigational Site Hokkaido, Japan, 064-0915 GSK Investigational Site Hokkaido, Japan, 070-8644 GSK Investigational Site Hyogo, Japan, 651-0073 GSK Investigational Site Ibaraki, Japan, 300-0053 GSK Investigational Site Ibaraki, Japan, 310-0015 GSK Investigational Site Ishikawa, Japan, 920-8610 GSK Investigational Site Kagawa, Japan, 760-0073 GSK Investigational Site Kagawa, Japan, 763-8502 GSK Investigational Site Kanagawa, Japan, 239-0821 GSK Investigational Site Kyoto, Japan, 601-1495 GSK Investigational Site Kyoto, Japan, 615-8087 GSK Investigational Site Miyagi, Japan, 981-8563 GSK Investigational Site Miyagi, Japan, 984-8560 GSK Investigational Site Nagano, Japan, 390-0303 GSK Investigational Site Nagano, Japan, 390-0832 GSK Investigational Site Nagano, Japan, 390-8601 GSK Investigational Site Nagano, Japan, 391-0011 GSK Investigational Site Oita, Japan, 870-0921 GSK Investigational Site Oita, Japan, 876-0047 GSK Investigational Site Okayama, Japan, 701-0304 GSK Investigational Site Osaka, Japan, 530-0012 GSK Investigational Site Osaka, Japan, 545-8586 GSK Investigational Site Osaka, Japan, 576-0016 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Tokyo, Japan, 185-0014 GSK Investigational Site Tokyo, Japan, 187-0024 GSK Investigational Site Toyama, Japan, 930-0194 GSK Investigational Site Wakayama, Japan, 641-8510 GSK Investigational Site Yamanashi, Japan, 400-0031 收起 << |
NCT00759564 | - | Completed | - | - | |
NCT01192191 | - | Completed | - | - | |
NCT01475461 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT00853112 | Hypertension, Pulmonary | Phase 2 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT00424294 | - | Terminated(See Detailed Descri... 展开 >>ption field) 收起 << | - | - | |
NCT02578004 | - | Completed | - | Tunisia ... 展开 >> Latifa KHLIFI Sousse, Tunisia, 4000 收起 << | |
NCT02193815 | Psoriasis Vulgaris | Phase 1 | Completed | - | Germany ... 展开 >> Bioskin GmbH Hamburg, Germany, 20095 收起 << |
NCT01342211 | Hypercholesterolemia ... 展开 >> Dyslipidemia 收起 << | Phase 2 | Completed | - | - |
NCT01475461 | - | Completed | - | - | |
NCT01517373 | - | Completed | - | - | |
NCT02193815 | - | Completed | - | - | |
NCT01342211 | - | Completed | - | - | |
NCT02363634 | Mood Anxiety | Not Applicable | Completed | - | United States, Florida ... 展开 >> Miami Research Associates Miami, Florida, United States, 33143 收起 << |
NCT03669757 | Psoriasis Vulgaris | Phase 1 | Recruiting | February 2019 | Germany ... 展开 >> Investigational Site Recruiting Schwerin, Mecklenburg-Vorpommern, Germany, 19055 Investigational Site Recruiting Hamburg, Germany, 20095 收起 << |
NCT01370018 | HIV Disease | Not Applicable | Completed | - | United States, New York ... 展开 >> Cabrini Medical Center New York, New York, United States, 10003 收起 << |
NCT01517373 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT02082977 | Cancer | Phase 1 | Terminated(The maximal dose an... 展开 >>d schedule attained with GSK2816126 has shown insufficient evidence of clinical activity, and does not justify further clinical investigation) 收起 << | - | United States, Illinois ... 展开 >> GSK Investigational Site Chicago, Illinois, United States, 60611 United States, New York GSK Investigational Site New York, New York, United States, 10021 France GSK Investigational Site Villejuif cedex, France, 94805 United Kingdom GSK Investigational Site Sutton, Surrey, United Kingdom, SM2 5PT GSK Investigational Site Southampton, United Kingdom, SO16 6YD 收起 << |
NCT00989235 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT00989235 | - | Completed | - | - | |
NCT01342926 | Atrophy, Geographic | Phase 2 | Completed | - | - |
NCT00894322 | - | Completed | - | - | |
NCT01396148 | - | Completed | - | - | |
NCT00471237 | Osteoporosis | Phase 2 | Terminated(Terminated for futi... 展开 >>lity by sponsor after a pre-planned interim review of data) 收起 << | - | - |
NCT01342926 | - | Completed | - | - | |
NCT01684215 | Neoplasms Bre... 展开 >>ast Neoplasms 收起 << | Phase 2 | Completed | - | Japan ... 展开 >> Aichi Cancer Center Hospital Nagoya, Aichi, Japan, 464-8681 National Cancer Center Hospital East Kashiwa, Chiba, Japan, 277-8577 National Hospital Organization Hokkaido Cancer Center Sapporo, Hokkaido, Japan, 003-0804 Kumamoto Shinto General Hospital Kumamoto-city, Kumamoto, Japan, 862-8655 Saitama Cancer Center Kita-adachi-gun, Saitama, Japan, 362-0806 National Cancer Center Hospital Chuo-Ku, Tokyo, Japan, 104-0045 Chiba Cancer Center Chiba, Japan, 260-8717 National Hospital Organization Shikoku Cancer Center Ehime, Japan, 791-0280 National Hospital Organization Kyushu Cancer Center Fukuoka, Japan, 811-1395 Hiroshima City Hiroshima Citizens Hospital Hiroshima, Japan, 730-8518 Iwate Medical University Hospital Iwate, Japan, 020-8505 Hakuaikai Medical Corporation Sagara Hospital Kagoshima, Japan, 892-0833 Kumamoto University Hospital Kumamoto, Japan, 860-8556 Kumamoto City Hospital Kumamoto, Japan, 862-8505 Kyoto University Hospital Kyoto, Japan, 606-8507 National Hospital Organization Osaka National Hospital Osaka, Japan, 540-0006 收起 << |
NCT00894322 | Type 2 Diabetes Mellitus | Phase 1 Phase 2 | Completed | - | United States, Nebraska ... 展开 >> Research Site Lincoln, Nebraska, United States 收起 << |
NCT03310190 | - | Recruiting | June 15, 2020 | Canada, Alberta ... 展开 >> University of Calgary /ID# 166416 Recruiting Calgary, Alberta, Canada, T2N 4Z6 Cross Cancer Institute /ID# 166417 Not yet recruiting Edmonton, Alberta, Canada, T6G 1Z2 Canada, New Brunswick The Moncton Hospital /ID# 166043 Recruiting Moncton, New Brunswick, Canada, E1C 6Z8 Saint John Regional Hospital /ID# 202190 Not yet recruiting Saint John, New Brunswick, Canada, E2L 4L2 Canada, Ontario William Osler Health System /ID# 202049 Not yet recruiting Brampton, Ontario, Canada, L6R 3J7 Michael Garron Hospital/Toronto East Health Network /ID# 209463 Not yet recruiting East York, Ontario, Canada, M4C 3E7 Kingston Health Sciences Centr /ID# 169252 Recruiting Kingston, Ontario, Canada, K7L 2V7 The Ottawa Hospital Research /ID# 166041 Recruiting Ottawa, Ontario, Canada, K1H 8L6 Health Sciences North /ID# 205817 Recruiting Sudbury, Ontario, Canada, P3N 1H5 Canada, Quebec Jewish General Hospital /ID# 166418 Recruiting Montreal, Quebec, Canada, H3T 1E2 Cisss Du Bas-Saint-Laurent Hopital Regional de Rimouski /Id# 201202 Recruiting Rimouski, Quebec, Canada, G5L 5T1 Canada CancerCare Manitoba /ID# 170751 Recruiting Manitoba, Canada, R3E 0V9 Thunder Bay Regional Health Re /ID# 204740 Not yet recruiting Thunder Bay, Canada, P7B 6V4 收起 << | |
NCT01396148 | Gastrointestinal Stromal Tumor... 展开 >>s 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles Los Angeles, California, United States, 90027 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Czechia Fakultni nemocnice Brno Brno, Czechia, 613 00 FN Brno Brno, Czechia, 625 00 Masarykuv onkologicky ustav Brno, Czechia, 656 33 France CHU de La Timone, Hopital enfants Marseille cedex 5, France, 13385 Hopital d'Enfants de la Timone Marseille cedex 5, France, 13385 Hopital de la Timone Marseille cedex 5, France, 13385 收起 << |
NCT01684215 | - | Completed | - | - | |
NCT00471237 | - | Terminated(Terminated for futi... 展开 >>lity by sponsor after a pre-planned interim review of data) 收起 << | - | - | |
NCT01366521 | Asthma | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> GSK Investigational Site Winston-Salem, North Carolina, United States, 27103 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 Estonia GSK Investigational Site Tallinn, Estonia, 13619 GSK Investigational Site Tartu, Estonia, 51014 France GSK Investigational Site Marseille cedex 20, France, 13915 GSK Investigational Site Montpellier, France, 34295 GSK Investigational Site Pessac Cedex, France, 33604 Germany GSK Investigational Site Gauting, Bayern, Germany, 82131 GSK Investigational Site Frankfurt am Main, Hessen, Germany, 60596 GSK Investigational Site Frankfurt, Hessen, Germany, 60596 GSK Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39112 GSK Investigational Site Berlin, Germany, 14050 收起 << |
NCT01512160 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT01366521 | - | Completed | - | - | |
NCT01512160 | Post-surgical Dental Pain | Phase 2 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | United States, Texas ... 展开 >> Pfizer Investigational Site Austin, Texas, United States, 78744 收起 << |
NCT02319148 | Healthy Volunteers | Phase 1 | Completed | - | Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 << |
NCT02319148 | - | Completed | - | - | |
NCT01529346 | Postoperative Dental Pain | Phase 2 | Completed | - | United States, Texas ... 展开 >> Central Texas Oral Surgery Associates Austin, Texas, United States, 78705 Premier Research Group Limited Austin, Texas, United States, 78705 PPD Development, LP Austin, Texas, United States, 78744 收起 << |
NCT00404768 | Obstetric Labour, Premature | Phase 2 | Completed | - | - |
NCT01529346 | - | Completed | - | - | |
NCT02341482 | - | Completed | - | - | |
NCT00404768 | - | Completed | - | - | |
NCT01577381 | Age-Related Maculopathy | Phase 2 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT01819922 | Healthy | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT03274648 | BehçEt Disease | Not Applicable | Not yet recruiting | January 2018 | - |
NCT00903617 | Dyslipidaemias | Phase 2 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Pembroke Pines, Florida, United States, 33026 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46260 United States, Kentucky GSK Investigational Site Louisville, Kentucky, United States, 40213 United States, Maine GSK Investigational Site Auburn, Maine, United States, 04210 United States, Minnesota GSK Investigational Site Brooklyn Center, Minnesota, United States, 55430 United States, North Carolina GSK Investigational Site Statesville, North Carolina, United States, 28677 United States, Ohio GSK Investigational Site Cincinnati, Ohio, United States, 45246 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78205 United States, Virginia GSK Investigational Site Richmond, Virginia, United States, 23294 United States, Washington GSK Investigational Site Olympia, Washington, United States, 98502 GSK Investigational Site Seattle, Washington, United States, 98104 收起 << |
NCT01577381 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT02341482 | Healthy | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 收起 << |
NCT01819922 | - | Completed | - | - | |
NCT01121536 | Depression | Phase 3 | Terminated(Business decision r... 展开 >>elated to efficacy rather than tolerability limitations, not stopped for any safety reasons.) 收起 << | - | - |
NCT00903617 | - | Completed | - | - | |
NCT01121536 | - | Terminated(Business decision r... 展开 >>elated to efficacy rather than tolerability limitations, not stopped for any safety reasons.) 收起 << | - | - | |
NCT01925274 | Metastatic Colorectal Cancer | Phase 2 | Terminated(Enrollment to the s... 展开 >>tudy was terminated on 11Nvo2014 due to slow recruitment. There were no safety or efficacy issues that contributed to this decision.) 收起 << | - | United States, California ... 展开 >> CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 Drug Management Only: UCLA West Medical Pharmacy, Att: Steven L Wong, Pharm D Los Angeles, California, United States, 90095-7349 Drug Management Only: UCLA West Medical Pharmacy Los Angeles, California, United States, 90095-7349 UCLA West Medical Pharmacy Los Angeles, California, United States, 90095-7349 Regulatory Management Only: TRIO-US Central Administration Los Angeles, California, United States, 90095 TRIO-US Central Administration (Regulatory Management only) Los Angeles, California, United States, 90095 TRIO_US Los Angeles, California, United States, 90095 West Valley Hematology/Oncology Med Group Northridge, California, United States, 91328 United States, Missouri Siteman Cancer Center - West County Creve Coeur, Missouri, United States, 63141 Barnes-Jewish Hospital Saint Louis, Missouri, United States, 63110 Drug Shipping Address: Washington University Infusion Center Pharmacy Saint Louis, Missouri, United States, 63110 Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Siteman Cancer Center - South County Saint Louis, Missouri, United States, 63129 Siteman Cancer Center - St Peters Saint Peters, Missouri, United States, 63376 United States, Nevada Regulatory Office: Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89014 Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89052 Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89074 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89128 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89148 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89169 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Washington Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States, 99336 Kadlec Medical Center Richland, Washington, United States, 99352 Outpatient Imaging Center Richland, Washington, United States, 99352 Spokane Valley Cancer Center Spokane Valley, Washington, United States, 99216 Medical Oncology Associates, PS Spokane, Washington, United States, 99208 Japan Aichi cancer center central hospital Nagoya, Aichi, Japan, 464-8681 National Cancer Center Hospital East Kashiwa, Chiba, Japan, 277-8577 Korea, Republic of National Cancer Center Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Seoul National University Hospital / Department of Internal Medicine Seoul, Korea, Republic of, 110-744 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Asan Medical Center Seoul, Korea, Republic of, 138-736 Spain Hospital General Universitario Gregorio Marañón Madrid, Spain, 28009 收起 << |
NCT02373202 | Rheumatoid Arthritis | Phase 3 | Completed | - | Japan ... 展开 >> Investigational Site Number 392010 Asahi-Shi, Japan Investigational Site Number 392001 Asahikawa-Shi, Japan Investigational Site Number 392070 Beppu-Shi, Japan Investigational Site Number 392036 Chiba-Shi, Japan Investigational Site Number 392083 Chuo-Ku, Japan Investigational Site Number 392004 Fukui-Shi, Japan Investigational Site Number 392039 Fukuoka-Shi, Japan Investigational Site Number 392030 Ichinomiya-Shi, Japan Investigational Site Number 392002 Iizuka-Shi, Japan Investigational Site Number 392019 Kagoshima-Shi, Japan Investigational Site Number 392066 Kamakura-Shi, Japan Investigational Site Number 392050 Kato-Shi, Japan Investigational Site Number 392037 Kawachi-Nagano-Shi, Japan Investigational Site Number 392099 Kawasaki-Shi, Japan Investigational Site Number 392013 Kitakyushu-Shi, Japan Investigational Site Number 392097 Kochi-Shi, Japan Investigational Site Number 392065 Kushiro-Shi, Japan Investigational Site Number 392026 Matsuyama-Shi, Japan Investigational Site Number 392034 Miyagi-Gun, Japan Investigational Site Number 392076 Nagoya-Shi, Japan Investigational Site Number 392080 Nagoya-Shi, Japan Investigational Site Number 392046 Narashino-Shi, Japan Investigational Site Number 392059 Oita-Shi, Japan Investigational Site Number 392062 Okayama-Shi, Japan Investigational Site Number 392027 Osaki-Shi, Japan Investigational Site Number 392049 Sagamihara-Shi, Japan Investigational Site Number 392014 Sapporo-Shi, Japan Investigational Site Number 392041 Sapporo-Shi, Japan Investigational Site Number 392073 Sapporo-Shi, Japan Investigational Site Number 392006 Sasebo-Shi, Japan Investigational Site Number 392021 Sendai-Shi, Japan Investigational Site Number 392022 Sendai-Shi, Japan Investigational Site Number 392033 Sendai-Shi, Japan Investigational Site Number 392071 Sendai-Shi, Japan Investigational Site Number 392029 Shizuoka-Shi, Japan Investigational Site Number 392023 Takaoka-Shi, Japan Investigational Site Number 392003 Tomakomai-Shi, Japan Investigational Site Number 392074 Urasoe-Shi, Japan Investigational Site Number 392079 Urayasu-Shi, Japan Investigational Site Number 392048 Yokohama-Shi, Japan 收起 << |
NCT02373202 | - | Completed | - | - | |
NCT00893789 | Traumatic Brain Injury | Phase 3 | Terminated(Study has been stop... 展开 >>ped by sponsor decision.) 收起 << | - | - |
NCT03726671 | Healthy | Not Applicable | Recruiting | March 2021 | United States, North Carolina ... 展开 >> UNC Chapel Hill Nutrition Research Institute Recruiting Kannapolis, North Carolina, United States, 28081 Contact: Julie Stegall, MSW 704-250-5048 julie_stegall@unc.edu Principal Investigator: Steven H Zeisel, MD, PhD 收起 << |
NCT03754920 | Fasting | Not Applicable | Active, not recruiting | September 9, 2019 | China, Shanghai ... 展开 >> Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai, Shanghai, China, 200030 收起 << |
NCT00893789 | - | Terminated(Study has been stop... 展开 >>ped by sponsor decision.) 收起 << | - | - | |
NCT01925274 | - | Terminated(Enrollment to the s... 展开 >>tudy was terminated on 11Nvo2014 due to slow recruitment. There were no safety or efficacy issues that contributed to this decision.) 收起 << | - | - | |
NCT01792635 | Diabetes Mellitus, Type 2 | Phase 2 | Terminated(The study was termi... 展开 >>nated prematurely on 16 May 2014 due to a safety concern.) 收起 << | - | United States, California ... 展开 >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 收起 << |
NCT00910962 | Acute Coronary Syndrome | Phase 2 | Completed | - | - |
NCT01792635 | - | Terminated(The study was termi... 展开 >>nated prematurely on 16 May 2014 due to a safety concern.) 收起 << | - | - | |
NCT02477410 | Hunger Satiet... 展开 >>y Response Protein Synthesis 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Department of Nutrition, Exercise and Sports Frederiksberg, Denmark, 1958 收起 << |
NCT01970865 | ALK-positive Non Small Cell Lu... 展开 >>ng Cancer (NSCLC) and ROS1-positive NSCLC 收起 << | Phase 2 | Active, not recruiting | February 19, 2019 | - |
NCT02565628 | Idiopathic Parkinson's Disease | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 United States, Florida MD Clinical Hallandale Beach, Florida, United States, 33009 QPS-MRA, LLC (Broward Research Group) Hollywood, Florida, United States, 33024 Qps-Mra Llc South Miami, Florida, United States, 33143 QPS-MRA, LLC (Miami research Associates) South Miami, Florida, United States, 33143 QPS-MRA, LLC (MRA Clinical Research) South Miami, Florida, United States, 33143 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30331 United States, New Jersey CRI Worldwide, LLC Marlton, New Jersey, United States, 08053 United States, Ohio CTI Clinical Research Center Cincinnati, Ohio, United States, 45255 收起 << |
NCT02565628 | - | Completed | - | - | |
NCT00453479 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | Netherlands ... 展开 >> GSK Investigational Site Eindhoven, Netherlands, 5623 EJ GSK Investigational Site Harderwijk, Netherlands, 3844 DG GSK Investigational Site Utrecht, Netherlands, 3584 CJ GSK Investigational Site Zuidlaren, Netherlands, 9471 GP 收起 << |
NCT00453479 | - | Completed | - | - | |
NCT00239356 | Schizophrenia | Phase 3 | Completed | - | Canada, Ontario ... 展开 >> Local Institution Ottawa, Ontario, Canada Canada, Quebec Local Institution Sherbrooke, Quebec, Canada Croatia Local Institution Rijeka, Croatia Local Institution Zagreb, Croatia Czech Republic Local Institution Hradec Kralove, Czech Republic Local Institution Prague 6, Czech Republic France Local Institution Nantes Orvault, France Local Institution Rennes Cedex, France Local Institution Uzes, France Hungary Local Institution Budapest, Hungary Local Institution Gyor, Hungary Netherlands Local Institution Vught, Netherlands Poland Local Institution Krakow, Poland Local Institution Poznan, Poland Romania Local Institution Bucharest, Romania Russian Federation Local Institution St. Petersburg, Russian Federation South Africa Local Institution Westdene, Free State, South Africa Local Institution Johannesburg, Gauteng, South Africa Local Institution Cape Town, Western Cape, South Africa United Kingdom Local Institution Antrim, United Kingdom 收起 << |
NCT01929863 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Miami, Florida, United States, 33169 收起 << |
NCT00239356 | - | Completed | - | - | |
NCT00048932 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT01929863 | - | Completed | - | - | |
NCT00048932 | - | Completed | - | - | |
NCT01970865 | - | Active, not recruiting | - | - | |
NCT00910962 | - | Completed | - | - | |
NCT02202161 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21225 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 收起 << |
NCT00048568 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT00451321 | Diabetes Mellitus, Type 1 | Phase 2 | Terminated | - | United States, Alabama ... 展开 >> GSK Investigational Site Birmingham, Alabama, United States, 35294 United States, California GSK Investigational Site Walnut Creek, California, United States, 94598 United States, Colorado GSK Investigational Site Aurora, Colorado, United States, 80045 United States, District of Columbia GSK Investigational Site Washington, D.C., District of Columbia, United States, 20037 United States, Florida GSK Investigational Site Jacksonville, Florida, United States, 32207 GSK Investigational Site Pinellas Park, Florida, United States, 33781 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60637 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21201 United States, Massachusetts GSK Investigational Site Worcester, Massachusetts, United States, 1655 United States, Michigan GSK Investigational Site Kalamazoo, Michigan, United States, 49048 United States, Minnesota GSK Investigational Site Minneapolis, Minnesota, United States, 55455 United States, Mississippi GSK Investigational Site Gulfport, Mississippi, United States, 39501 United States, Nebraska GSK Investigational Site Omaha, Nebraska, United States, 68131 United States, Ohio GSK Investigational Site Mentor, Ohio, United States, 44060 United States, South Dakota GSK Investigational Site Rapid City, South Dakota, United States, 57701 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229-4801 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M4G 3E8 收起 << |
NCT02693366 | Glomerulosclerosis, Focal Segm... 展开 >>ental Renal Insufficiency, Chronic 收起 << | Phase 1 | Active, not recruiting | March 2018 | Brazil ... 展开 >> Universitary Hospital Clementino Fraga Filho - UFRJ Rio de Janeiro, Brazil, 21941913 收起 << |
NCT02202161 | - | Completed | - | - | |
NCT03263962 | - | Completed | - | Italy ... 展开 >> IRCCS Policlinico San Matteo Pavia, Italy, 27100 收起 << | |
NCT01734993 | Rheumatoid Arthritis | Phase 3 | Completed | - | France ... 展开 >> Bordeaux, France, 33076 Montpellier, France, 34295 Nantes, France, 44035 Paris, France, 75679 Strasbourg, France, 67098 Toulouse, France, 31059 收起 << |
NCT01376323 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, Alabama ... 展开 >> GSK Investigational Site Anniston, Alabama, United States, 36207 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 GSK Investigational Site Miramar, Florida, United States, 33025 France GSK Investigational Site Nantes cedex 01, France, 44093 GSK Investigational Site Pierre-Bénite Cedex, France, 69495 GSK Investigational Site Rennes Cedex, France, 35046 GSK Investigational Site Rueil-Malmaison, France, 92502 Spain GSK Investigational Site Alicante, Spain, 03114 GSK Investigational Site Badalona, Spain, 08916 GSK Investigational Site Granada, Spain, 18004 GSK Investigational Site Madrid, Spain, 28046 United Kingdom GSK Investigational Site Edinburgh, Midlothian, United Kingdom, EH4 2XU GSK Investigational Site Cambridge, United Kingdom, CB2 0GG GSK Investigational Site Coventry, United Kingdom, CV2 2DX GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 4LP 收起 << |
NCT02114203 | Phase 1 Sickle Cell | Phase 1 | Completed | - | United States, Illinois ... 展开 >> University of Illinois Hospital and Health Sciences System Chicago, Illinois, United States, 60612-5836 University of Illinois at Chicago Clinical Research Center Chicago, Illinois, United States, 60612 University of Illinois Hospital and Health Sciences System Chicago, Illinois, United States, 60612 United States, Massachusetts Boston Medical Center E7E Boston, Massachusetts, United States, 02118 Boston Medical Center Boston, Massachusetts, United States, 02118 Boston University Medical Center Boston, Massachusetts, United States, 02118 United States, New York Interfaith Medical Center Brooklyn, New York, United States, 11213 Interfaith Medical Center Brooklyn, New York, United States, 11238 United States, North Carolina UNC Hospitals' Investigational Drug Service Pharmacy Chapel Hill, North Carolina, United States, 27514 UNC School of Medicine Clinical and Translational Research Center Chapel Hill, North Carolina, United States, 27599 United States, Virginia Investigational Drug Services Richmond, Virginia, United States, 23298 Virginia Commonwealth University Richmond, Virginia, United States, 23298 Belgium Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Italy Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico Milano, Italy, 20122 A.O.O.R Villa Sofia - V. Cervello Palermo, Italy, 90146 Netherlands Centre for Human Drug Research Leiden, Netherlands, 2333 CL United Kingdom Royal Liverpool and Broadgreen University Hospital Trust Liverpool, Merseyside, United Kingdom, L7 8XP Guy's and St Thomas' NHS Foundation Trust London, United Kingdom, SE1 9RT King's College Hospital NHS Foundation Trust London, United Kingdom, SE5 9RS Imperial College Healthcare NHS Trust London, United Kingdom, W12 0HS Central Manchester University Hospitals NHS Foundation Trust Manchester, United Kingdom, M13 9WL Manchester Royal Infirmary Manchester, United Kingdom, M13 9WL Oxford University Hospitals NHS Trust Oxford, United Kingdom, OX3 7LE 收起 << |
NCT00048568 | - | Completed | - | - | |
NCT00451321 | - | Terminated | - | - | |
NCT02114203 | - | Completed | - | - | |
NCT00138424 | - | Terminated | - | - | |
NCT00138424 | BK Virus (Nephropathy) | Phase 1 Phase 2 | Terminated | - | United States, Alabama ... 展开 >> University of Alabama Hospital - Nephrology Birmingham, Alabama, United States, 35249-0001 United States, California California Pacific Medical Center - Sutter Pacific Medical Foundation - Transplant Nephrology San Francisco, California, United States, 94115-1932 University of California San Francisco Medical Center at Parnassus - Organ Transplant San Francisco, California, United States, 94143-2204 United States, Colorado University of Colorado Denver Aurora, Colorado, United States, 80045-2541 United States, Illinois Northwestern University - Comprehensive Transplant Center Chicago, Illinois, United States, 60611-2927 The University of Chicago Medical Center - Kindney Trasnplant - Nephrology Chicago, Illinois, United States, 60637-1447 United States, Minnesota University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine Minneapolis, Minnesota, United States, 55455-0356 Mayo Clinic, Rochester - Infectious Diseases Rochester, Minnesota, United States, 55905-0001 United States, New Hampshire Dartmouth-Hitchcock Medical Center - Infectious Disease Lebanon, New Hampshire, United States, 03756-1000 United States, Texas Dallas Nephrology Associates - Dallas Transplant Institute Dallas, Texas, United States, 75204-6168 United States, Washington University of Washington - Medicine Seattle, Washington, United States, 98195-7110 United States, Wisconsin University of Wisconsin Hospital and Clinics - Clinical Science Center - Nephrology Madison, Wisconsin, United States, 53792-0001 收起 << |
NCT01376323 | - | Completed | - | - | |
NCT03228459 | Kidney Diseases ... 展开 >> Subclinical Disease and/or Syndrome Atherosclerosis Early Diagnosis Ultrasound 收起 << | Not Applicable | Recruiting | December 31, 2027 | Spain ... 展开 >> Primary Care centre Recruiting Lleida, Spain, 25007 Contact: Cristina Farrás Salles 0034661343421 cfarras.lleida.ics@gencat.cat Contact: Marcelino Bermudez Lopez 0034973702482 ext 2482 mbermudez@irblleida.cat Institut de recerca Biomèdica de Lleida Recruiting Lleida, Spain, 25198 Contact: Àngels Betriu Bars 0034973702481 ext 2481 abetriu@irblleida.cat Contact: Jose Manuel Valdivielso Revilla 0034973703560 ext 3560 valdivielso@medicina.udl.cat Principal Investigator: Ferran Barbé Illa Principal Investigator: Manuel Portero Otín Principal Investigator: Francisco Purroy Garcia Principal Investigator: Albert Lecube Torelló 收起 << |
NCT01734993 | - | Completed | - | - | |
NCT03506581 | - | Completed | - | - | |
NCT02871570 | Moderate Hepatic Impairment ... 展开 >> Normal Hepatic Function 收起 << | Phase 1 | Completed | - | United States, Florida ... 展开 >> Orlando Clincial Research Center Orlando, Florida, United States, 32809 收起 << |
NCT02563899 | - | Completed | - | - | |
NCT02871570 | - | Completed | - | - | |
NCT01028911 | Alzheimer's Disease | Phase 1 | Terminated(This study terminat... 展开 >>ed 27Apr2010 due to slow recruitment and the need to use the existing information to determine dosing for another study.) 收起 << | - | United States, Kansas ... 展开 >> Pfizer Investigational Site Wichita, Kansas, United States, 67207 Pfizer Investigational Site Wichita, Kansas, United States, 67211 收起 << |
NCT01285518 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, California ... 展开 >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Ft. Meyers, Florida, United States, 33901 Elite Research Institute Miami, Florida, United States, 33169 Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Miramar, Florida, United States, 33025 United States, Texas Cetero Research San Antonio, Texas, United States, 78229 收起 << |
NCT01285518 | - | Completed | - | - | |
NCT03077048 | Renal Insufficiency, Chronic | Phase 1 Phase 2 | Completed | - | Czechia ... 展开 >> Thomayer Hospital Clinical - Pharmacology Unit (CPU) Prague, Czechia, 140 59 收起 << |
NCT01577745 | - | Completed | - | - | |
NCT01036022 | Colitis, Ulcerative | Phase 2 | Completed | - | Belgium ... 展开 >> GSK Investigational Site Bonheiden, Belgium, 2820 GSK Investigational Site Brussels, Belgium, 1200 GSK Investigational Site Gent, Belgium, 9000 Canada, Alberta GSK Investigational Site Edmonton, Alberta, Canada, T6G 2C8 Canada, Ontario GSK Investigational Site Kingston, Ontario, Canada, K7L 5G2 GSK Investigational Site London, Ontario, Canada, N6A 4G5 GSK Investigational Site Vaughan, Ontario, Canada, L4L 4Y7 Canada GSK Investigational Site Quebec, Canada, G1S 4L8 Germany GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Muenster, Nordrhein-Westfalen, Germany, 48149 GSK Investigational Site Ludwigshafen, Rheinland-Pfalz, Germany, 67067 GSK Investigational Site Dresden, Sachsen, Germany, 01307 GSK Investigational Site Leipzig, Sachsen, Germany, 04129 GSK Investigational Site Kiel, Schleswig-Holstein, Germany, 24105 GSK Investigational Site Jena, Thueringen, Germany, 07747 GSK Investigational Site Berlin, Germany, 10117 GSK Investigational Site Hamburg, Germany, 20148 GSK Investigational Site Hamburg, Germany, 20246 Norway GSK Investigational Site Lørenskog, Norway, 1478 GSK Investigational Site Oslo, Norway, 0514 GSK Investigational Site Oslo, Norway, N-0456 GSK Investigational Site Tønsberg, Norway, 3116 Sweden GSK Investigational Site Göteborg, Sweden, SE-416 85 GSK Investigational Site Lund, Sweden, SE-221 85 GSK Investigational Site Stockholm, Sweden, SE-111 86 GSK Investigational Site Stockholm, Sweden, SE-171 76 收起 << |
NCT01028911 | - | Terminated(This study terminat... 展开 >>ed 27Apr2010 due to slow recruitment and the need to use the existing information to determine dosing for another study.) 收起 << | - | - | |
NCT00635089 | - | Completed | - | - | |
NCT01577745 | Solid Tumors | Phase 1 | Completed | - | United States, California ... 展开 >> Research Site Los Angeles, California, United States, 90404 United States, Connecticut Research Site New Haven, Connecticut, United States, 06513 United States, Massachusetts Research Site Boston, Massachusetts, United States United States, Michigan Research Site Ann Arbor, Michigan, United States, 48103 United States, Minnesota Research Site Minneapolis, Minnesota, United States United States, New York Research Site New York, New York, United States, 10002 United States, Ohio Research Site Cincinnati, Ohio, United States, 45201 Research Site Cleveland, Ohio, United States, 44105 United States, Texas Research Site Houston, Texas, United States, 77030 United States, Washington Research Site Seattle, Washington, United States, 98112 Research Site Tacoma, Washington, United States, 98405 收起 << |
NCT03260166 | Cutaneous Lupus Erythematosus ... 展开 >> Systemic Lupus Erythematosus Rash 收起 << | Phase 2 | Recruiting | February 2019 | China, Hunan ... 展开 >> The Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Xiangqi Tang, MD, PhD +86-731-84896038 xiangyagcp@126.com Principal Investigator: Qianjin Lu, MD, PhD Sub-Investigator: Hai Long, MD, PhD 收起 << |
NCT00397891 | Alzheimer Disease | Phase 1 | Completed | - | Japan ... 展开 >> Pfizer Investigational Site Chiba, Japan Pfizer Investigational Site Saitama, Japan Pfizer Investigational Site Shizuoka, Japan Pfizer Investigational Site Tokyo, Japan 收起 << |
NCT00635089 | Eosinophilic Esophagitis | Phase 3 | Completed | - | - |
NCT00420056 | Lymphoma, Mantle-Cell | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 New York Presbyterian Hospital New York, New York, United States, 10021 Weill Medical College of Cornell University - New York Presbyterian Hospital New York, New York, United States, 10021 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 收起 << |
NCT00397891 | - | Completed | - | - | |
NCT01235741 | Obesity | Phase 2 | Terminated(Results from previo... 展开 >>us study DFA102 demonstrated neutralizing activity to metreleptin in invitro assay in 2 participants.) 收起 << | - | United States, California ... 展开 >> Research Site Greenbrae, California, United States Research Site La Jolla, California, United States United States, Colorado Research Site Denver, Colorado, United States United States, Florida Research Site Winter Park, Florida, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Louisiana Research Site Baton Rouge, Louisiana, United States United States, Maryland Research Site Hyattsville, Maryland, United States United States, Massachusetts Research Site Boston, Massachusetts, United States United States, Missouri Research Site St. Louis, Missouri, United States United States, Montana Research Site Butte, Montana, United States United States, New York Research Site New York, New York, United States United States, Oklahoma Research Site Tulsa, Oklahoma, United States United States, Pennsylvania Research Site Philadelphia, Pennsylvania, United States United States, Texas Research Site Austin, Texas, United States United States, Utah Research Site Salt Lake City, Utah, United States United States, Virginia Research Site Arlington, Virginia, United States Research Site Norfolk, Virginia, United States Research Site Richmond, Virginia, United States 收起 << |
NCT02038764 | Diabetes Mellitus, Type 1 | Phase 1 | Completed | - | United States, California ... 展开 >> VA San Diego Healthcare System (Drug Shipment) San Diego, California, United States, 92161 Veterans Administration San Diego Healthcare System San Diego, California, United States, 92161 University of California, San Francisco San Francisco, California, United States, 94143 United States, Colorado Barbara Davis Center Aurora, Colorado, United States, 80045 United States, Connecticut Yale School of Medicine New Haven, Connecticut, United States, 06510 Yale New Haven Hospital - Investigational Drug Services New Haven, Connecticut, United States, 06511 Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 United States, Illinois Duchossois Center for Advanced Medicine Chicago, Illinois, United States, 60637 The University of Chicago Medical Center Chicago, Illinois, United States, 60637 University of Chicago Clinical Resource Center Chicago, Illinois, United States, 60637 University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Massachusetts Umass Memorial Medical Center Worcester, Massachusetts, United States, 01655 University of Massachusetts Medical School Worcester, Massachusetts, United States, 01655 United States, Minnesota University Of Minnesota Fairview Pharmacy Services Minneapolis, Minnesota, United States, 55454 University Of Minnesota Medical School Minneapolis, Minnesota, United States, 55455 United States, Missouri Barnes- Jewish HOSP Att: Kathryn Vehe Saint Louis, Missouri, United States, 63110 Washington University - Center for Advanced Medicine Saint Louis, Missouri, United States, 63110 Washington University Saint Louis, Missouri, United States, 63110 United States, North Carolina Duke Clinical Research Unit Durham, North Carolina, United States, 27710 Duke University Health Systems (DUHS) Investigational Drug Services Durham, North Carolina, United States, 27710 收起 << |
NCT02038764 | - | Completed | - | - | |
NCT01036022 | - | Completed | - | - | |
NCT02509117 | Healthy Subjects | Phase 1 | Completed | - | United States, California ... 展开 >> California Clinical Trials Medical Group, Inc Glendale, California, United States, 91206 Glendale Adventist Medical Center Glendale, California, United States, 91206 收起 << |
NCT00365859 | - | Completed | - | - | |
NCT02637115 | Metabolic Syndrome x ... 展开 >> Glucose Metabolism Disorders Dyslipidemias Obesity 收起 << | Not Applicable | Completed | - | Belgium ... 展开 >> Cliniques universitaires Saint-Luc Brussels, Belgium, 1200 收起 << |
NCT02332798 | Schizophrenia | Phase 1 | Completed | - | United States, California ... 展开 >> Collaborative Neuroscience Network, LLC. Long Beach, California, United States, 90806 收起 << |
NCT00365859 | Autistic Disorder ... 展开 >> Behavioral Symptoms 收起 << | Phase 3 | Completed | - | - |
NCT01235741 | - | Terminated(Results from previo... 展开 >>us study DFA102 demonstrated neutralizing activity to metreleptin in invitro assay in 2 participants.) 收起 << | - | - | |
NCT02793232 | Healthy Subjects | Phase 1 | Completed | - | Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 << |
NCT02190721 | Neutropenia | Phase 2 | Completed | - | - |
NCT02750930 | - | Terminated(The termination was... 展开 >> result of GSK business considerations and not due to quality, safety or efficacy concerns with any albiglutide formulations or study conduct) 收起 << | - | - | |
NCT02793232 | - | Completed | - | - | |
NCT02509117 | - | Completed | - | - | |
NCT02750930 | Diabetes Mellitus, Type 2 | Phase 4 | Terminated(The termination was... 展开 >> result of GSK business considerations and not due to quality, safety or efficacy concerns with any albiglutide formulations or study conduct) 收起 << | - | - |
NCT02190721 | - | Completed | - | - | |
NCT03493386 | Anaemia | Phase 1 | Completed | - | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 813-0017 收起 << |
NCT03041961 | Healthy Young Men | Not Applicable | Completed | - | United Kingdom ... 展开 >> Department of Life Sciences and Medecine London, Central London, United Kingdom, SE1 9NH 收起 << |
NCT03006289 | - | Unknown | November 2017 | - | |
NCT02332798 | - | Completed | - | - | |
NCT03555890 | Rhinitis | Phase 1 | Completed | - | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 812-0025 收起 << |
NCT02041299 | Iron Overload ... 展开 >> Sickle Cell Disease Other Anemias 收起 << | Phase 4 | Recruiting | September 2019 | - |
NCT03472742 | - | Recruiting | July 31, 2021 | Japan ... 展开 >> Niigata University Medical & Dental Hospital Recruiting Niigata, Japan, 951-8510 Contact: Division of Gastroenterology and Hepatology 收起 << | |
NCT02322450 | Essential Hypertension | Phase 2 | Completed | - | France ... 展开 >> Hôpital Arthur Gardiner Dinard, France, 35800 Hôpital Cardiologique, CHRU de Lille Lille, France, 59037 Hospices Civils de Lyon - Hôpital de la Croix Rousse Lyon, France, 69317 Hôpital Européen Georges Pompidou Paris, France, 75015 收起 << |
NCT03677596 | Leukemia Prec... 展开 >>ursor b-Cell Lymphoblastic Leukemia-Lymphoma ACUTE LYMPHOBLASTIC LEUKEMIA 收起 << | Phase 4 | Not yet recruiting | May 16, 2025 | - |
NCT02666287 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 1 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site London, United Kingdom, NW10 7EW 收起 << |
NCT03483090 | Osteoarthritis, Knee | Phase 2 | Recruiting | July 30, 2020 | Australia, Queensland ... 展开 >> University of the Sunshine Coast Clinical Trials Centre, Morayfield Health Hub Recruiting Morayfield, Queensland, Australia, 4506 Contact: Jessica Baird +61 7 5456 3797 trials@usc.edu.au Contact: Georgina Street +61 7 5456 3798 gstreet@usc.edu.au Principal Investigator: Susan Thackwray University of the Sunshine Coast Clinical Trials Centre, USC Health Clinics Recruiting Sippy Downs, Queensland, Australia, 4556 Contact: Jessica Baird +61 7 5456 3797 trials@usc.edu.au Contact: Georgina Street +61 7 5456 3798 gstreet@usc.edu.au Principal Investigator: Susan Thackwray Australia, South Australia CSIRO Nutrition and Health Research Clinic Recruiting Adelaide, South Australia, Australia, 5000 Contact: Bianca Benassi-Evans Australia, Victoria Emeritus Research Recruiting Camberwell, Victoria, Australia, 3124 Contact: Edwin Young +61 3 950 96166 edwinyoung@emeritusresearch.com Contact: Teresa Ringeri +61 3 950 96166 teresaringeri@emeritusresearch.com Principal Investigator: Andrew Ostor 收起 << |
NCT03470441 | Acute Myocardial Infarction ... 展开 >> STEMI 收起 << | Phase 2 | Not yet recruiting | December 2018 | - |
NCT02837380 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 1 | Completed | - | China ... 展开 >> GSK Investigational Site Shanghai, China, 200030 收起 << |
NCT00162305 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, Florida ... 展开 >> Local Institution Fort Lauderdale, Florida, United States, 33301 Local Institution Miami, Florida, United States, 33169 Local Institution Orlando, Florida, United States, 32809 United States, Louisiana Local Institution New Orleans, Louisiana, United States, 70119 United States, Texas Local Institution San Antonio, Texas, United States, 78229-3894 收起 << |
NCT02698553 | Depressive Disorder, Major | Phase 1 | Completed | - | China ... 展开 >> GSK Investigational Site Shanghai, China, 200030 收起 << |
NCT02027857 | Brain Electrical Impedance; ... 展开 >> Non-invasive Intracranial Pressure 收起 << | Not Applicable | Unknown | June 2015 | China, Shaanxi ... 展开 >> Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University Not yet recruiting Xi'an City, Shaanxi, China, 710032 Contact: Hu Shijie, M.D.,Ph.D. 086-29-84773307 hushijie@fmmu.edu.cn Contact: Fei Zhou, M.D.,Ph.D. 086-13992888996 feizhou@fmmu.edu.cn Principal Investigator: Hu Shijie, M.D.,Ph.D. 收起 << |
NCT02578953 | Prostatic Hyperplasia | Phase 1 | Completed | - | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 813-0017 收起 << |
NCT02925546 | Heart Failure, Congestive | Phase 1 | Completed | - | United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 << |
NCT03479892 | Metabolism and Nutrition Disor... 展开 >>der Obesity 收起 << | Phase 1 | Recruiting | May 4, 2019 | United States, Texas ... 展开 >> Novo Nordisk Investigational Site Recruiting San Antonio, Texas, United States, 78209 收起 << |
NCT03159442 | Chronic Obstructive Pulmonary ... 展开 >>Disease - COPD 收起 << | Phase 1 | Completed | - | United Kingdom ... 展开 >> Research Site London, United Kingdom, HA1 3UJ 收起 << |
NCT02283047 | Hypertension ... 展开 >>Overweight Sedentary 收起 << | Not Applicable | Completed | - | Spain ... 展开 >> Faculty of Physical Activity and Sport Sciences Vitoria-gasteiz, Araba/alava, Spain, 01007 收起 << |
NCT03534752 | - | Recruiting | April 1, 2020 | Switzerland ... 展开 >> Lausanne University Hospitals Recruiting Lausanne, Vaud, Switzerland, 1011 Contact: F , MD 收起 << | |
NCT02333240 | Pre-Eclampsia ... 展开 >> Hypertension, Pregnancy-Induced 收起 << | Not Applicable | Completed | - | United Kingdom ... 展开 >> Royal Berkshire NHS Foundation Trust Reading, Berkshire, United Kingdom, RG1 5AN Northampton General Hospital NHS Trust Northampton, Northamptonshire, United Kingdom, NN1 5BD Oxford University Hospitals NHS Foundation Trust Oxford, Oxfordshire, United Kingdom, OX3 9DU Stoke Mandeville Hospital Aylesbury, United Kingdom, HP21 8AL Horton General Hospital Banbury, United Kingdom, OX16 9AL 收起 << |
NCT00254293 | Rheumatoid Arthritis | Phase 1 Phase 2 | Completed | - | United States, Florida ... 展开 >> Orlando Clinical Research Center Orlando, Florida, United States, 32806 United States, Georgia Winship Cancer Institute, Emory University Atlanta, Georgia, United States, 30322 United States, Louisiana New Orleans Center For Clinical Research New Orleans, Louisiana, United States, 70119 United States, Minnesota Davita Clinical Research Minneapolis, Minnesota, United States, 55404 United States, North Carolina The Arthritis Clinic & Carolina Bone & Joint Charlotte, North Carolina, United States, 28210 收起 << |
NCT02732444 | - | Completed | - | Brazil ... 展开 >> Hospital of clinics of the federal university of uberlândia Uberlandia, Minas Gerais, Brazil 收起 << | |
NCT03394651 | - | Recruiting | April 1, 2022 | China, Shanghai ... 展开 >> Changhai Hospital Recruiting Shanghai, Shanghai, China, 200433 Contact: Qi-Xiang Song, MD 8615021223013 rex_song918@qq.com 收起 << | |
NCT00087607 | Hepatitis C, Chronic | Phase 4 | Completed | - | - |
NCT00254293 | - | Completed | - | - | |
NCT00087607 | - | Completed | - | - | |
NCT03395704 | Hereditary Hemochromatosis | Phase 2 | Recruiting | December 2018 | United States, Arkansas ... 展开 >> Investigative Site Recruiting North Little Rock, Arkansas, United States, 72117 United States, California Investigative Site Recruiting Palo Alto, California, United States, 94305 Investigative Site Recruiting Rialto, California, United States, 92377 Investigational Site Recruiting San Diego, California, United States, 91942 United States, Michigan Investigative Site Recruiting Wyoming, Michigan, United States, 49519 United States, Mississippi Investigative Site Recruiting Jackson, Mississippi, United States, 39216 United States, New York Investigative Site Recruiting East Setauket, New York, United States, 11733 Investigative Site Recruiting Manhasset, New York, United States, 11030 Investigative Site Recruiting New York, New York, United States, 10029 United States, Texas Investigative Site Recruiting Dallas, Texas, United States, 75246 Investigative Site Recruiting Fort Worth, Texas, United States, 76104 Investigative Site Recruiting Houston, Texas, United States, 77058 Investigative Site Recruiting San Antonio, Texas, United States, 78215 United States, Washington Investigative Site Recruiting Seattle, Washington, United States, 98104 Australia, New South Wales Investigative Site Recruiting Westmead, New South Wales, Australia, 2145 Australia, Queensland Investigative Site Recruiting Brisbane, Queensland, Australia, 4120 Investigative Site Recruiting Herston, Queensland, Australia, 4029 Australia, Victoria Investigative Site Recruiting Melbourne, Victoria, Australia, 3004 France Investigative Site Recruiting Bondy, France, 93140 Investigative Site Recruiting Orléans, France, 45000 Investigative Site Recruiting Pessac, France, 33604 Investigative Site Recruiting Rennes Cedex 9, France, 35033 United Kingdom Investigative Site Recruiting Bradford, England, United Kingdom, BD9 6RJ Investigative Site Recruiting Newcastle Upon Tyne, England, United Kingdom, NE7 7DN Investigative Site Recruiting Portsmouth, England, United Kingdom, PO6 3LY 收起 << |
NCT00611455 | Arthritis, Rheumatoid | Phase 3 | Terminated(Ofatumumab IV trial... 展开 >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) 收起 << | - | - |
NCT01449253 | Pulmonary Hypertension Seconda... 展开 >>ry to Lung Disease and/or Hypoxia 收起 << | Phase 4 | Unknown | July 2013 | India ... 展开 >> All India Institute Of Medical Sciences Recruiting New Delhi, Delhi, India, 110029 Contact: Sajal Ajmani, MBBS 9873570408 sajalajmani@gmail.com Principal Investigator: Surendra K Sharma, MD, Ph D 收起 << |
NCT00048165 | Heart Transplantation | Phase 4 | Completed | - | - |
NCT00048165 | - | Completed | - | - | |
NCT00603525 | Arthritis, Rheumatoid | Phase 3 | Terminated(Ofatumumab IV trial... 展开 >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) 收起 << | - | - |
NCT02832362 | Common Cold | Phase 1 | Completed | - | Canada, Quebec ... 展开 >> GSK Investigational Site Quebec City, Quebec, Canada, G1P 0A2 收起 << |
NCT00392925 | Overweight Ob... 展开 >>esity 收起 << | Phase 2 | Completed | - | United States, Florida ... 展开 >> Research Site Deland, Florida, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Indiana Research Site Indianapolis, Indiana, United States United States, Kansas Research Site Overland Park, Kansas, United States United States, Louisiana Research Site Baton Rouge, Louisiana, United States United States, Michigan Research Site Detroit, Michigan, United States United States, Minnesota Research Site Edina, Minnesota, United States United States, Montana Research Site Butte, Montana, United States United States, Ohio Research Site Cincinnati, Ohio, United States United States, Oregon Research Site Portland, Oregon, United States United States, Utah Research Site Salt Lake City, Utah, United States United States, Washington Research Site Olympia, Washington, United States 收起 << |
NCT00611455 | - | Terminated(Ofatumumab IV trial... 展开 >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) 收起 << | - | - | |
NCT00364793 | HIV Infections | Phase 1 Phase 2 | Completed | - | Argentina ... 展开 >> Local Institution Buenos Aires, Argentina, 1425 Local Institution Capital Federal, Argentina, 1425 Colombia Local Institution Cali, Colombia Mexico Local Institution Df, Distrito Federal, Mexico, 06720 Local Institution Guadalajara, Jalisco, Mexico, 44280 Local Institution Guadalajara, Jalisco, Mexico, 44520 Local Institution Morelia, Michioacan, Mexico, 58000 Local Institution Monterrey, Nuevo Leon, Mexico, 64460 Local Institution Colima, Mexico, 28019 Local Institution Puebla, Mexico, 72000 Local Institution San Luis Potosi, Mexico, 78240 Panama Local Institution Ciudad De Panama, Panama, 0816-00383 South Africa Local Institution Bloemfontein, Free State, South Africa, 9301 Local Institution Westdene, Gauteng, South Africa, 2092 Local Institution Cape Town, Western Cape, South Africa, 7505 Thailand Local Institution Bangkok, Thailand, 10330 Local Institution Bangkok, Thailand, 10700 收起 << |
NCT00603525 | - | Terminated(Ofatumumab IV trial... 展开 >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) 收起 << | - | - | |
NCT00392925 | - | Completed | - | - | |
NCT00705367 | - | Completed | - | - | |
NCT00452530 | Deep Vein Thrombosis ... 展开 >> Pulmonary Embolism 收起 << | Phase 3 | Completed | - | - |
NCT00364793 | - | Completed | - | - | |
NCT00256750 | Kidney Transplantation ... 展开 >> Chronic Kidney Failure 收起 << | Phase 3 | Completed | - | - |
NCT00374322 | Neoplasms, Breast | Phase 3 | Completed | - | - |
NCT00452530 | - | Completed | - | - | |
NCT03324685 | Drug Interactions | Phase 1 | Completed | - | United States, Florida ... 展开 >> Research Site Daytona Beach, Florida, United States, 32117 收起 << |
NCT00705367 | Lupus Nephritis | Phase 1 | Completed | - | China, Shanghai ... 展开 >> Local Institution Shanghai, Shanghai, China, 200001 收起 << |
NCT03574142 | Healthy Subjects | Phase 1 | Completed | - | China ... 展开 >> Research Site Beijing, China, 100029 收起 << |
NCT03058458 | Healthy Volunteers ... 展开 >> Asthma 收起 << | Phase 1 | Completed | - | United Kingdom ... 展开 >> Investigator Site Harrow, United Kingdom 收起 << |
NCT03340935 | Malignant Neoplasm ... 展开 >> Cancer 收起 << | Not Applicable | Recruiting | June 30, 2018 | Italy ... 展开 >> Fondazione IRCCS Istituto Nazionale dei Tumori Recruiting Milan, Italy, 20133 Contact: Claudio Vernieri, M.D., Ph.D. +39 02 23903066 claudio.vernieri@istitutotumori.mi.it 收起 << |
NCT00256750 | - | Completed | - | - | |
NCT00374322 | - | Completed | - | - | |
NCT01508936 | Eosinophilic Asthma | Phase 3 | Completed | - | - |
NCT01508936 | - | Completed | - | - | |
NCT00371683 | Deep Vein Thrombosis ... 展开 >> Pulmonary Embolism 收起 << | Phase 3 | Completed | - | - |
NCT00371683 | - | Completed | - | - | |
NCT01270464 | Eosinophilic Asthma | Phase 3 | Completed | - | - |
NCT01270464 | - | Completed | - | - | |
NCT01287039 | Eosinophilic Asthma | Phase 3 | Completed | - | - |
NCT00569803 | - | Completed | - | - | |
NCT01287039 | - | Completed | - | - | |
NCT02311790 | Insulin Sensitivity | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Jean Mayer Human Nutrition Research Center on Aging Boston, Massachusetts, United States, 02111 收起 << |
NCT00569803 | Transplantation | Phase 1 | Completed | - | United States, Texas ... 展开 >> Ppd Development Austin, Texas, United States, 78744 收起 << |
NCT00673387 | Overweight Ob... 展开 >>esity 收起 << | Phase 2 | Completed | - | - |
NCT00534313 | Psoriatic Arthritis | Phase 2 | Terminated(Lack of efficacy wi... 展开 >>th respect to skin-related lesions in the short-term phase) 收起 << | - | - |
NCT00114777 | Renal Transplantation | Phase 3 | Completed | - | - |
NCT00673387 | - | Completed | - | - | |
NCT01610492 | Glomerulonephritis, Membranous | Phase 2 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site Exeter, Devon, United Kingdom, EX2 5DW GSK Investigational Site Stevenage, Hertfordshire, United Kingdom, SG1 4AB GSK Investigational Site Cambridge, United Kingdom, CB2 0QQ GSK Investigational Site Glasgow, United Kingdom, G11 6NT GSK Investigational Site Manchester, United Kingdom, M13 9WL GSK Investigational Site Reading, United Kingdom, RG1 5AN GSK Investigational Site Salford, United Kingdom, M6 8HD GSK Investigational Site Whitechapel, London, United Kingdom, E1 1BB 收起 << |
NCT00372112 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | Australia, New South Wales ... 展开 >> GSK Investigational Site Camperdown, New South Wales, Australia, 2050 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 Bulgaria GSK Investigational Site Ruse, Bulgaria, 7000 GSK Investigational Site Sofia, Bulgaria, 1431 GSK Investigational Site Sofia, Bulgaria, 1606 Germany GSK Investigational Site Weinheim, Baden-Wuerttemberg, Germany, 69469 GSK Investigational Site Hannover, Niedersachsen, Germany, 30159 GSK Investigational Site Geesthacht, Schleswig-Holstein, Germany, 21502 Netherlands GSK Investigational Site Breda, Netherlands, 4819 EV GSK Investigational Site Hoorn, Netherlands, 1624 NP New Zealand GSK Investigational Site Auckland, New Zealand, 1005 GSK Investigational Site Tauranga, New Zealand Romania GSK Investigational Site Bucharest, Romania, 050159 GSK Investigational Site Iasi, Romania, 700506 收起 << |
NCT01610492 | - | Completed | - | - | |
NCT01789970 | Low Back Pain | Phase 3 | Completed | - | - |
NCT00114777 | - | Completed | - | - | |
NCT01525238 | - | Completed | - | - | |
NCT00534313 | - | Terminated(Lack of efficacy wi... 展开 >>th respect to skin-related lesions in the short-term phase) 收起 << | - | - | |
NCT01525238 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Alabama ... 展开 >> The Children Hospital Of Alabama Birmingham, Alabama, United States, 35233 United States, California Axis Clinical Trials Los Angeles, California, United States, 90036 United States, Florida Nemours Childrens Hospital Orlando, Florida, United States, 32827 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Kentucky Kosair Charities Pediatric Clinical Research Unit Louisville, Kentucky, United States, 40202 United States, Louisiana Lsuhsc-Shreveport Shreveport, Louisiana, United States, 71103 United States, Missouri Childrens Mercy Hospital Kansas City, Missouri, United States, 64108 United States, New York Women And Children'S Hopsital Of Buffalo Buffalo, New York, United States, 14222 United States, Ohio Promedica Toledo Children'S Hospital Toledo, Ohio, United States, 43606 Mercy Children'S Hospital Toledo, Ohio, United States, 43608 United States, Pennsylvania Children'S Hospital Of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children'S Hospital Of Pittsburgh Of Upmc Pittsburgh, Pennsylvania, United States, 15224 United States, Tennessee Methodist Le Bonheur Hlthcare Memphis, Tennessee, United States, 38103 United States, Texas Christus Santa Rosa Childrens Hospital San Antonio, Texas, United States, 78207 Mexico Local Institution Guadalajara, Jalisco, Mexico, 44150 Local Institution Monterrey, Nuevo Leon, Mexico, 64460 Local Institution Veracruz, Mexico, 91910 收起 << |
NCT01225822 | Venous Thromboembolism | Phase 2 | Completed | - | - |
NCT02722044 | Rheumatoid Arthritis | Phase 3 | Completed | - | United States, Michigan ... 展开 >> Henry Ford Health System Detroit, Michigan, United States, 48202 United States, North Carolina Medication Management, LLC Greensboro, North Carolina, United States, 27408 United States, Oklahoma Lynn Health Science Institute Oklahoma City, Oklahoma, United States, 73112 United States, Pennsylvania Altoona Center for Clinical Research, PC Duncansville, Pennsylvania, United States, 16635 United States, Texas Austin Regional Clinic, PA Austin, Texas, United States, 78731 Accurate Clinical Management Houston, Texas, United States, 77004 Accurate Clinical Research, Inc. Houston, Texas, United States, 77034 收起 << |
NCT00372112 | - | Completed | - | - | |
NCT01225822 | - | Completed | - | - | |
NCT01789970 | - | Completed | - | - | |
NCT02722044 | - | Completed | - | - | |
NCT00420199 | Active Rheumatoid Arthritis | Phase 3 | Completed | - | Belgium ... 展开 >> Local Institution Bruxelles, Belgium, 1200 Local Institution Yvoir, Belgium, 5530 Germany Local Institution Berlin, Germany, 14059 Local Institution Berlin, Germany, BE-10117 Netherlands Local Institution Amsterdam, Netherlands, 1105 AZ Spain Local Institution Barcelona, Spain, 08036 Local Institution Barcelona, Spain, 08907 Sweden Local Institution Stockholm, Sweden, 171 76 United Kingdom Local Institution London, Greater London, United Kingdom, SE19RT Local Institution Leeds, North Yorkshire, United Kingdom, LS7 4SA 收起 << |
NCT00819234 | Obesity | Phase 2 | Completed | - | - |
NCT03741218 | Obesity | Not Applicable | Recruiting | March 2020 | Spain ... 展开 >> Institute of Food Science, Technology and Nutrition, National Research Council (ICTAN-CSIC) Recruiting Madrid, Spain, 28040 Contact: Jara Pérez-Jiménez, PhD +34915492300 ext 231406 jara.perez@ictan.csic.es 收起 << |
NCT00420199 | - | Completed | - | - | |
NCT02947568 | - | Recruiting | December 2019 | Hungary ... 展开 >> 2nd Department of Medicine and Nephrological Center Recruiting Pécs, Baranya, Hungary, 7624 Contact: Gergo A Molnar, MD, PhD +3672536050 gergo.molnar@aok.pte.hu Contact: Eszter Sélley, MD +3672536050 eszter.selley@aok.pte.hu Sub-Investigator: Béla Melegh, MD Sub-Investigator: Lilla Lakner, MD Sub-Investigator: Kulcsár Imre, MD Sub-Investigator: Bene Judit, MD Principal Investigator: István Wittmann, MD 收起 << | |
NCT00927082 | Hepatitis B, Chronic | Phase 4 | Completed | - | - |
NCT00819234 | - | Completed | - | - | |
NCT03460652 | ADHD | Phase 3 | Recruiting | March 2019 | United States, Arkansas ... 展开 >> Woodland International Research Recruiting Little Rock, Arkansas, United States, 72211 Contact: Lacey Earls 501-221-8681 lacey@woodlandintlresearchgrp.com Principal Investigator: Jim Aukstuolis, MD United States, Colorado MCB Clinical Research Centers Recruiting Colorado Springs, Colorado, United States, 80910 Contact: Nichole Gonzalez 719-634-6576 ngonzalez@mcbcrc.com Principal Investigator: Andrew Sedillo, MD United States, Florida Meridien Research Recruiting Bradenton, Florida, United States, 34201 Contact: Margaret Bell 941-756-8680 mbell@meridienresearch.net Principal Investigator: Andrew Cutler, MD Clinical Neuroscience Solutions, Inc. Recruiting Jacksonville, Florida, United States, 32256 Contact: Sandeep Jandir 904-281-5757 sjandir@cnshealthcare.com Principal Investigator: Nandita Jones, MD Innovative Clinical Research, Inc. Recruiting Lauderhill, Florida, United States, 33319 Contact: Kadian Watson 954-990-6326 kwatson@segaltrials.com Principal Investigator: Rishi Kakar, MD Meridien Research Recruiting Maitland, Florida, United States, 32751 Contact: Sondra Chapman 407-644-1165 schapman@meridienresearch.net Principal Investigator: Andrea Marraffino, MD Clinical Neuroscience Solutions, Inc. Recruiting Orlando, Florida, United States, 32801 Contact: Rebecca Klipper 407-425-5100 rklipper@cnshealthcare.com Principal Investigator: Robert Molpus, MD United States, Illinois Capstone Clinical Research Recruiting Libertyville, Illinois, United States, 60048 Contact: Kelly Burns 847-549-7214 kburns@capstoneclinical.com Principal Investigator: Michael Greenbaum, MD United States, Kansas Psychiatric Associates Recruiting Overland Park, Kansas, United States, 66211 Contact: Glynis Murphy, PhD 913-438-8221 research@murphyclinic.com Principal Investigator: William Murphy, MD United States, Nevada Center for Psychiatry and Behavioral Medicine, Inc. Recruiting Las Vegas, Nevada, United States, 89128 Contact: Jordan Karbins 702-838-0742 jordankabins@gmail.com Principal Investigator: Ann Childress, MD United States, New Jersey Hassman Research Institute Recruiting Berlin, New Jersey, United States, 08009 Contact: Vania Dasilva 856-753-7335 vdasilva@hritrials.com Principal Investigator: Howard Hassman, MD United States, Ohio Neuro-Behavioral Clinical Research Recruiting Canton, Ohio, United States, 44718 Contact: Natalie Kuemerle 330-493-1118 nkuemerle@nb-cr.com Principal Investigator: Shishuka Malhotra, MD Midwest Clinical Research Center, LLC Recruiting Dayton, Ohio, United States, 45417 Contact: Rebecca Vernon 937-424-1050 rvernon@midwestclinical.com Principal Investigator: Otto Dueno, MD United States, Oregon Oregon Center for Clinical Investigations, Inc. Recruiting Portland, Oregon, United States, 97214 Contact: Christina Friesen 503-276-6224 christina.friesen@occi.org Principal Investigator: Beal Essink, MD Oregon Center for Clinical Investigations, Inc. Recruiting Salem, Oregon, United States, 97301 Contact: Emily Valdez 503-540-0100 emily.valdez@occi.org Principal Investigator: Drissana Tran, MD United States, Tennessee Clinical Neuroscience Solutions, Inc. Recruiting Memphis, Tennessee, United States, 38119 Contact: Kelly Iskiwitz, BS 901-843-1045 kiskiwitz@cnshealthcare.com Principal Investigator: Valerie Arnold, MD United States, Texas FutureSearch Trials Recruiting Austin, Texas, United States, 78731 Contact: Erin Ashmore 214-369-2600 ext 109 erina@fstrials.com Principal Investigator: Michael Downing, MD Bayou City Research, Ltd. Recruiting Houston, Texas, United States, 77007 Contact: Kathy Harpst 832-251-7000 ext 302 Principal Investigator: Matthew Brams, MD Houston Clinical Trials Recruiting Houston, Texas, United States, 77098 Contact: Janice Roggenkamp 713-527-8448 jroggenkamp@houstonclintrials.com Principal Investigator: Alain Katic, MD 收起 << |
NCT00927082 | - | Completed | - | - | |
NCT01240863 | Chronic Pain | Phase 3 | Completed | - | - |
NCT01240863 | - | Completed | - | - | |
NCT01163851 | - | Completed | - | - | |
NCT01021553 | - | Completed | - | - | |
NCT00423319 | - | Completed | - | - | |
NCT00423319 | Deep Vein Thrombosis ... 展开 >> Pulmonary Embolism 收起 << | Phase 3 | Completed | - | - |
NCT03054194 | Healthy Participants | Phase 1 | Completed | - | United States, Texas ... 展开 >> Eisai Trial Site San Antonio, Texas, United States, 78217 收起 << |
NCT02061098 | Overweight | Phase 1 Phase 2 | Completed | - | Spain ... 展开 >> UCAM (San Antonio Catholic University from Murcia) Murcia, Spain, 30107 收起 << |
NCT01163851 | Hypercholesterolemia ... 展开 >> Dyslipidemia 收起 << | Phase 1 | Completed | - | United States, Arizona ... 展开 >> Premier Research Group, Limited Peoria, Arizona, United States, 85381 Dedicated Phase 1, Inc. Phoenix, Arizona, United States, 85013 Premier Research Group Limited Phoenix, Arizona, United States, 85027 United States, Kansas Vince and Associates Clinical Research Overland Park, Kansas, United States, 66211 Vince and Associates Clinical Research Overland Park, Kansas, United States, 66212 收起 << |
NCT00111800 | - | Completed | - | - | |
NCT00087568 | - | Completed | - | - | |
NCT00087568 | Hepatitis C, Chronic | Phase 4 | Completed | - | - |
NCT00111800 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT03030053 | Mental Processes | Not Applicable | Active, not recruiting | December 2018 | United Kingdom ... 展开 >> Hugh Sinclair Unit of Human Nutrition, University of Reading Reading, Berkshire, United Kingdom, RG6 5SG 收起 << |
NCT03558789 | - | Recruiting | November 1, 2022 | France ... 展开 >> CH Valence Recruiting Valence, France, 26953 Contact: Guillaume Buiret, MD +475757528 gbuiret@ch-valence.fr Contact: Sandrine Beauchard sbeauchard@ch-valence.fr Principal Investigator: guillaume buiret, MD 收起 << | |
NCT00814762 | AIDS | Phase 1 | Completed | - | Germany ... 展开 >> GSK Investigational Site Erlangen, Bayern, Germany, 91054 GSK Investigational Site Muenchen, Bayern, Germany, 80335 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 50937 GSK Investigational Site Berlin, Germany, 12157 GSK Investigational Site Hamburg, Germany, 20099 GSK Investigational Site Hamburg, Germany, 20246 收起 << |
NCT00763867 | Heart Failure | Phase 3 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic Arizona Phoenix, Arizona, United States, 85054 United States, Georgia Morehouse School of Medicine Atlanta, Georgia, United States, 30310 United States, Massachusetts Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 United States, Minnesota Minnesota Heart Failure Network Minneapolis, Minnesota, United States, 55415 Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Utah University of Utah Health Sciences Center Murray, Utah, United States, 84107 United States, Vermont University of Vermont - Fletcher Allen Health Care Burlington, Vermont, United States, 05401 Canada, Quebec Montreal Heart Institute Montreal, Quebec, Canada, H1T - 1C8 收起 << |
NCT01021553 | Premature Ejaculation | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site San Diego, California, United States, 92120 GSK Investigational Site San Jose, California, United States, 95128 United States, Indiana GSK Investigational Site Fort Wayne, Indiana, United States, 46825 United States, New York GSK Investigational Site New York, New York, United States, 10016 United States, Pennsylvania GSK Investigational Site Bala-Cynwyd, Pennsylvania, United States, 19004 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 Netherlands GSK Investigational Site Amsterdam, Netherlands, 1081 HV GSK Investigational Site Utrecht, Netherlands, 3584 CJ 收起 << |
NCT01268566 | - | Completed | - | - | |
NCT01268566 | Glioblastoma Multiforme | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Research Site Tucson, Arizona, United States United States, California Research Site Los Angeles, California, United States Research Site Stanford, California, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Massachusetts Research Site Boston, Massachusetts, United States United States, Michigan Research Site Detroit, Michigan, United States United States, New York Research Site New York, New York, United States United States, Ohio Research Site Canton, Ohio, United States United States, Pennsylvania Research Site Pittsburgh, Pennsylvania, United States United States, Tennessee Research Site Nashville, Tennessee, United States United States, Texas Research Site San Antonio, Texas, United States United States, Washington Research Site Seattle, Washington, United States 收起 << |
NCT00867087 | Lymphoma, B-Cell | Phase 2 | Completed | - | - |
NCT00107653 | - | Completed | - | - | |
NCT00107653 | Hepatitis C, Chronic | Phase 4 | Completed | - | - |
NCT00763867 | - | Completed | - | - | |
NCT02532998 | Pharmacodynamics ... 展开 >> Healthy Subjects 收起 << | Phase 1 | Completed | - | United Kingdom ... 展开 >> Research Site Harrow, United Kingdom 收起 << |
NCT01491932 | Dyskinesias P... 展开 >>arkinson Disease Movement Disorders Parkinsonian Disorders Anti-Dyskinesia Agents 收起 << | Phase 2 | Completed | - | - |
NCT03351751 | Healthy Volunteers | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 收起 << |
NCT02532998 | - | Completed | - | - | |
NCT02271984 | Healthy | Phase 1 | Completed | - | Germany ... 展开 >> Please contact the Merck KGaA Communication Center Darmstadt, Germany 收起 << |
NCT00867087 | - | Completed | - | - | |
NCT02271984 | - | Completed | - | - | |
NCT00817063 | Eczema | Phase 3 | Completed | - | - |
NCT01316939 | Crohn's Disease | Phase 3 | Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 << | - | - |
NCT03672513 | Menopause Nut... 展开 >>ritional Intervention Bone Diseases 收起 << | Not Applicable | Completed | - | Spain ... 展开 >> Universidad de Granada Granada, Spain, 18071 收起 << |
NCT01316939 | - | Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 << | - | - | |
NCT02814656 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 1 | Completed | - | United Kingdom ... 展开 >> Research Site London, United Kingdom 收起 << |
NCT01318993 | Crohn's Disease | Phase 3 | Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 << | - | - |
NCT01114620 | - | Completed | - | - | |
NCT01362348 | - | Terminated(Lack of efficacy id... 展开 >>entified during a preliminary analysis) 收起 << | - | - | |
NCT01362348 | Macular Degeneration | Phase 2 | Terminated(Lack of efficacy id... 展开 >>entified during a preliminary analysis) 收起 << | - | United States, Arizona ... 展开 >> GSK Investigational Site Phoenix, Arizona, United States, 85014 United States, Florida GSK Investigational Site Miami, Florida, United States, 33143 GSK Investigational Site Winter Haven, Florida, United States, 33880 United States, Georgia GSK Investigational Site Decatur, Georgia, United States, 30030 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02114 United States, Michigan GSK Investigational Site Grand Rapids, Michigan, United States, 49525 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Texas GSK Investigational Site Austin, Texas, United States, 78705 GSK Investigational Site Houston, Texas, United States, 77030 France GSK Investigational Site Paris cedex 10, France, 75475 GSK Investigational Site Paris cedex 12, France, 75571 Germany GSK Investigational Site Muenchen, Bayern, Germany, 80336 GSK Investigational Site Bonn, Nordrhein-Westfalen, Germany, 53127 GSK Investigational Site Muenster, Nordrhein-Westfalen, Germany, 48145 GSK Investigational Site Leipzig, Sachsen, Germany, 04103 收起 << |
NCT01090492 | Raynaud's Disease ... 展开 >> Peripheral Vascular Disease 收起 << | Phase 2 | Completed | - | - |
NCT00817063 | - | Completed | - | - | |
NCT01114620 | Influenza | Phase 4 | Completed | - | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 813-8588 收起 << |
NCT01090492 | - | Completed | - | - | |
NCT00793871 | Gastrointestinal Neoplasms, Ga... 展开 >>strointestinal Stromal Tumors 收起 << | Phase 4 | Completed | - | China, Jiangsu ... 展开 >> Nanjing Bayi Hospital Nanjing, Jiangsu, China, 210002 China Beijing Cancer Hospital Beijing, China, 100035 307 Hospital of PLA Beijing, China, 100071 Cancer Institute & Hospital Chinese Academy of Medical Sciences and PUMC Bejing, China, 100021 收起 << |
NCT00793871 | - | Completed | - | - | |
NCT01318993 | - | Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 << | - | - | |
NCT02293902 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT03397641 | Atrial Fibrillation | Phase 1 | Completed | - | United Kingdom ... 展开 >> Quotient Clinical Nottingham, United Kingdom, NG11 6JS 收起 << |
NCT02293902 | - | Completed | - | - | |
NCT01727791 | Healthy Lactating Women | Phase 4 | Completed | - | Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 << |
NCT01001169 | - | Completed | - | - | |
NCT01001169 | Influenza | Phase 2 | Completed | - | Japan ... 展开 >> GSK Investigational Site Tokyo, Japan, 157-8535 收起 << |
NCT01229436 | - | Completed | - | - | |
NCT01229436 | Dupuytren's Contracture | Phase 3 | Completed | - | Denmark ... 展开 >> Pfizer Investigational Site Copenhagen, Denmark, 1402 K Pfizer Investigational Site Silkeborg, Denmark, 8600 France Pfizer Investigational Site Montpellier cedex 5, France, 34295 Pfizer Investigational Site Nice, France, 06000 Pfizer Investigational Site Paris, France, 75016 Pfizer Investigational Site Paris, France, Cedex 15 75908 Germany Pfizer Investigational Site Bad Neustadt, Germany, 97616 Pfizer Investigational Site Berlin, Germany, 10627 Pfizer Investigational Site Bonn, Germany, 53123 Pfizer Investigational Site Muenster, Germany, 48149 Pfizer Investigational Site Nurnberg, Germany, 90471 Pfizer Investigational Site Tubingen, Germany, 72076 Hungary Pfizer Investigational Site Miskolc, Hungary, 3526 Italy Pfizer Investigational Site Sesto San Giovanni, Milano, Italy, 20099 Pfizer Investigational Site Modena, Italy, 41124 Pfizer Investigational Site Savona, Italy, 17100 Spain Pfizer Investigational Site Elche, Alicante, Spain, 03203 Pfizer Investigational Site Hospitalet De Llobregat, Barcelona/ Spain, Spain, 08907 Pfizer Investigational Site Barcelona, Spain, 08022 Pfizer Investigational Site Barcelona, Spain, 08036 Pfizer Investigational Site Málaga, Spain, 29010 Sweden Pfizer Investigational Site Malmö, Sweden, SE-205 02 Pfizer Investigational Site Stockholm, Sweden, SE 118 83 Pfizer Investigational Site Uppsala, Sweden, 751 85 United Kingdom Pfizer Investigational Site Derby, United Kingdom, DE22 3NE Pfizer Investigational Site Glasgow, United Kingdom, G4 0SF Pfizer Investigational Site Norwich, United Kingdom, NR4 7UY Pfizer Investigational Site Southampton, United Kingdom, SO16 6YD 收起 << |
NCT01727791 | - | Completed | - | - | |
NCT02463435 | Severe Obesity | Not Applicable | Completed | - | Brazil ... 展开 >> Unidade de Pesquisa Clínica do Hospital das Clínicas/UFG Goiânia, Goiás, Brazil, 74605-020 收起 << |
NCT01240915 | Colitis, Ulcerative | Phase 2 | Completed | - | - |
NCT03136380 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 1 | Completed | - | Japan ... 展开 >> GSK Investigational Site Tokyo, Japan, 162-0053 收起 << |
NCT02204371 | Telangiectasia, Hereditary Hem... 展开 >>orrhagic 收起 << | Phase 2 | Terminated(The study was termi... 展开 >>nated as the asset was sold to another company who decided not to pursue this indication with this drug.) 收起 << | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90095 United States, Georgia GSK Investigational Site Augusta, Georgia, United States, 30912-3135 United States, Missouri GSK Investigational Site Saint Louis, Missouri, United States, 63110 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Utah GSK Investigational Site Salt Lake City, Utah, United States, 84132 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M5B 1W8 收起 << |
NCT03291782 | Gout | Phase 1 | Active, not recruiting | October 10, 2018 | United States, Florida ... 展开 >> Covance Daytona Beach Clinical Research Unit Daytona Beach, Florida, United States, 32117 收起 << |
NCT00555906 | Multiple Myeloma | Phase 2 | Completed | - | United States, Illinois ... 展开 >> Northwestern Medical Faculty Foundation Chicago, Illinois, United States, 60611 Northwestern Memorial Hospital/Main Labs Chicago, Illinois, United States, 60611 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 University of Kansas Cancer Center and Medical Pavilion Westwood, Kansas, United States, 66205 United States, Maryland University of Maryland Baltimore, Maryland, United States, 21201 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110-1093 Barnes-Jewish Hospital St. Louis, Missouri, United States, 63110 Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 New York Presbyterian, Weill Cornell Medical College New York, New York, United States, 10065 United States, Pennsylvania University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Hollings Cancer Center Charleston, South Carolina, United States, 29425 Medical University of South Carolina Charleston, South Carolina, United States, 29425 Czech Republic Vseobecna fakultni nemocnice v Praze Praha 2, Czech Republic, 12808 Germany Universitaetsklinikum Heidelberg Heidelberg, Germany, 69120 Klinikum Johannes-Gutenberg -Universitaet, III. Medizinische Klinik und Poliklinik Mainz, Germany, 55131 收起 << |
NCT02204371 | - | Terminated(The study was termi... 展开 >>nated as the asset was sold to another company who decided not to pursue this indication with this drug.) 收起 << | - | - | |
NCT01240915 | - | Completed | - | - | |
NCT02179918 | Advanced Solid Tumors | Phase 1 | Completed | - | United States, California ... 展开 >> Research Administration Office Los Angeles, California, United States, 90095 Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles, California, United States, 90095 UCLA Hematology-Oncology Clinic Los Angeles, California, United States, 90095 UCLA Oncology Center Los Angeles, California, United States, 90095 United States, Connecticut Smilow Cancer Center at Yale-New Haven Hospital New Haven, Connecticut, United States, 06510 Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States, 06510 United States, Texas South Texas Accelerated Research Therapeutics, LLC San Antonio, Texas, United States, 78229 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195 收起 << |
NCT01712061 | Diabetic Nephropathy | Phase 2 | Completed | - | - |
NCT01712061 | - | Completed | - | - | |
NCT02179918 | - | Completed | - | - | |
NCT00555906 | - | Completed | - | - | |
NCT02358109 | Cardiovascular Diseases ... 展开 >> Diabetes Dyslipidemias Metabolic Syndrome Quality of Life 收起 << | Not Applicable | Completed | - | Spain ... 展开 >> Department of Physiology, Faculty of Farmacy, University of Granada Granada, Andalucía, Spain, 18071 收起 << |
NCT02752867 | Cognitive Impairment | Not Applicable | Recruiting | April 2018 | China, Beijing ... 展开 >> Department of Neurology,Dongfang Hospital,Beijing University of Chinese Medicine Recruiting Beijing, Beijing, China, 100078 Contact: Yunling Zhang, PhD,MD 86 10 67689634 收起 << |
NCT03657186 | Overweight We... 展开 >>ight Loss 收起 << | Not Applicable | Recruiting | August 2019 | Germany ... 展开 >> Analyze & Realize Recruiting Berlin, Germany, 10369 Contact: Udo Bongartz, Dr. med. Barbara Grube Recruiting Berlin, Germany, 10709 Contact: Barbara Grube Jörg Förstermann Recruiting Berlin, Germany, 14059 Contact: Jörg Förstermann 收起 << |
NCT02164552 | - | Unknown | December 2014 | Saudi Arabia ... 展开 >> Center of Excellence for Osteoporosis Research, King Abdulaziz University Recruiting Jeddah, Makkah, Saudi Arabia, 21589 Contact: Veronica B Orbacedo, BSc 0096612640000 ext 25574 vorbacedo@yahoo.com Contact: Ramia Al-sobhi, BSc 0096612640000 ext 25528 ceor@kau.edu.sa Sub-Investigator: Ahmed Y Ali, MD Sub-Investigator: Ghazi Y Refai, MD Sub-Investigator: Mohammed H Qari, FRCPA Sub-Investigator: Heba S Kary, MD 收起 << | |
NCT02191462 | Pharmacokinetics | Phase 1 | Completed | - | Canada, Ontario ... 展开 >> KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 收起 << |
NCT00359177 | Vomiting | Phase 1 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Gainesville, Florida, United States, 32608 GSK Investigational Site Orlando, Florida, United States, 32809 收起 << |
NCT01677325 | NAFLD( Non-alcoholic Fatty Liv... 展开 >>er Disease ) 收起 << | Phase 1 | Completed | - | - |
NCT02130557 | Leukemia, Myelogenous, Chronic... 展开 >>, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive 收起 << | Phase 3 | Active, not recruiting | April 4, 2020 | - |
NCT01935804 | Diabetes Mellitus ... 展开 >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders 收起 << | Phase 2 | Completed | - | Saudi Arabia ... 展开 >> Center of Excellence for Osteoporosis Research, King Abdulaziz University Jeddah, Makkah, Saudi Arabia, 21589 收起 << |
NCT00778622 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | China, Beijing ... 展开 >> Local Institution Beijing, Beijing, China, 100028 Local Institution Beijing, Beijing, China, 100034 Local Institution Beijing, Beijing, China, 100044 Local Institution Beijing, Beijing, China, 100088 Local Institution Beijing, Beijing, China, 100730 Local Institution Beijing, Beijing, China, 101100 Local Institution Beijing, Beijing, China, 200016 China, Guangdong Local Institution Guangdong Province, Guangdong, China, 510180 Local Institution Guangdong Province, Guangdong, China, 528000 Local Institution Guangdong, Guangdong, China, 510180 China, Shanghai Local Institution Shanghai, Shanghai, China, 200003 Local Institution Shanghai, Shanghai, China, 200092 Local Institution Shanghai, Shanghai, China, 201100 Local Institution Shanghai, Shanghai, China, 201200 收起 << |
NCT00778622 | - | Completed | - | - | |
NCT01435382 | Hypercholesterolemia ... 展开 >> Dyslipidemias Hyperlipidemias Lipid Metabolism Disorders Metabolic Diseases 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida Elite Research Institute Miami, Florida, United States, 33169 United States, Kansas Vince and Associates Clinical Research Overland Park, Kansas, United States, 66212 United States, Maryland PAREXEL International - Baltimore Early Phase Clinical Unit Baltimore, Maryland, United States, 21225 United States, Michigan Jasper Clinic, Inc. Kalamazoo, Michigan, United States, 49007 United States, Minnesota Prism Research Saint Paul, Minnesota, United States, 55114 United States, Ohio Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45212 收起 << |
NCT03469232 | Intense-exuberant Stomach Fire... 展开 >> Syndrom Acute Pericoronitis Recurrent Aphthous Stomatitis Recurrent Herpes Simplex Labialis 收起 << | Phase 1 Phase 2 | Recruiting | November 1, 2018 | China, Beijing ... 展开 >> Third affiliated hospital of Beijing University of traditional Chinese medicine Recruiting Beijing, Beijing, China, 100029 Contact: Lu Qiang, Professor 8610-52075325 Principal Investigator: Lu Qiang, Professor Dongfang Hospital Affiliated to Beijing University of traditional Chinese medicine Recruiting Beijing, Beijing, China, 100078 Contact: Hong Mu, Professor 010-67618333 Principal Investigator: Hong Mu, Professor China, Sichuan Affiliated Hospital to Chengdu University of traditional Chinese medicine Recruiting Chengdu, Sichuan, China, 610075 Contact: Yuling Zuo, Professor 028-87769902 Principal Investigator: Yuling Zuo, Professor 收起 << |
NCT01712074 | Alzheimer's Disease | Phase 2 | Terminated(The study was termi... 展开 >>nated October 23, 2015 as pre-specified, interim analysis futility criteria were met. The termination was not due to safety concerns.) 收起 << | - | - |
NCT02130557 | - | Active, not recruiting | - | - | |
NCT01473407 | Chronic Kidney Disease ... 展开 >> Chronic Renal Failure 收起 << | Phase 3 | Completed | - | - |
NCT01435382 | - | Completed | - | - | |
NCT01473420 | Chronic Renal Failure ... 展开 >> Chronic Kidney Disease 收起 << | Phase 3 | Completed | - | - |
NCT01473407 | - | Completed | - | - | |
NCT03021291 | Overweight and Obesity | Not Applicable | Completed | - | United States, California ... 展开 >> Arternis Institute for Clinical Research San Diego, California, United States, 92103 Clinical Trial Investigators Tustin, California, United States, 92780 United States, Colorado University of Colorado Aurora, Colorado, United States, 80045 United States, Florida Westside Center for Clinical Research Jacksonville, Florida, United States, 32205 United States, Louisiana Pennington Biomedical Research Baton Rouge, Louisiana, United States, 70808 United States, Massachusetts Boston University Medical Center Boston, Massachusetts, United States, 02118 United States, New York Cornell Weill Medical College New York, New York, United States, 10065 United States, Ohio Radiant Research Cincinnati, Ohio, United States, 45249 Aventiv Research Columbus, Ohio, United States, 43213 United States, Pennsylvania Geisinger Health System Danville, Pennsylvania, United States, 17822 United States, Texas Texas Diabetes and Endocrinology Round Rock, Texas, United States, 78681 Czechia Health & Care SRO Prague, Czechia, 182 00 Denmark University of Cophenhagen Copenhagen, Denmark, DK-1958 Italy IRCCS Policlinico San Donato Milan, Italy, 20097 University of Rome Rome, Italy, 00186 Spain University of Navarra Pamplona, Spain, 31008 收起 << |
NCT00570063 | Schizophrenia | Phase 2 | Terminated | - | United States, California ... 展开 >> California Clinical Trials Medical Group, Inc. Glendale, California, United States, 91206 Glendale Adventist Medical Center Glendale, California, United States, 91206 Telecare-Cresta Loma Lemon Grove, California, United States, 91945 California Clinical Trials Medical Group Paramount, California, United States, 90723 LaPaz Geropsychiatric Center Paramount, California, United States, 90723 California Clinical Trials Medical Group San Diego, California, United States, 92123 United States, Connecticut Connecticut Mental Health Center-Yale University, Clinical Neuroscience Research Unit New Haven, Connecticut, United States, 06519 United States, New Jersey CRI Worldwide, LLC Willingboro, New Jersey, United States, 08046 United States, Oklahoma St. Anthony Hospital Oklahoma City, Oklahoma, United States, 73101 IPS Research Company Oklahoma City, Oklahoma, United States, 73103 收起 << |
NCT01712074 | - | Terminated(The study was termi... 展开 >>nated October 23, 2015 as pre-specified, interim analysis futility criteria were met. The termination was not due to safety concerns.) 收起 << | - | - | |
NCT00886821 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, Florida ... 展开 >> Cetero Research Miami Gardens, Florida, United States, 33169 United States, Texas Cetero Research - San Antonio San Antonio, Texas, United States, 78229 收起 << |
NCT01473420 | - | Completed | - | - | |
NCT00886821 | - | Completed | - | - | |
NCT01994291 | - | Terminated | - | - | |
NCT01312909 | Smoking Cessation | Phase 4 | Completed | - | - |
NCT00531752 | - | Completed | - | - | |
NCT00570063 | - | Terminated | - | - | |
NCT00531752 | Attention Deficit Hyperactivit... 展开 >>y Disorder 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Bay Area Research Institute Lafayette, California, United States, 94549 Pharmacology Research Institute Los Alamitos, California, United States, 90720 Pharmacology Research Institute Newport Beach, California, United States, 92660 United States, Illinois The University of Illinois at Chicago, Institute for Juvenile Research Chicago, Illinois, United States, 60608 United States, Massachusetts Massachusetts General Hospital, ADHD Program Cambridge, Massachusetts, United States, 02138 United States, New York New York University School of Medicine New York, New York, United States, 10010 United States, Virginia NeuroScience, Inc Herndon, Virginia, United States, 20170 收起 << |
NCT01312909 | - | Completed | - | - | |
NCT02408562 | Parkinson's Disease | Phase 1 Phase 2 | Terminated(Issues with develop... 展开 >>ment and supply of infusion system for delivery of IMP. Prolonged approval process for the clinical study sNN0031-004.) 收起 << | - | Germany ... 展开 >> Klinikum-Bremerhaven Bremerhaven, Germany, DE-27574 Sweden Lund University Hospital Lund, Sweden, 22185 Karolinska University Hospital Huddinge Stockholm, Sweden, 141 86 United Kingdom King's College Hospital London, United Kingdom, SE5 9RS John Radcliffe Hospital Oxford, United Kingdom, OX3 9DU 收起 << |
NCT01994291 | Macular Edema, Diabetic | Phase 2 | Terminated | - | - |
NCT02007512 | Breast Cancer | Phase 2 | Active, not recruiting | March 29, 2019 | - |
NCT03008954 | Overweight Ob... 展开 >>esity 收起 << | Not Applicable | Completed | - | Czechia ... 展开 >> Hradec Králové Hradec, Czechia, 500 00 Charles University Prague, Czechia, 121 08 Denmark University of Cophenhagen Copenhagen, Denmark, DK-1958 Italy Federico University Hospital Naples, Italy, 80131 Policlinico Umberto I Rome, Italy, 00161 收起 << |
NCT02650193 | Non-metastatic Breast Cancer | Phase 2 | Completed | - | Hungary ... 展开 >> CRU Hungary Kft.,CRU Early Phase Unit, Miskolci Semmelweis Kórház és Egyetemi Oktató Kórház Miskolc, BAZ Megye, Hungary, 3529 Debreceni Egyetem Klinikai Központ, ÁOK, Onkológiai Klinika Debrecen, Hajdú-bihar Megye, Hungary, 4032 Országos Onkológiai Intézet Budapest, Hungary, 1122 Spain Hospital Universitario Arnau de Vilanova Lleida, Cataluna, Spain, 25198 Hospital Universitario de Fuenlabrada, Servicio de oncologia Fuenlanbrada, Madrid, Spain, 28942 START Madrid - CIOCC, Unidad de fases 1 planta 3, Hospital Universitario HM Sanchinarro Madrid, Spain, 28050 Hospital Arnau de Vilanova. planta 6, unidad de Oncología Valencia, Spain, 46015 收起 << |
NCT02007512 | - | Active, not recruiting | - | - | |
NCT01860196 | Adult Cerebral Palsy | Phase 4 | Completed | - | - |
NCT02034266 | Type 1 Diabetes | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> University Health Network, Division of Neurology, Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 收起 << |
NCT02650193 | - | Completed | - | - | |
NCT02800967 | Hypertension ... 展开 >>Overweight 收起 << | Not Applicable | Unknown | June 2017 | Serbia ... 展开 >> Centre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, University of Belgrade Belgrade, Serbia, 11000 收起 << |
NCT03620760 | Unstable Angina Pectoris ... 展开 >> Coronary Stent Implantation 收起 << | Phase 4 | Recruiting | December 31, 2020 | China, Beijing ... 展开 >> Xiaofan Wu Recruiting Beijing, Beijing, China, 100029 Contact: Xiaofan Wu, Master 收起 << |
NCT02757625 | - | Completed | - | - | |
NCT01628107 | - | Completed | - | - | |
NCT01628107 | Chronic Renal Failure Requirin... 展开 >>g Hemodialysis 收起 << | Phase 3 | Completed | - | - |
NCT01006122 | Excessive Daytime Sleepiness ... 展开 >> Narcolepsy 收起 << | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Pfizer Investigational Site Phoenix, Arizona, United States, 85006 Pfizer Investigational Site Phoenix, Arizona, United States, 85051 Pfizer Investigational Site Tucson, Arizona, United States, 85712 United States, California Pfizer Investigational Site Los Angeles, California, United States, 90048 Pfizer Investigational Site Orange, California, United States, 92868 United States, Florida Pfizer Investigational Site Brandon, Florida, United States, 33511 Pfizer Investigational Site St. Petersburg, Florida, United States, 33707 United States, Georgia Pfizer Investigational Site Atlanta, Georgia, United States, 30342 Pfizer Investigational Site Macon, Georgia, United States, 31201 United States, Illinois Pfizer Investigational Site Vernon Hills, Illinois, United States, 60061 United States, Kentucky Pfizer Investigational Site Crestview Hills, Kentucky, United States, 41017 Pfizer Investigational Site Louisville, Kentucky, United States, 40217 United States, Mississippi Pfizer Investigational Site Hattiesburg, Mississippi, United States, 39401 Pfizer Investigational Site Hattiesburg, Mississippi, United States, 39402 United States, North Carolina Pfizer Investigational Site Durham, North Carolina, United States, 27710 United States, Ohio Pfizer Investigational Site Dublin, Ohio, United States, 43017 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19114 Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19139 United States, South Carolina Pfizer Investigational Site Columbia, South Carolina, United States, 29201 United States, Texas Pfizer Investigational Site Austin, Texas, United States, 78731 Pfizer Investigational Site Houston, Texas, United States, 77063 收起 << |
NCT02757625 | ICU Sedation | Phase 3 | Completed | - | Japan ... 展开 >> Asahikawa Medical University Hospital Asahikawa, Hokkaido, Japan, 078-8510 Hyogo Prefectural Kobe Children's Hospital Kobe, Hyogo, Japan, 650-0047 Shikoku Medical Center for Children and Adults Zentsuji, Kagawa, Japan, 765-8507 Osaka Women's and Children's Hospital Izumi, Osaka, Japan, 594-1101 Osaka Medical College Hospital Takatsuki, Osaka, Japan, 569-8686 Jichi Medical University Hospital Shimotsuke, Tochigi, Japan, 329-0498 Juntendo University Hospital Bunkyo-ku, Tokyo, Japan, 113-8431 Tokyo Metropolitan Children's Medical Center Fuchu, Tokyo, Japan, 183-8561 University Hospital, Kyoto Prefectural University of Medicine Kyoto, Japan, 602-8566 Okayama University Hospital Okayama, Japan, 700-8558 Osaka City General Hospital Osaka, Japan, 534-0021 Shizuoka Children's Hospital Shizuoka, Japan, 420-8660 收起 << |
NCT01628120 | - | Completed | - | - | |
NCT02334943 | Immune Deficiency ... 展开 >> HIV-related Gut Disease - Cause Unknown Activation of Latent Virus Other Diagnoses, Comorbidities, and Complications 收起 << | Not Applicable | Completed | - | France ... 展开 >> University hospital Montpellier Montpellier, France, 34295 收起 << |
NCT00565812 | Osteoarthritis | Phase 2 | Completed | - | - |
NCT02366637 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Terminated(Study terminated on... 展开 >> 7 April 2015 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study) 收起 << | - | United Kingdom ... 展开 >> Medicines Evaluation Unit Ltd Wythenshawe, Manchester, United Kingdom, M23 9QZ Nottingham University Hospital NHS Trust Nottingham, Nottinghamshire, United Kingdom, NG5 1PB University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom, B15 2WB Heart of England NHS Foundation Trust Birmingham, United Kingdom, B9 5SS Respiratory Medicine, Bradford Institute of Health Research Bradford, United Kingdom, BD9 6RJ 收起 << |
NCT01628120 | Chronic Renal Failure Requirin... 展开 >>g Hemodialysis 收起 << | Phase 3 | Completed | - | - |
NCT00755807 | Multiple Sclerosis | Phase 3 | Completed | - | - |
NCT00755807 | - | Completed | - | - | |
NCT01006122 | - | Completed | - | - | |
NCT00425061 | Asthma | Phase 2 | Completed | - | - |
NCT03446209 | Familial Mediterranean Fever | Phase 2 | Recruiting | May 30, 2020 | Germany ... 展开 >> Universitätsklinikum Köln, Klinik I für Innere Medizin Recruiting Cologne, NRW, Germany, 50937 Contact: David Kofler, PD Dr. med. 49 221 478-87925 david.kofler@uk-koeln.de Contact: Stefan Krämer, Dr. med +49 221 478-4004 stefan.kraemer@uk-koeln.de Charité Universitätsmedizin Berlin, Klinik für Rheumatologie und Klinische Immunologie, Abteilung -Neue Therapien & Studien Recruiting Berlin, Germany, 10117 Contact: Eugen Feist, Prof. Dr. med. 49 - 30/ 450 513 025 Eugen.Feist@charite.de Contact: Claudia Kedor, MD 49 - 30/ 450 513 025 Claudia.Kedor@charite.de University Hospital Tuebingen; Department of oncology, hematology, rheumatology, immunology and pulmology Recruiting Tuebingen, Germany, 72076 Contact: Joerg C Henes, MD +4970712982711 joerg.henes@med.uni-tuebingen.de Sub-Investigator: Theodoros Xenitidis, MD 收起 << |
NCT02351908 | HIV | Phase 4 | Completed | - | United Kingdom ... 展开 >> SSAT Clinical Research Facility London, United Kingdom, SW10 9NH 收起 << |
NCT03127852 | Heart Failure ... 展开 >> Chronic Obstructive Pulmonary Disease Chronic Kidney Disease Uncontrolled Hypertension Diabetes 收起 << | Not Applicable | Recruiting | August 23, 2018 | Canada, Ontario ... 展开 >> University Health Network Recruiting Toronto, Ontario, Canada Contact: Emily Seto, PhD 416-669-9295 emily.seto@utoronto.ca 收起 << |
NCT02366637 | - | Terminated(Study terminated on... 展开 >> 7 April 2015 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study) 收起 << | - | - | |
NCT02760238 | - | Recruiting | October 2025 | Canada, Ontario ... 展开 >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 1Z5 Contact: Vikas Gupta, MD 416-946-2885 vikas.gupta@uhn.ca 收起 << | |
NCT01285323 | Eosinophilic Asthma | Phase 3 | Completed | - | - |
NCT02027987 | Traumatic Brain Injury | Phase 1 | Unknown | December 2016 | China, Shaanxi ... 展开 >> Institute of Neurosurgery, Xijing Hospital, Fourth Military Medical University Recruiting Xi'an City, Shaanxi, China, 710032 Contact: Hu S Jie, M.D., Ph.D. 086 029 84773307 hushijie@fmmu.edu.cn Contact: Fei Zhou, M.D., Ph.D. 086 029 13992888996 feizhou@fmmu.edu.cn Principal Investigator: Hu S Jie, M.D., Ph.D. 收起 << |
NCT00425061 | - | Completed | - | - | |
NCT03528005 | Fragility Mul... 展开 >>timorbidity 收起 << | Not Applicable | Recruiting | December 31, 2019 | Taiwan ... 展开 >> Hualien Tzu Chi Hospital,Buddhist Tzu Chi Medical Foundation Recruiting Hualien City, Taiwan, 970 Contact: Sheng-lun Kao, MD 88638561825 ext 9 stevenkao7434@gmail.com Shulin Primary Care center Recruiting New Taipei City, Taiwan, 238 Contact: Chia-Yun Chang, MD 886226812134 Yingge Primary Health Care center Recruiting New Taipei City, Taiwan, 239 Contact: Tzu-Hsing Hung, MD 886226702304 tpc252@ntpc.gov.tw Cheng's primary care clinic Not yet recruiting New Taipei City, Taiwan, 241 Contact: Ting-Ching Tang, MD drmichelletang@gmail.com National Yang-Ming University Hospital Recruiting Yilan, Taiwan, 264 Contact: Chun-feng Huang, MDPhD 88639325192 16083@ymuh.ym.edu.tw Taipei Veterans General Hospital Yuanshan Branch Recruiting Yilan, Taiwan, 264 Contact: Wei-Ju Lee, MDPhD 8869222141 ext 5210 leewju@gmail.com 收起 << |
NCT01285323 | - | Completed | - | - | |
NCT03233568 | - | Completed | - | Italy ... 展开 >> San Donato Hospital San Donato Milanese, MI, Italy, 20097 收起 << | |
NCT01104701 | Type 2 Diabetes | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Research Site Phoenix, Arizona, United States United States, Nebraska Research Site Lincoln, Nebraska, United States 收起 << |
NCT00107718 | Melanoma | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90089 GSK Investigational Site San Francisco, California, United States, 94115 GSK Investigational Site Santa Monica, California, United States, 90404-2104 United States, Connecticut GSK Investigational Site New Haven, Connecticut, United States, 06520 United States, Florida GSK Investigational Site Jacksonville, Florida, United States, 32209 GSK Investigational Site Miami Beach, Florida, United States, 33140 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60637 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46202 United States, Maryland GSK Investigational Site Lutherville-Timonium, Maryland, United States, 21093 United States, New York GSK Investigational Site New York, New York, United States, 10016 United States, Ohio GSK Investigational Site Toledo, Ohio, United States, 43614-5809 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213-2584 Australia, New South Wales GSK Investigational Site Waratah, New South Wales, Australia, 2298 GSK Investigational Site Westmead, New South Wales, Australia, 2145 Australia, Queensland GSK Investigational Site Douglas, Queensland, Australia, 4814 GSK Investigational Site South Brisbane, Queensland, Australia, 4101 GSK Investigational Site Woolloongabba, Queensland, Australia, 4102 Australia, Tasmania GSK Investigational Site Hobart, Tasmania, Australia, 7000 Australia, Victoria GSK Investigational Site East Melbourne, Victoria, Australia, 3002 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 收起 << |
NCT01104701 | - | Completed | - | - | |
NCT03588000 | Diabetes Mellitus, Type 2 | Not Applicable | Active, not recruiting | October 2020 | China ... 展开 >> Community Health Service Center of Malu Town, Jiading District Shanghai, China, 201801 Community Health Service Center of Nanxiang Town, Jiading District Shanghai, China, 201802 Community Health Service Center of Zhenxin, Jiading District Shanghai, China, 201824 Community Health Service Center of Juyuan New District, Jiading District Shanghai, China, 201899 收起 << |
NCT00549744 | Asthma | Phase 2 | Completed | - | New Zealand ... 展开 >> GSK Investigational Site Wellington, New Zealand, 6035 South Africa GSK Investigational Site George, Eastern Cape, South Africa, 6529 GSK Investigational Site Bloemfontein, South Africa, 9301 收起 << |
NCT00565812 | - | Completed | - | - | |
NCT02461992 | Hemophilia A | Phase 1 | Completed | - | China ... 展开 >> Phase I Unit, Clinical Pharmacology Research Center, Peking Union Medical College Hospital Beijing, China, 100032 Hematology Department,Beijing Children's Hospital, Capital Medical University Beijing, China, 100045 收起 << |
NCT02461992 | - | Completed | - | - | |
NCT01641393 | Exocrine Pancreatic Insufficie... 展开 >>ncy: Cystic Fibrosis 收起 << | Phase 3 | Completed | - | - |
NCT03558503 | Bladder Cancer ... 展开 >> Urothelial Carcinoma Urothelial Carcinoma Bladder 收起 << | Phase 2 | Recruiting | September 2020 | United States, Arizona ... 展开 >> Mayo Clinic Not yet recruiting Phoenix, Arizona, United States, 85054 Contact: Mark Tyson, MD Tyson.Mark@mayo.edu Contact: Christina Mihok Mihok.Christina@mayo.edu United States, Arkansas Arkansas Urology Recruiting Little Rock, Arkansas, United States, 72211 Contact: Richard Emanuel D'Anna, MD 501-219-8900 alturodoc@hotmail.com Contact: Katie O'Brien 501.219.8900 ext 2002 katie@arkansasurology.com United States, California Tower Urology Not yet recruiting Los Angeles, California, United States, 90048 Contact: Arnold Cinman, MD 310-854-9898 cinman5676@towerurology.com Contact: Shiblee Nomanee 310854-9898 ext 168 nomanees@towerurology.com UCLA - University of California, Los Angeles Not yet recruiting Los Angeles, California, United States, 90095 Contact: Chamie Karim, MD 310-206-8183 kchamie@mednet.ucla.edu Contact (310)794-5929 Providence Medical Institute Recruiting Santa Monica, California, United States, 90404 Contact: Jennifer Linehan, MD 520-440-5142 Jennifer.Linehan@providence.org Contact: Kelly Garver 310-582-7456 Garverk@JWCI.ORG United States, Iowa University of Iowa Not yet recruiting Iowa City, Iowa, United States, 52242 Contact: Michael O'Donnell, MD 319-356-2421 michael-odonnell@uiowa.edu Contact (319)384-5458 United States, Maryland John Hopkins University Not yet recruiting Baltimore, Maryland, United States, 21218 Contact: Max Kates, MD 410-550-3506 Mkates@jhmi.edu Contact 410-955-6850 United States, Michigan University of Michigan Comprehensive Cancer Center Not yet recruiting Ann Arbor, Michigan, United States, 48109 Contact: Alon Weizer, MD 734-647-8903 aweizer@med.umich.edu United States, Nebraska Adult & Pediatric Urology, PC Recruiting Omaha, Nebraska, United States, 68114 Contact: Trainer Andrew, MD 402-399-7894 atrainer@adultpediatricuro.com Contact: Kim Ganzel 402-397-7894 research@adultpediatricuro.com United States, New York Manhattan Medical Research Recruiting New York, New York, United States, 10016 Contact: Huang William, MD Contact: Carmela Graci-Pipitone 917-409-3919 cgpipitone@manhattanmedicalresearch.com Weill Cornell Medical College Not yet recruiting New York, New York, United States, 10065 Contact: Douglas Scherr, MD 212-746-5788 dss2001@med.cornell.edu Contact: Thomas Flynn 212.746.4739 thf3001@med.cornell.edu Montefiore Medical Center (Albert Einstein) Not yet recruiting New York, New York, United States, 10461 Contact: Alexander Sankin, MD 718-920-4531 asankin@montefiore.org Contact 347-842-1715 Western New York Urology Associates Recruiting New York, New York, United States, 14225 Contact: Kent Chevli, MD kchevli@wnyurology.com Contact: Stephanie Malczewski 716-844-5553 smalczewski@wnyurology.com United States, North Carolina The University of North Carolina Not yet recruiting Chapel Hill, North Carolina, United States, 27572 Contact: Angela Smith, MD 919-966-8217 angela_smith@med.unc.edu Contact 919-537-3505 United States, Oregon Oregon Urology Not yet recruiting Springfield, Oregon, United States, 97477 Contact: Bryan Mehlhaff, MD 541-284-5509 investigator@oregonurology.com Contact: Stephanie Kerns 541-284-5508 stephanie@oregonurology.com United States, Pennsylvania Penn State Hershey State College Not yet recruiting Hershey, Pennsylvania, United States, 17033 Contact: Jay Raman, MD 717-531-8887 jraman@hmc.psu.edu Contact: Kathleen Lehman (717) 531-5930 klehman3@hmc.psu.edu United States, South Carolina Carolina Urologic Research Center Recruiting Myrtle Beach, South Carolina, United States, 29572 Contact: Neil Shore, MD 843-839-1679 Nshore@gsuro.com Contact: Lindsey Rabon 843-839-1679 LRabon@atlanticurologyclinics.com United States, Texas Urology San Antonio Not yet recruiting Fredericksburg, Texas, United States, 78233 Contact: Daniel Saltzstein, MD 210-617-4116 saltzstein@urologysa.com Contact: Kethsaly Salinas 210-617-4116 kethsaly.Salinas@urologysa.com Baylor College of Medicine Not yet recruiting Houston, Texas, United States, 77030 Contact: Seth Lerner, MD 713-798-4001 slerner@bcm.edu; godoy@bcm.edu Contact 713-798-8514 Israel Carmel Medical Center Not yet recruiting Haifa, Israel, 3436212 Contact: Boris Fridman, MD 972-537176389 BORISFR@clalit.org.il Contact: Hilla Cohen 972-544753731 HillaCo@clalit.org.il Rabin Medical Center Not yet recruiting Petah tikva, Israel, 49372 Contact: Yaron Erlich, CM yarone@clalit.org.il Contact: Natali Oginets 972-542003783 nataliog@clalit.org.il Sheba Medical Center Not yet recruiting Ramat Gan, Israel, 52621 Contact: Menahem Laufer, MD Contact: Efrat Ezra 972-545446438 Efrat.Ezra@sheba.health.gov.il 收起 << |
NCT02799264 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 1 | Completed | - | United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 << |
NCT03515291 | Myocardial Fibrosis | Phase 2 | Not yet recruiting | August 2020 | - |
NCT02639975 | Glaucoma | Phase 1 | Completed | - | - |
NCT03610334 | Healthy Volunteers | Phase 1 | Recruiting | July 2019 | France ... 展开 >> Centre d'Investigation Clinique - Centre de Pharmacologie Clinique et d'Evaluations Thérapeutiques (CIC-CPCET) Recruiting Marseille, France, 13385 Contact: Christine Audebert, MD 491384641 ext +33 christine.audebert@ap-hm.fr Contact: Laurence Attolini, PhD 491388003 ext +33 laurence.attolini@ap-hm.fr Principal Investigator: Christine Audebert, MD Sub-Investigator: Marie-Noelle Lefebvre, MD Sub-Investigator: Frank Rouby, MD 收起 << |
NCT02683746 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01233869 | Polycystic Kidney, Autosomal D... 展开 >>ominant 收起 << | Phase 2 | Completed | - | - |
NCT03189225 | Diabetes Mellitus | Not Applicable | Completed | - | United Kingdom ... 展开 >> Diabetes Centre, Heartlands Hospital Birmingham, United Kingdom, B9 5SS NHS Lothian Edinburgh, United Kingdom, EH16 4SA Highland Diabetes Institute Inverness, United Kingdom, IV2 3JH 收起 << |
NCT02683746 | - | Completed | - | - | |
NCT01703624 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 2 | Completed | - | United Kingdom ... 展开 >> Medicines Evaluation Unit Manchester, United Kingdom, M23 9QZ 收起 << |
NCT02287779 | Non-Alcoholic Steatohepatitis | Phase 1 | Completed | - | United States, Tennessee ... 展开 >> New Orleans Center for Clinical Research Knoxsville, Tennessee, United States, 37920 收起 << |
NCT01803776 | Overweight Gl... 展开 >>ucose Metabolism Disorders Lipid Metabolism Disorders Blood Pressure 收起 << | Not Applicable | Active, not recruiting | November 2022 | Finland ... 展开 >> University of Eastern Finland Kuopio, Finland, 70211 收起 << |
NCT00397722 | Social Phobia | Phase 2 | Completed | - | - |
NCT02287779 | - | Completed | - | - | |
NCT01233869 | - | Completed | - | - | |
NCT02969044 | - | Completed | - | - | |
NCT02613910 | Pemphigus | Phase 3 | Terminated(Novartis has acquir... 展开 >>ed the rights to ofatumumab and terminated the OPV116910 and OPV117059 studies. This decision is not linked to any safety consideration.) 收起 << | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90045 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48103 收起 << |
NCT03121911 | Expiratory Flow Limitation ... 展开 >> Recent Myocardial Infarction 收起 << | Not Applicable | Not yet recruiting | October 31, 2020 | - |
NCT02969044 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT00269087 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> GSK Investigational Site Kodaira, Japan, 187-0002 GSK Investigational Site Kyoto, Japan, 612-0026 GSK Investigational Site Osaka, Japan, 596-8501 GSK Investigational Site Tokyo, Japan, 164-0012 收起 << |
NCT02876952 | Myocardial Infarction | Not Applicable | Recruiting | June 2018 | Spain ... 展开 >> Department of Physical Education and Sport. Faculty of Education and Sport-Physical Activity and Sport Section. University of the Basque Country Recruiting Vitoria-gasteiz, Araba/álava, Spain, 01007 Contact: SARA MALDONADO-MARTIN, PhD sara.maldonado@ehu.eus Sub-Investigator: Juan Jose GOIRIENA, PhD 收起 << |
NCT02613910 | - | Terminated(Novartis has acquir... 展开 >>ed the rights to ofatumumab and terminated the OPV116910 and OPV117059 studies. This decision is not linked to any safety consideration.) 收起 << | - | - | |
NCT02197910 | Pre-hypertension | Not Applicable | Unknown | March 2016 | Italy ... 展开 >> S. Orsola-Malpighi University Hospital Recruiting Bologna, BO, Italy, 40138 Contact: Arrigo FG Cicero, MD, PhD ++39516362224 arrigo.cicero@unibo.it Sub-Investigator: Arrigo FG Cicero, MD, PhD Principal Investigator: Claudio Borghi, MD, PhD Sub-Investigator: Maddalena Veronesi, MD Sub-Investigator: Sergio D'Addato, MD, PhD 收起 << |
NCT01809587 | Constipation ... 展开 >>Irregular Bowel Movement Frequency 收起 << | Phase 3 | Completed | - | Germany ... 展开 >> Analyze & Realize Ag Berlin, Germany, 10369 收起 << |
NCT01213394 | Kidney Transplantation ... 展开 >> Cardiovascular Diseases 收起 << | Phase 3 | Terminated(Poor recruitment.) | - | Canada, Ontario ... 展开 >> St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 收起 << |
NCT02533648 | Type 2 Diabetes Mellitus | Phase 3 | Unknown | May 2016 | France ... 展开 >> CRNH Rhône Alpes Recruiting Lyon, France, 69310 Contact: Martine LAVILLE, Professor +33. 4 78 86 29 81 martine.laville@chu-lyon.fr Contact: Nathalie FEUGIER +33. 4 78 86 19 72 nathalie.feugier@chu-lyon.fr Principal Investigator: Martine LAVILLE, professor 收起 << |
NCT01644396 | Moderate to Severe Plaque Psor... 展开 >>iasis 收起 << | Phase 4 | Completed | - | Russian Federation ... 展开 >> Site Reference ID/Investigator# 67547 Ekaterinburg, Russian Federation, 620076 Site Reference ID/Investigator# 78433 Kazan, Russian Federation, 420012 Site Reference ID/Investigator# 67542 Moscow, Russian Federation, 107076 Site Reference ID/Investigator# 67546 Saratov, Russian Federation, 410028 Site Reference ID/Investigator# 78417 Smolensk, Russian Federation, 214018 Site Reference ID/Investigator# 78413 St. Petersburg, Russian Federation, 190013 Site Reference ID/Investigator# 67545 St. Petersburg, Russian Federation, 194044 收起 << |
NCT01644396 | - | Completed | - | - | |
NCT03525678 | Multiple Myeloma | Phase 2 | Recruiting | June 30, 2020 | - |
NCT02548767 | Chronic Disease of Cardiovascu... 展开 >>lar System Type 2 Diabetes Obesity 收起 << | Not Applicable | Recruiting | June 2020 | United States, California ... 展开 >> University of California, Davis Recruiting Davis, California, United States, 95616 Clinical Research Center Recruiting Sacramento, California, United States, 95655 Contact 916-843-9441 Touro University California Translational Research Clinic and Student Health Clinic Active, not recruiting Vallejo, California, United States, 94592 收起 << |
NCT02729051 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT02660736 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, Texas ... 展开 >> GSK Investigational Site Austin, Texas, United States, 78744 收起 << |
NCT03008785 | Bloodpressure | Not Applicable | Completed | - | Brazil ... 展开 >> Guilherme Morais Puga Uberlandia, Minas Gerais, Brazil, 38400-678 收起 << |
尊敬的 Ambeed 客户您好,
请您选择所在区域,我们将转接对应客服为您服务!